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A B STR A C T
T he highly contaminated St. Lawrence Estuary beluga whale (SLB) population
exhibits health problems and various pathologies possibly associated with pollutant
exposure, which are not found in less exposed Canadian Arctic belugas (CAB).
Biotransformation mediates contaminant fate and effects through conversion to less
persistent,

more excretable products (detoxification)

and through formation of

retained/persistent, secondary contaminants (bioactivation). In this thesis, the metabolic
potential o f these two differentially exposed beluga populations towards PCBs and
PBDEs was investigated. Qualitatively similar hepatic xenobiotic-metabolizing enzyme
profiles (cytochromes P4501A, 2B, 3A, 2E, epoxide hydrolase and UDP-glucuronosyl
transferase) were immunochemically detected between SLB and CAB, indicating that
CAB can be used to model contaminant biotransformation in the endangered SLB. Viable
SLB and CAB microsomes exhibited catalytic activities characteristic o f CYP1A
(ethoxyresorufin-Q-deethylase, 51 to 260 pmol/mg/min), CYP3A (6p~testosterone
hydroxylase, 113 to 899 pmol/mg/min) and UDPGT (1 -naphthylglucuronidase, 830 to
4956 pmol/mg/min), but not o f CYP2B. Residue analysis revealed retained PCB and
PBDE metabolites in SLB and CAB livers. Sum-

(X-) hydroxy-

(HO-) PCB and

Z-

methylsulfonyl- (MeSCh-) PCB concentrations were significantly greater in SLB (65 ± 22
and 3801 ± 1322 ng/g lipid) than in CAB (3.1 ± 0.5 and 77 ± 23 ng/g lipid). HO-PBDE
congeners were detectable, but below the MLOQ in both populations. Different congener
profiles and significantly higher Z-PBDE (2210 ± 656 cf. 53 ± 16 ng/g lipid) and Z-PCB
(31 937 ± 6498 cf. 1939 ± 436 ng/g lipid) were also found in SLB versus CAB,
respectively.

A

model

CAB

individual

demonstrated

CYP-mediated
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oxidative

metabolism o f ortho-meta unsubstituted BDE 15, BDE28 and BDE47 in vitro. PCBs
that are putative CYP1A substrates (CB15, CB77) were more rapidly metabolized in
vitro than C Y P1A/CYP2B-type (CB26, CB31), which were depleted faster than CYP2Btype (CB52). Water-soluble metabolites o f CB15 and BDE 15 were detected. Weight o f
evidence (enzyme characterization, liver analysis, in vitro metabolism) indicated an
oxidative biotransformation pathway for PCBs and PBDEs in belugas. These results
suggest

contaminant bioactivation through

formation o f retained/persistent

and

potentially toxic PCB (and possibly PBDE) metabolites. Evidence o f possible
bioactivation mechanisms via biotransformation supports the association between
contaminant exposure and health problems in the endangered SLB population.
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LIST O F ABBREVIATIONS
Ab
AHH
AhR

antibody
aryl hydrocarbon hydroxylase
aryl hydrocarbon receptor

BDE#

bromodiphenyl ether, numbered according to Ballschmiter and Zell
(1980)* rales for polychlorinated biphenyls

BFR

brominated flame retardant

BROD

benzyloxyresorufin O-deethylase

CAB

Canadian Arctic beluga whale

CB#

chlorobiphenyl, numbered according to Ballschmiter and Zell
(1980)*

CHL

chlordane

CYP

cytochrome P450 isozyme

DDD

6 /5,-2 ,2 -(4

-chlorophenyl)-1,1 -dichloroethane

DDE

6is-2,2-(4-chlorophenyl)-1,1 -dichloroethene

DDT

bis-2,2-(4-chlorophenyl)-1,1,1 -trichloroethane

EH

epoxide hydrolase

EROD

ethoxyresorufin O-deethylase

GC-ECD

gas chromatography-electron capture detection

GC-MS(ECNI)

gas chromatography-mass spectrometry (electron capture negative
ionization mode)

GST

glutathione ^-transferase

HCB

hexachlorobenzene

HCH

hexachlorocyclohexane

4-HO-HpCS

4-hydroxy-heptachlorostyrene

HO-PBDE

hydroxy-polybrominated diphenyl ether

HO-PCB

hydroxy-polychlorinated biphenyl

HPC

halogenated phenolic contaminant

HPLC

high-performance liquid chromatography

IS

internal standard

MeO-PBDE

methoxy-polybrominated diphenyl ether

MeO-PCB

methoxy-polychlorinated biphenyl

MeSG 2 -PCB

methyl sulfonyl polychlorinated biphenyl

MFO

mixed function oxidase

MLOQ

method limit o f quantification

MROD

methoxyresorufin O-deethylase

OC

organochlorine

OCS

octachlorostyrene
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xviii

PBDE

polybrominated diphenyl ether

PBT

persistent bioaccumulative toxin

PCB
PROD

polychlorinated biphenyl
pentoxyresorufin O-deethylase

SIM

selected ion monitoring

SLB

St. Lawrence beluga whale

ti /2

halflife

T4

thyroxine

TIC

total ion current

TTR

transthyretin

UDPGT

uridine diphosphoglucuronosyl transferase

* Ballschmiter, K., Zell, M., 1980. Analysis o f polychlorinated biphenyls (PCB) by glass
capillary gas chromatography. Fresenius J. Anal. Chem. 302, 20-31.
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CHAPTER 1
General Introduction

Contamination o f the environment and its inhabitants by anthropogenic organic
chemicals has been occurring since the early twentieth century, but especially in the mid
twentieth century when chemical manufacturers began large scale production o f a whole
range o f chemicals useful to industry and society. For instance, fe-2,2-(4-chlorophenyl)1,1,1 -trichloroethane

(DDT)

was

discovered

as

an

insecticide

in

1939

and

polychlorinated biphenyls (PCBs) began their commercial use mainly as electrical
insulators in 1929. Intentional distribution and accidental release to the environment lead
to the subsequent presence o f these chemicals, now referred to as persistent organic
pollutants or persistent bioaccumulative toxins (PBTs), in humans and in wildlife
(Lipnick and Muir, 2001). Years after the imposition o f severe restrictions limiting the
production and/or release o f many o f these “traditional” PBTs, they continue to be found
in the environment and in biota, and research continues to provide new and varied
evidence o f their toxicological effects (e.g. Goldey et al, 1995; Kelce et ah, 1995; Kester
et al.,

2 0 0 0 ).

The currently unrestricted release o f polybrominated diphenyl ether (PBDE)
flame retardants, close structural analogues o f PCBs, has lead to their widespread
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environmental distribution (Damerud et al, 2001). PBDE levels are exponentially
increasing in humans and in wildlife, particularly in North America (Hites, 2004),
indicating a major new environmental contamination problem (de Boer et al., 1998).

1.1 PCBs
There are theoretically 209 different PCB isomers and congeners, consisting o f 1
to 10 chlorine substituents around a biphenyl ring system (Fig. 1.1). PCBs were produced
in North America solely by the Monsanto Company, with all but perhaps 10% o f the
possible congeners present in commercial mixtures (de Voogt and Brinkman, 1989). The
first report o f PCBs in biota, specifically in fish and birds, was published nearly forty
years after PCBs were first used commercially (Jensen, 1966). In 1969, Jensen et al.
reported PCBs in marine mammals as well, while studying grey seals (Halichoerus
grypus) and ringed seals (Phoca hispida) from the Baltic Sea. These and many
subsequent studies evidenced the persistent, bioaccumulative and toxic properties of
PCBs, which lead to their ban in both Canada and the USA by 1977.

1.1.1 Persistence and distribution
In addition to numerous accidental spills and contaminations (e.g. Higuchi, 1976),
PCBs have been and continue today to be released into the North American environment
mainly through, for instance, leakage from currently used products and also from landfills
(Tanabe, 1988). After entering the environment, PCBs may undergo cyclic volatilization
to the atmosphere followed by deposition to terrestrial and aqueous media, resulting in
their long-range transport (Ballschmiter, 1991). Although an excellent property for their
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intended usage, the relative inertness o f PCBs in various environmental media
(Ballschmiter, 1991) and in biological systems (Tanabe et al., 1988) results in their slow
degradation. For these reasons, PCBs and other organochlorine contaminants are globally
distributed in the environment, from the Arctic (Addison and Smith, 1974; Norstrom and
Muir, 1988, Muir et al., 1992) to the Antarctic (Sladen et al., 1966; Subramanian et al.,
1983, 1986) and all latitudes in between (Holden and Marsden, 1967; Gaskin et al., 1971,
1974; Tarasuki et al., 1975).

PCBs are also ubiquitous in the marine mammal

populations o f the world (Tanabe, 1983).
Suggesting future continued contamination o f marine environments, it was
predicted in 1988 that only around 30% o f the total PCBs produced (estimated at about
106 tonnes globally by de Voogt and Brinkman (1989)) had thus far made it to the
environment (Tanabe, 1988), and that only 3% o f this had yet made it to the oceans
(Marquenie and Reijnders, 1989). In addition, there are indications that cold regions at
latitudinal extremes act as ultimate sinks for organic contaminants (Wania and MacKay,
1993), implicating the particular vulnerability o f the Arctic and species therein to
anthropogenic organic contamination. As evidence, over the last few decades PCB
concentrations have tended to be steady or decreasing in cetacean and pinniped species
inhabiting regions o f mid-latitude (Baltic Sea, North Sea, northwest Atlantic Oceans), but
steady or increasing in those populations o f species inhabiting polar regions (west Arctic
Ocean, Antarctic Ocean) (Aguilar et al., 2002).
Nonetheless, marine mammals from temperate latitudes that are closer to PCB
sources, such as Baltic seals and St. Lawrence beluga whales, currently still exhibit
elevated lipid-corrected levels o f PCBs than their conspecifics from more remote regions

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

(Muir et al., 1996; Metcalfe et al., 1999; Nyman et al., 2001, 2003). For instance, in the
late 1980s concentrations of PCBs and DDT-related compounds were reported to be 15to 30-fold higher in SLB adipose tissue than in adipose o f their Arctic counterparts in
Cumberland Sound, western Greenland, Beaufort Sea and Hudson Bay (Muir et al.,
1996). In brain, liver and muscle tissues o f SLB, PCB concentrations were found to be
13, 11 and 11 times higher, respectively, than in beluga whales from Hendrickson Island
in the Canadian Arctic (CAB) (Metcalfe et al., 1999). The PCB and DDT levels in SLB
adipose tissues are both more than 15 fold higher than those found in beluga whales from
Svalbard, Norway (Andersen et al., 2001).

1.1.2 Bioaccumulation and biomagnification
PCBs meet the three requirements for bioaccumulation. They are bioavailable,
slowly metabolized and slowly excreted (Sijm, 2001). Upon deposition in marine and
other aqueous environments, PCBs readily bioconcentrate in organisms at low trophic
levels directly from water due to their hydrophobic nature (Thomann, 1989). As PCB
levels are then higher in biological systems than in the surrounding media, food chain
transfer, along with absorption and storage, o f these and other OCs has resulted in their
elevated levels in top predators (biomagnification) (Norstrom and Muir, 1994). In
addition, the tendency to partition into fatty tissues decreases PCB mobility in an
organism and further increases biological persistence (Jones and de Voogt, 1999).
The large lipid stores (blubber) in, and longevity of, marine mammals confers a
predisposition o f these species to accumulate organic contaminants (Colbom and Smolen,
1996). Indeed cetaceans, particularly piscivorous species, have elevated levels o f PCBs in
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comparison to other exposed organisms, such as birds, humans, and other terrestrial
mammals (Tanabe et al., 1988). In an Arctic marine food chain, X-PCB showed a
biomagnification factor o f 1.5 from zooplankton (Calanus spp.) to cod [Boreogadus
saida) and 24.4 from fish to beluga whale (Hoekstra et al., 2003). Metabolism is
nonetheless a major factor mediating the bioaccumulation and toxicity o f such
contaminants (Sijm, 2001), as is discussed in detail later in this introduction. Moreover,
the apparently lower metabolic capacity o f beluga whales and other cetaceans has been
suggested as a reason for greater PCB biomagnification in these species in comparison to
other marine and terrestrial mammals (Tanabe, 1988; Norstrom and Muir, 1994).

1.1.3 Toxic effects
In PCB-exposed laboratory animals, thyroidogenic, estrogenic and androgenic
effects have been reported, as well as related neurobehavioural, reproductive and
developmental toxicities (Ulbrich and Stahlmann, 2004). Deleterious health effects have
been reported in wildlife, generally in high trophic level organisms that have been
chronically exposed to PCBs and other OCs over their lifetimes. Although definitive
cause-effect linkages cannot be drawn, there have been some major health and survival
issues documented in marine mammal populations since the 1960s, which many suggest
may be related to pollutant exposures (Tanabe, 2002). The main putative toxic effects
have been immunological dysfunction and resulting infectious diseases, reproductive
im pairm en t,

as well as mass strandings and/or mortalities.

Many recent outbreaks o f infectious viral diseases in various marine mammal
populations have resulted in thousands o f deaths (De Guise et al., 2003). Because these
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populations have been highly contaminated, and chronic exposure o f PCBs to laboratory
animals has lead to greater susceptibility to viral outbreak, Eis (1989) suggested that
organochlorine exposures may be a factor in these mass mortalities. Immunotoxicity o f
PCBs has been demonstrated in many experimental organisms, but there is a dearth o f
such studies in marine mammals (De Guise et al., 2003). A study was done on pinnipeds,
wherein harbour seals (Phoca vitulina) that were fed environmentally contaminated
Baltic herring, versus less contaminated herring, exhibited various impairments in
immune functioning (de Swart et al., 1994). Lahvis et al. (1995) found a negative
correlation between blood levels o f OCs and lymphocyte proliferation in free-ranging
bottlenose dolphins (Tursiops truncatus). PCB mixtures, at levels found in St. Lawrence
beluga whales, caused reduced leukocyte cell proliferation in beluga studies in vitro, also
supporting the role o f OC-mediated immunological dysfunction in cetaceans (De Guise et
al., 1998).
Similar to studies of immunotoxicity, many reproductive and developmental
disorders have been documented in marine mammals, but few have been linked to
contaminant exposures. Olsson et al. (1994) suggested that high rates o f sterility in
female Baltic grey and ringed seals (30 and 70%, respectively) were associated with PCB
and DDT metabolites. OC exposure has also been suggested to be related to testes
abnormalities in minke whales (Balaenoptera acutorostrata) (Fujise et al., 1988) and
premature births in Californian sea lions (DeLong et al., 1973). Reijnders (1986) found
that seals fed PCB contaminated fish exhibited reproductive failure.
These immunological and reproductive pathologies may be related to the
endocrine disrupting and metabolic activating potential o f PCBs. The immune system is
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regulated, in part, by estrogens and androgens (Grossman, 1985), which are better known
as reproductive hormones. Thyroid hormones, part of the endocrine system, influence
immune

function

as well as cellular differentiation,

growth, metabolism

and

reproduction. Harbour seals fed PCB contaminated fish, showed depleted thyroid
hormone and vitamin A levels (Brouwer et al., 1989). Negative correlations between
PCB levels and various steroid hormone levels have been found in harbour seals
(Reijnders, 1999) and Dali’s porpoises (Phocoenoides dalli) (Subramanian et al., 1987).
Interactions o f some PCBs with metabolic enzyme systems have been reported in
some marine mammals. In beluga whales from the MacKenzie River Delta in the
Canadian Arctic, there was a strong correlation between immunodetectable cytochrome
P450 (CYP) 1A and adipose levels o f ort/zo-substituted coplanar PCB congeners (White
et al., 1994), suggesting induction o f the CYP1A enzyme by these PCBs. Higher
CYP 1A-mediated ethoxyresorufin O-deethylase (EROD) activity was measured in
contaminated Baltic seals than that measured in seals from reference sites (Nyman et al.,
2003). EROD and PROD (pentoxyresorufin O-deethylase) activities were correlated to
PCB tissue residue levels in northern fur seals near Japan (Tanabe et ah, 1994). It is
important to consider that the role o f metabolism and PCB metabolites is unclear in many
of the correlative studies o f PCB toxicity in wildlife. However, some o f the toxic effects
that have been associated with PCBs have been documented in experimental animals
dosed with persistent hydroxylated- (HO-) PCB and methylsulfonyl- (MeSOa-) PCB
metabolites (Fig. 1.1, discussed later).
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1.2 PBDEs
Polybrominated diphenyl ethers are structurally similar to PCBs, except that an
ether linkage separates the two biphenyl rings and chlorine atoms are replaced by
bromine atoms (Fig. 1.1). PBDEs are the most commonly used brominated flame
retardant (BFR) additives to polymeric materials, such as textiles and electronics
equipment. When heated, bromine atoms released from the compounds react reductively
to slow the progression o f fires. Unlike PCBs, only a handful o f congeners are present in
the technical formulations, commercially distributed as the Penta- (a mixture of mainly
2.2 ’,4,4 ’-tetra-BDE (BDE47) and 2,2 ’,4,4 ’,5-penta-BDE (BDE99) and minor amounts o f
2,4,4’-tri-BDE (BDE28), 2,2’,4,4’,6-penta-BDE (BDE100), 2,2’,4,4’,5,5’-hexa-BDE
(BDE153) and 2,2’,4,4’,5,6’-hexa-BDE (BDE154)), Octa- (mainly 2,2’,3,4,4’,5’,6-heptaBDE (BDE183) and BDE153) and Deca- (mainly the fully brominated deca-BDE
(BDE209)) mixtures. These BFRs are manufactured in North America primarily by the
Great Lakes Chemical Corporation (Indianapolis, IN) and also by Albemarle Corporation
(Richmond, VA).
Environmental contamination was first discovered when Anderson and Blomkvist
(1981) found PBDEs in fish from Sweden. Similar persistent, bioaccumulative and toxic
properties to PCBs have lead to a ban on the Penta- and Octa-mixtures in the EU and a
voluntary stop-production on the Penta- and Octa- formulations by Great Lakes Chemical
by the end o f 2004. However, there are currently no restrictions on usage/release/disposal
o f PBDEs in most o f the United States or in Canada. As well, there is no ban on the labile
deca-BDE, which may be converted to persistent, bioaccumulative lower brominated
congeners (see below).
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1.2.1 Persistence and distribution
PBDEs are released into the environment from manufacturing facilities, landfills
and leaching from products in use (Damerud et al., 2001). From air to waters and
sediments to wildlife, PBDEs have been found in virtually all abiotic and biotic media
sampled in various regions o f the world (de Boer et al., 2000). In fact, PBDEs have been
detected in deep-sea dwelling sperm whales, implying that PBDE contamination has
made it to the deep waters o f the oceans (de Boer et al., 1998). These data and long-range
transport models (Wania and Dugani, 2003) imply that PBDEs are now ubiquitously
distributed throughout the world, akin to PCBs.
Also like PCBs and other PBTs, PBDEs are generally found at higher
concentrations in marine mammals inhabiting temperate locales, which are highly
industrialized and populated with humans, than in Arctic animals (Lebeuf et al., 2004). In
the most recent year with data from both regions, 1997, St. Lawrence beluga whales had
more than 20 fold higher adipose X-PBDE levels (lipid weight basis) than belugas from
the eastern Canadian Arctic (Cumberland Sound) (Law et al., 2003). Unlike the
traditional PBTs, however, PBDE levels have been increasing exponentially in most
humans and wildlife sampled over the past 30 years (Hites, 2004). In fact, the time it
takes for PBDE concentrations to double in mid-latitude marine mammals is just around
5 years. For Arctic marine mammals, the doubling time is slightly but not significantly
higher at around 7 years (Hites, 2004).
PBDEs persist in the environment (de Boer et al., 2000). de Boer et al. (1998)
suggested that PBDEs are even more biologically persistent than PCBs based on slow
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metabolism o f BDE47, 99 and 209 in an in vitro assay with one fish and four marine
mammal species. However, the higher lability o f carbon-bromine bonds versus carbonchlorine bonds may result in greater importance o f environmental and/or metabolic
reductive dehalogenation pathways for the degradation o f PBDEs (WHO, 1994). This is
particularly likely for highly brominated congeners which have been shown to degrade
rapidly under UV light in various media (Eriksson et al., 2004). For BDE209, the halflife
(ti/2) was ju st 30 min in 80:20 methanokwater. In Sweden, where there has been a trend
towards alternative flame retardants, there is some evidence from human milk data that
PBDE concentrations may already be starting to decrease (Meironyte-Guvenius et al.,
2001; Lind et al., 2003). PBDE levels in North America, in contrast, are rapidly
increasing (Hites, 2004; Ryan, 2004). Regardless, continued escape from already
manufactured products and the abiotic and biotic stability o f some congeners alludes to
the potential for long-term environmental issues with PBDE contamination.

1.2.2 Bioaccumulation and biomagnification
Akin to PCBs, the hydrophobic PBDEs tend to concentrate on particulate matter
and in biota (de Boer et al., 2000). This bioaccumulation appears to be structure-specific.
The dominant congener in biota is almost always BDE47, with BDEs 99 and 100 also
representing a major portion o f the X-PBDE concentrations. This pattern does not mimic
that o f the commercial PentaBDE formulation or o f that found in sediments (Fig. 1.2).
Elevated biological levels o f BDE47 may be related to more rapid uptake or to
biotransformation o f higher brominated congeners (e.g. BDE99) (Stapleton et al., 2004a).
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Fig. 1.2. PBDE congener patterns in North America and Europe expressed as a
percentage o f X-PBDE for the Penta product (black bars), sediment (grey bars) and nonArctic marine mammals (seal, porpoise and whale species) (white bars). The error bars
represent ± S.E. Modified from Hale et al. (2001) and Hites (2004).
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Given that DecaBDE is produced in the largest quantities globally (Hites, 2004), lower
bioavailability and possible metabolic conversions, as seen in rat (Morck et al., 2003),
may explain the low levels o f BDE209 in biota. Gustaffson et al. (1999) found that BDEs
47 and 99 were bioaccumulated in blue mussels to a much greater extent than PCBs o f
similar hydrophobicity, indicating the comparable or higher bioaccumulation potential for
PBDEs versus PCBs.
Wolkers et al. (2004) showed that BDEs 47, 99 and 100 biomagnify from cod to
beluga whale in an Arctic (Svalbard) foodchain. BDE154, though, did not appear to be at
higher levels in beluga in comparison to cod, suggesting some metabolism o f this
congener in beluga whale. Marine mammals from temperate latitudes (seals, porpoises
and whales from North America and the UK) generally exhibit elevated PBDE levels in
comparison to humans (Hites, 2004) and other terrestrial mammals (Damerud et al.,
2001). These data suggest that as for PCBs and other OCs, relative to other biota, marine
mammals species may be most susceptible to PBDE contamination and biological effects.
Although metabolic potential may be a major factor in the vulnerability o f marine
mammals towards PCB accumulation, there is hardly sufficient data on the metabolic and
excretory capacity of any marine mammals towards PBDEs (Hakk and Letcher, 2003).

1.2.3 Toxic effects
The apparent similitude between PBDEs and the more thoroughly studied and
better understood PCBs (i.e. chemical structure, lipophilicity, stability) suggests that
these two classes of pollutants may share mechanisms o f toxic action and/or effects.
Indeed, PBDEs do exhibit some o f the previously mentioned toxicities of PCBs, at least
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in laboratory organisms. Commercial PBDE and PCB mixtures (Bromkal 70-5DE and
Aroclor 1254, respectively,) have shown immunotoxic effects, such as reduced
splenocyte numbers, in mice (Damerud and Thuvander, 1999). In rats, however, effects
were only seen with the PCB formulation. Meerts et al. (2001) demonstrated that a
number o f PBDE congeners act as xenoestrogens in an in vitro human cellular assay
(>10 6 fold less agonistic than 17(3-estradiol, the natural ligand), but that some HO-PBDE
congeners demonstrated even greater estrogenic potency than 17(3-estradiol. In both rats
and mice, in vivo PBDE exposure resulted in decreased thyroid hormone levels (Fowles
et al., 1994; Damerud and Sinjari, 1996). In another human cell-based assay, PBDEs did
not compete with the thyroid hormone thyroxine (T4 ) for the transport protein
transthyretin (TTR). However, certain HO-PBDE congeners were potent competitors
(Meerts et al., 2000). HO-PBDE congeners that are structurally similar to T 4 (i.e. one
phenyl ring, a HO-group para to the ether linkage, and bromine atoms on carbons
adjacent to the para-carbon with the HO-group) exhibit greater thyroidogenic activity
than HO-PCBs. In addition, PBDEs appear to be developmental neurotoxicants in
laboratory rodents (Erikkson et al., 2002; Viberg et al., 2003).
There are varied reports o f the enzyme inducing ability o f PBDEs towards CYP
and phase II activities. Induction o f EROD, MROD (methoxyresorufin O-deethylase),
especially PROD, and phase II UDPGT was seen in laboratory rats orally dosed with
BDE47 (Hallgren and Damerud, 1998). Chen et al. (2001) also found EROD induction
by a few environmentally unimportant PBDE congeners in rat, chick, rainbow trout and
human hepatocytes, but not by BDE47 or BDE99. Also, Zhou et al. (2002) showed
EROD, PROD and UPDGT induction in rats treated with DE-71 and their offspring.
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However, environmentally relevant congeners (BDEs 47, 99, 100, 153, 154, and/or 183)
have not elicited EROD induction in fish (Boon et a l, 2002) or human cell lines (Peters
et al., 2003).
Despite this data from experimental animals, virtually no data exists on PBDE
toxicokinetics or potential biological effects in marine mammals. There is but a single
report o f PBDE toxicity in a pinniped species. Hall et al. (2003) found a significant
positive relationship between adipose PBDE levels in grey seal pups and thyroid
hormone concentrations, unlike the negative relationship seen in laboratory rodents. The
authors suggest that this may be due to hormesis (Calabrese and Baldwin, 2003), wherein
the homeostatic imbalance is overcompensated for by elevated production o f thyroid
hormones at low PBDE levels. Clearly, the mechanism(s) o f action and toxic effects o f
PBDEs in marine mammals require further study.

1.3 Biotransformation
The biological fate o f a contaminant depends on uptake, distribution, metabolism,
and excretion. Biotransformation influences the residence time o f a contaminant in an
organism through catalytic formation o f more hydrophilic and thus more readily
excretable metabolites. This process should primarily result in the detoxification o f PBTs.
However, metabolism may be a bioactivation process leading to the formation o f retained
metabolites that are toxicologically active. Thus, not only the toxicokinetics, but also the
inherent toxicity o f a compound depends on metabolic capacity.
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I.3.1 Phase 1 and I I reactions
Biotransformation reactions are categorized into phase I and phase II processes.
Foreign compounds that are able to enter cells and bind to proteins are generally small,
neutral and lipophilic (Stine and Brown, 1996). Therefore in phase I, xenobiotics are
oxidized, hydrolyzed or reduced to less hydrophobic, more reactive metabolites. In phase
II, these metabolites are conjugated to larger, hydrophilic endogenous molecules or ions,
which are then readily excreted from an organism.
The phase I cytochromes P450 (CYP) are a superfamily o f heme-based enzymes
found in mammals, fish, birds and microorganisms. In mammals, the highest CYP
activity is in the smooth endoplasmic reticulum o f the liver. Most foreign compounds,
including environmental pollutants, drugs and antibiotics, as well as endogenous
compounds, such as steroids, bile acids, fatty acids and prostaglandins are biotransformed
by CYP enzymes (Goksoyr and Forlin, 1992; Stegeman and Hahn, 1994; Lewis et al.,
1998, 2002). CYP1A, CYP2B, CYP3A, CYP2E and epoxide hydrolase (EH) are major
enzymes mediating the phase I metabolism o f anthropogenic compounds (Nebert et al.,
1991). The main phase II enzyme systems are the glutathione-S-transferases (GSTs),
uridine diphosphoglucuronosyl transferases (UDPGTs) and sulfo-transferases (SULTs)
(George, 1994; Wolkers et al., 1998). GSTs mediate the conjugation o f glutathione to
arene epoxide bearing phase I intermediates. UDPGTs and/or SULTs mediate the
conjugation o f glucuronic acid and 3'-phosphoadenosine-5'-phosphosulfate (PAPS),
respectively, to the HO-group o f phenols, for instance. Although these processes were
previously thought o f as detoxifying, it is now known that for many organic
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contaminants, intoxication may be the result o f biotransformation (e.g. polycyclic
aromatic hydrocarbons, PAHs) (Stine and Brown, 1996).
The induced and constitutive levels o f individual CYP and phase II enzymes are
species- and population-specific (Boobis et al., 1990; Smith, 1991). For marine
mammals, particularly cetaceans, there are limited reports o f immunochemical or
catalytic characterizations o f metabolic potential. For instance, enzymes cross-reactive
with CYP1A, CYP2B and CYP2E antibodies have been determined in beluga whales
(White et al., 1994, 2000; Wilson et al., 2000). CYP 1A-mediated 7-ethoxyresorufin (Odeethylase activity, EROD) and benzo[a]pyrene (aryl hydrocarbon hydroxylase activity,
AHH) activities have also been reported in belugas from the MacKenzie River Delta in
the Canadian Arctic (White et al., 1994, 2000). A more comprehensive study o f phase I
and II enzyme expression and activity is needed to assess the metabolic capacities o f
beluga whales, particularly from differentially exposed populations, towards potentially
toxic, environmental xenobiotics.

1.3.2 PCBs
Boon et al (1994, 1997) devised a classification scheme for the oxidative
metabolism o f PCBs in marine mammals. This categorization was based on the congener
patterns among species o f marine mammals and comparisons to the patterns in prey
species (i.e. fish). In cetaceans, several features o f the general PCB congener pattern
(ratio to CB153) were observed: (1) congeners with vicinal H atoms, a property found to
increase metabolic rates in laboratory animals, were depleted in comparison to other
congeners, (2) congeners with vicinal ortho-meta H atom pairs were significantly lower
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than in fish and (3) congeners with vicinal meta-para H atom pairs were similar to that in
fish (Boon et al., 1992). In seals, the findings were similar, except that congeners with
vicinal meta-para H atom pairs were also depleted in comparison to fish. This difference
may be accounted by the fact that cetaceans appear to have lower CYP2B type activities
than pinnipeds. On the basis o f these results, PCBs were classified into six metabolic
groups (Table 1.1). Nonetheless, these CYP isozyme activities towards PCBs are only
inferred from relative tissue concentrations. For many marine m ammal species enzymes
that mediate the metabolism o f specific PCB congeners have not yet actually been
characterized.
Patterns o f parent PCBs in tissues are only suggestive o f metabolic activity and
capacity, but the presence of retained metabolite residues in these tissues provides direct
evidence. Although oxidative phase I metabolites o f PCBs, HO-PCBs, have not yet been
determined in beluga whales, these phenolic metabolites have been found in some
cetaceans (Bennett et al., 2003; Hoekstra et al., 2003) and pinnipeds (Jansson et al., 1975;
Bergman et al., 1994). HO-PCBs have also been detected in other mammals, humans,
fish and birds (Klasson-Wehler et al., 1998; Asplund et al., 1999; Meironyte-Guvenius et
al., 2002; Campbell et al., 2003; Hoekstra et al., 2003; Li et al., 2003a; Letcher et al.,
2004; Sandala et al., 2004), suggesting the general presence o f these secondary
contaminants in biota.
The CYP-mediated conversion o f PCBs to HO-PCBs proceeds by either arene
epoxide formation and subsequent ring opening or by direct HO-insertion on the biphenyl
ring (Letcher et al., 2000a). HO-PCBs are not likely bioaccumulated, but are retained in
biota due to an affinity for TTR that can be up to ten times greater than o f thyroxine.
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Table 1.1. PCB metabolic classification scheme for marine mammals. Modified from
Boon et al. (1994, 1997). The proposed metabolism refers to homologues o f rat CYPs, as
for most m arine mammals CYPs have not been thoroughly characterized.

meta-para
ortho-meta
Metabolic
Vicinal H-Atom Pairs Vicinal H-Atom Pairs
Group
I

none

none

II

V

none

III

V

IV

-

V

-

VI

✓

# orthoC1 atoms
-

2

-

recalcitrant

or more

0

2

✓

Proposed
Metabolism

or

recalcitrant

CYP1A

1

or less

CYP2B/3A

3 or more

1

or less

CYP2B/3A

CYP1A/2B/3A
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These metabolites thus appear to be localized mainly in blood, but distribution in other
tissues is less well studied (Letcher et al., 2000). In general, only HO-PCBs formed from
persistent, higher chlorinated parent PCBs with the HO-group in the para- or sometimes
meta-position are retained, whereas most HO-PCBs are readily conjugated and
eliminated. In laboratory rodents, it has been demonstrated that these metabolites are
thyroidogenic due to competitive binding to TTR and disturbance o f thyroid hormone
metabolism (Brouwer et al., 1986). As well, HO-PCBs altered vitamin A levels in rats
(Brouwer et al., 1986). Some o f these toxicities were seen in seals fed PCB contaminated
fish, suggesting the role o f metabolites in PCB toxicity in marine mammals (Brouwer et
al., 1989). van den Hurk et al. (2002) found that HO-PCBs, especially those with metapara unsubstituted sites, inhibited phase II sulfation and glucuronidation activities in
channel catfish (Ictaluris punctatus). Inhibition o f thyroxine sulfation has been shown in
rats in vitro, suggesting another mechanism o f HO-PCB action which may be related to
the documented developmental neurotoxic effects of PCBs (Schuur et al., 1998).
Indirect evidence for CYP2B-type biotransformation in beluga whales comes
from the detection o f another group o f persistent PCB metabolites, MeSCh-PCBs, in both
SLB and CAB blubber tissues (Letcher et al., 2000b). In this case, PCB metabolism starts
with the CYP-mediated formation o f an arene epoxide, followed by conjugation to
glutathione. A thiol (-SH) derivative is formed, then methylated (-SCH 3 ), and finally
oxidized (-SOCH 3 or -SO 2 CH 3) (Mio and Sumino, 1985). Methyl sulfone metabolites o f
PCBs have also been detected in other whale species (Haraguchi et al., 1989; Troisi et al.,
1998; Hoekstra et al., 2003), seals (Jensen and Jansson, 1976; Letcher et al., 1998),
porpoises (Troisi et al., 1998; Karlson et al., 2000; Chu et al., 2003) as well as in humans
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and birds, but at barely above the detection limits in most fish species (Letcher et ah,
2000a). MeSCh-PCBs are hydrophobic enough to be persistent and bioaccumulate in fatty
tissues. M any of these congeners are resistant to metabolism, and may also be
preferentially retained in the liver (particularly 3-MeSCh-congeners) due specific protein
binding. In general, the biologically retained congeners are meta- or para-M eSOjsubstituted, resulting in a pair o f isomers, with chlorine substitution on the MeSCLcontaining ring at the 2,5- or 2,5,6-positions. As well, these metabolites tend to have 3 to
7 chlorine atoms in all, with one chlorine atom occupying the para-position on the nonMeSCb-substituted ring (Letcher et al., 2000a). MeSCb-PCBs have been shown to affect
enzyme activities and exhibit endocrine disrupting properties.

3

-MeSC>2 -PCBs were

strong inducers o f CYP2B/2C/3A-type activities in vivo in rats; however, 4 -MeSC>2 -PCBs
were not (Kato et ah, 1995a,b). Some 3- and 4 -MeS 0 2 -PCBs reduced thyroid hormone
levels in rats (Kato et ah, 1998) and elicited reproductive dysfunction in mink in vivo
(Lund et ah, 1999).
PCB metabolism and metabolite formation in marine mammals has more recently
also been assessed in a limited number o f studies through the use o f in vitro phase I
biotransformation

assays.

Studies

have

measured

depletion

o f PCB-15,

2,7-

dichlorodibenzodioxin and 1,2,3,4,8 - pentadibenzofuran in sperm whale (Boon et ah,
2001) and PCB depletion in grey seal (Li et ah, 2003b) and ringed seal hepatic
microsomes (Letcher et ah, 1998). W hite et ah (2000) quantified the transformation o f
two PCB congeners in beluga and pilot whale liver microsomes: CB77, which is a
CYP1A substrate in rat, and CB52, which is a phenobarbital-inducible type CYP2B
substrate in rat. For CB77, mono-HO-PCB metabolites were detected. However,
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depletion and metabolite formation o f a broad range metabolically-relevant PCB
congeners, including those which may be parent compounds to retained HO-PCBs, has
not been examined in any marine mammal species.

1.3.3 PBDEs
Limited data exists regarding the metabolism o f PBDEs in marine mammals.
Residue patterns in higher trophic organisms are nonetheless suggestive o f metabolism
(Boon et al., 2002; Ikonomou et al., 2002; Wolkers et al., 2004). For instance, BDE100
appeared to be relatively depleted in comparison to prey species in both harbour seal
(Boon et al., 2002) and ringed seal (Wolkers et al., 2004). HO-BDEs and MeO-BDEs
have been reported as residues in fish (Haglund et al., 1997; Asplund et al., 1999; Letcher
et al., 2003; Marsh et al., 2004). MeO-BDEs have also been found in ringed seal and
beluga whale (Haglund et al., 1997; Wolkers et al., 2004). There is one report o f HOBDEs in the blood plasma o f an individual killer whale (Bennett et al., 2004). Several
tetrabrominated HO-PBDE congeners were very recently found in the plasma o f
snapping turtles (Chelydra serpentina) and several species o f benthic- and pelagicfeeding fish species from the Detroit River area o f the Great Lakes (Chu et al., 2004;
Valters et al., 2004). There is currently a debate as to whether HO-/MeO-BDE residues
found in marine biota are natural products or are the result o f PBDE metabolism.
Although HO-PCBs are not known to occur naturally, some o f the ortho-substituted HO/MeO-BDEs found in Baltic salmon are known to be produced by marine sponges and
algae (Marsh et al., 2004).
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The possibility that PBDEs may undergo biotransformation processes as the
structurally related PCBs, such as via pathways leading to HO-metabolite formation, is
supported b y the findings in laboratory rodents and some fish species (Hakk and Letcher,
2003). 6 m and Klasson-Wehler (1998) showed that low levels o f HO-metabolites were
detected in the liver and lung o f rats orally dosed with BDE47. Higher amounts o f
metabolites, five HO-tetraBDEs and two HO-triBDEs, were detected in mouse liver in
the same study. Trace levels o f HO-BDE metabolites were retained in the livers o f rats
dosed with BDE99 (Hakk et al., 2002). In addition, tetra- and penta-brominated HO-BDE
metabolites were found in fecal extracts. Recently, evidence o f the formation o f HOmetabolites from BDE100 has also been shown in rat (Hakk et al., 2004). Some evidence
o f sulfur-containing metabolites was also shown in these two studies. Metabolism o f
BDE209 to hydroxylated and lower brominated metabolites has also been found in orally
dosed rats (Morck et al., 2003). Thus, akin to PCBs, PBDEs are oxidatively metabolized
to HO-metabolites, but unlike PCBs, PBDEs are also subject to dehalogenation reactions
in laboratory rodents. Kierkegaard et al. (2001) found HO-metabolites in northern pike
(Esox lucius) fed food spiked with BDE47. Carp (Cyprinus carpio) were fed food spiked
with either BDE 99, 183 or 209, and the formation o f lower brominated BDEs was
observed (Stapleton et al., 2004b,c). In contrast, de Boer et al. (1998) did not find
evidence for metabolism o f BDE47, 99 nor 209 in a 90 min in vitro assay using harbour
seal, whitebeaked dolphin, sperm whale and minke whale microsomes.
The involvement o f specific xenobiotic-metabolizing enzymes in the metabolism
of PBDEs is suggested by a single study. Meerts et al. (2000) found that PBDEs did not
effectively compete with T 4 for TTR in an in vitro assay. However, the metabolic
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products o f PBDEs incubated prior with CYP2B induced rat liver microsomes, were
strong competitors for T T R binding, suggesting the involvement o f CYP2B in the
metabolic formation o f HO-PBDEs in rat. The finding o f marine mammal CYP isozymes
with substrate specificity similar to rat CYP2B would suggest the metabolic potential o f
these species towards PBDEs.
As mentioned, limited toxicological data indicates that, at least in human in vitro
studies, HO-PBDEs exert strong thyroidogenic (Meerts et al., 2000), as well as estrogenic
effects (Meerts et al., 2001).

1.4 Canadian beluga whale populations
1.4.1 St. Lawrence Estuary beluga whales
The isolated population o f beluga whales living in the estuary o f the St. Lawrence
River near Quebec, Canada was listed as “Endangered” (COSEWIC, 1983, 1997) and is
currently listed as “Threatened” (COSEWIC, 2004). Current estimates o f St. Lawrence
beluga (SLB) population size are in the range o f 900 to 1200 individuals (Kingsley, 1999;
Gosselin et al., 2001). The population appears to be stable in size (Gosselin et a l, 2001;
Michaud and Beland, 2001), having not rebounded in number since it was decimated
during commercial exploitation that ended in the 1930s (Reeves and Mitchell, 1984). The
St. Lawrence River connects the North American Great Lakes, one o f the most highly
industrially and agriculturally contaminated regions of the world, to the Atlantic Ocean.
Exposure and body burdens o f organic pollutants, particularly PCBs and DDT, in the
SLB population are elevated not only in comparison to other St. Lawrence marine
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mammal species, but also in comparison to animals from other D. leucas populations
(Muir et al., 1996; Metcalfe et al., 1999; Lebeuf et al., 2004).
Toxicological studies o f contaminants in marine mammals have often focused on
this highly exposed St. Lawrence River Estuary population. Chronic lesions, high
occurrences o f neoplasms and indications o f reproductive and immune dysfunction were
found in a nine year epidemiological study o f necropsied St. Lawrence beluga whales
(Beland et al., 1993). As well, PCBs and other OCs were measured at levels above those
known to elicit similar toxic effects in laboratory animals. A link has been suggested
between these health issues in SLB and OC exposures (Martineau et al., 1994; De Guise
et al., 1995).

1.4.2 Arctic beluga whales
All beluga whales, with the exception o f those from the SLB population, inhabit
Arctic

regions.

The

Bering/Chukchi/Okhotsk

Arctic
Seas,

populations are
(3)

Canadian high

from

(1)

Svalbard,

Arctic/Greenland

and

(2)
(4)

Hudson/James Bay. Tissue PCB and other organochlorine levels in Arctic beluga whales
are significantly lower than those found in SLB (Metcalfe et al., 1999; Andersen et al.,
2001; Law et al., 2003); moreover, none o f the aforementioned pathologies or
impairments reported in SLB were found in belugas from Arctic regions (Beland et al.,
1993). However, declines in some populations

have been seen, generally due to

overhunting (COSEWIC,2004). The western Hudson Bay population, studied in

this

thesis, numbers around 24 000 to 48 000 (Richard, 1993). This population was listed as

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

26

“Not At Risk” by COSEWIC (1993), but is now listed as o f “Special Concern”
(COSEWIC, 2004).

1.5 Thesis Objectives
The study o f metabolism as a factor in organohalogen accumulation and toxicity
is particularly relevant for marine mammals (especially cetaceans) given their elevated
exposures, high capacity for accumulation, and potentially unique metabolic potential.
The aim o f this thesis is to investigate the biotransformation capacity o f beluga whales
from two differentially exposed populations towards PBDEs and PCBs. Ethical and
logistical considerations prevent direct dosing studies on cetaceans. Therefore, an
alternative “weight o f evidence” approach from three separate studies was used to
examine the possible role o f metabolism in the toxicological risks o f PCB and PBDE
exposures to these beluga whales. The three separate sub-objectives were as follows:

1) To determine metabolic potential towards PCBs and PBDEs via expression o f hepatic
phase I and II enzymes o f probable importance in mediating xenobiotic metabolism in
beluga whales. To examine possible enzyme expression differences between SLB, a
population highly exposed to enzyme-inducing contaminants, and the less exposed CAB
(Arviat area o f western Hudson Bay).

2) To examine indirect evidence o f metabolism through analysis o f PCB and PBDE
congener residue

profiles,

and

direct

evidence

through

analysis

o f putative

retained/persistent metabolite residues in SLB and CAB liver tissues. To investigate
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differential metabolic capacity between SLB and CAB suggested by liver contaminant
profiles.

3) To directly investigate the biotransformation o f specific PCB and PBDE congeners
and HO-PCB/-PBDE metabolite formation in a model CAB using an in vitro microsomal
assay.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

28
References
Addison, R.F., Smith, T.G., 1974. Organochlorine residue levels in arctic ringed seals variation with age and sex. OIKOS 25, 335-337.
Aguilar, A., Borrell, A., Reijinders, P.J.H., 2002. Geographical and temporal variation in
levels o f organochlorine contaminants in marine mammals. Mar. Environ. Res.
53, 425-452.
Andersen, G., Kovacs, K.M., Lydersen, € ., Skaare, J.U., Gjertz, I., Jenssen, B.M., 2001.
Concentrations and patterns o f organochlorine contaminants in white whales
(Delphinapterus leucas) from Svalbard, Norway. Sci. Total Environ. 264, 267281.
Andersson, O., Blomkvist, G., 1981. Polybrominated aromatic pollutants found in fish in
Sweden. Chemosphere 10, 1051-1060.
Asplund, L., Athanasiadou, M., Sjodin, A., Bergman, A., Borjeson, H., 1999.
Organohalogen substances in muscle, egg and blood from healthy Baltic salmon
(,Salmo salar) and Baltic salmon that produced offspring with the M74 syndrome.
Ambio 28, 67-76.
Ballschmiter, K., 1991. Global distribution o f organic compounds. J. Environ. Sci.
Health- Environ. Carcinog. Ecotoxicol. Rev. 9C, 1-46.
Beland, P., De Guise, S., Girard, C., Lagace, A., Martineau, D., Michaud, R., Muir,
D.C.G., Norstrom, R.J., Pelletier, E., Ray, S., Shugart, L.R., 1993. Toxic
compounds and health and reproductive effects in St. Lawrence beluga whales. J.
Great Lakes Res. 19, 766-775.
Bennett, E.R., Ross, P.S., Alaee, M., D ’Sa, I., Letcher, R.J., 2004. Polychlorinated and
polybrominated phenolic compounds in the blood o f killer whale (Orcinus orca)
fed a diet o f wild Pacific Herring (Clupea pallasi) In preparation.
Bergman, A., Klasson-Wehler, E. Kuroki, H., 1994. Selective retention o f hydroxylated
PCB metabolites in blood. Environ. Health Perspect. 102, 464-469.
Boobis, A.R., Sesardic, D., Murray, B.P., Edwards, R.J., Singleton, A.M., Rich, K.J.,
Murray, S., Delatorre, R., Segura, J., Pelkonen, O., Pasanen, M., Kobayashi, S.,
Zhiguang, T., Davies, D.S., 1990. Species variation in the response o f the
cytochrome P-450-dependent monooxygenase system to inducers and inhibitors.
Xenobiotica 20, 1139-1161.
Boon, J.P., van Arnhem, E. Jansen, S. Kannan, N., Petrick, G., Schulz, D., Duinker, J.C.,
Reijnders, P.J.H., Goksoyr, A., 1992. The toxicokinetics o f PCBs in marine
mammals with special reference to possible interactions o f individual congeners

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

29

w ith the cytochrome P45O-dependent monooxygenase system: An overview. In:
W alker, C.H., Livingstone, D.R., (Eds.), Persistent Pollutants in Marine
Ecosystems. Pergamon, Oxford, pp. 119-159.
Boon, J.P., Oostingh, I., Vandermeer, J., Hillebrand, M.T.J., 1994. A model for the
bioaccumulation o f chlorobiphenyl congeners in marine mammals. Eur. J.
Pharmacol.-Environ. Toxicol. Pharmacol. 270, 237-251.
Boon, J.P., van der Meer, J. Allchin, C.R., Law, R.J., Klungsoyr, J., Leonards, P.E.G.,
Spliid, H., Storr-Hansen, E., Mckenzie, C., Wells, D.E., 1997. Concentrationdependent changes o f PCB patterns in fish-eating mammals: Structural evidence
for induction o f cytochrome P450. Arch. Environ. Contam. Toxicol. 33, 298-311.
Boon, J.P., Lewis, W.E., Goksoyr, A., 2001. Immunochemical and catalytic
characterization o f hepatic microsomal cytochrome P450 in the sperm whale
(Physeter macrocephalus). Aquat.Toxicol. 52, 297-309.
Boon, J.P, Lewis, W.E., Tjoen-A-Choy, M.R., Allchin, C.R., Law, R.J., de Boer, J., Ten
Hallers-Tjabbes, C.C., Zegers, B.N., 2002. Levels o f polybrominated diphenyl
ether (PBDE) flame retardants in animals representing different trophic levels o f
the North Sea food web. Environ. Sci. Technol. 36, 4025-4032.
Boon, J.P., van Zanden, J.J., Lewis, W.E., Zegers, B.N., Goksoyr, A., Arukwe, A., 2002.
The expression o f CYP1A, vitellogenin and zona radiata proteins in Atlantic
salmon (Salmo salar) after oral dosing with two commercial PBDE flame
retardant mixtures: absence o f short-term responses. Mar. Environ. Res. 54, 719724.
Brouwer, A., Vandenberg, K.J., Blaner, W.S., Goodman, D.S., 1986. Transthyretin
(prealbumin) binding o f PCBs, a model for the mechanism o f interference with
vitamin A and thyroid hormone metabolism. Chemosphere 15, 1699-1706.
Brouwer, A., Reijnders, P.J.H., Koeman, J.H., 1989. Polychlorinated biphenyl (PCB)contaminated fish induces vitamin A and thyroid hormone deficiency in the
common seal (Phoca-Vitulina). Aquat. Toxicol. 15, 99-105.
Calabrese, E., Baldwin, L., 2003. Toxicology rethinks its central belief. Nature 421, 691692.
Campbell, L.M., Muir, D.C.G., Whittle, D.M., Backus, S.; Norstrom, R.J., Fisk, A.T.,
2003. Hydroxylated PCBs and other chlorinated phenolic compounds in lake trout
(Salvelinus namaycush) blood plasma from the Great Lakes Region. Environ. Sci.
Technol. 37, 1720-1725.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

30

Chen, G., Konstantinov, A.D., Chittim, B.G., Bols, N.C., Bunce, N.J., 2001. Synthesis o f
polybrominated diphenyl ethers and their capacity to induce CYP1A by the Ah
receptor pathway. Environ. Sci. Technol. 35, 3749-3756.
Chu, S.G., Femie, K.J., de Solla, S.R., Letcher, R.J., 2004. PCB and PBDE
biotransformation and hydroxylated metabolite exposure in snapping turtle
(Chelydra serpentina) from several sites in southwestern Ontario. In preparation.
Chu, S.G., Covaci, A., Haraguchi, K., Voorspoels, S., Van de Vijver, K., Das, K.,
Bouquegneau, J.M., De Coen, W., Blust, R., Schepens, P., 2003. Levels and
enantiomeric signatures o f methyl sulfonyl PCB and DDE metabolites in livers o f
harbor porpoises {Phocoena phocoena) from the southern North Sea. Environ.
Sci. Technol. 37, 4573-4578.
Colbom, T., Smolen, M.J., 1996. Epidemiological analysis o f persistent organochlorine
contaminants in cetaceans. Rev. Environ. Contam. Toxicol. 146, 91-172.
Committee on the Status o f Endangered Wildlife in Canada (COSEWIC), 1983.
COSEWIC Canadian Species at Risk Publication. Environment Canada, Ottawa.
Committee on the Status o f Endangered Wildlife in Canada (COSEWIC), 1997.
COSEWIC Canadian Species at Risk Publication. Environment Canada, Ottawa.
Committee on the Status o f Endangered Wildlife in Canada (COSEWIC), 2004.
COSEWIC Canadian Species at Risk Publication. Environment Canada, Ottawa.
Damerud, P.O., Sinjari, T., 1996. Effects o f polybrominated diphenyl ethers (PBDEs)
and polychlorinated biphenyls (PCBs) on thyroxine and TSH blood levels in rats
and mice. Organohalogen Compds. 29, 316-319.
Damerud, P.O., Thuvander, A., 1999. Effects o f polybrominated diphenyl ether (PBDE)
and polychlorinated biphenyl (PCB) on some immunological parameters after oral
exposure in rats and mice. Toxicol. Environ. Chem. 70, 229-242.
Damerud, P.O., Eriksen, G.S., Johannesson, T., Larsen, P.B., Viluksela, M., 2001.
Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology.
Environ. Health Perspect. 109, 49-68.
de Boer, J., Wester, P.G., Klamer, H.J.C., Lewis, W.E., Boon, J.P., 1998. Do flame
retardants threaten ocean life? Nature 394, 28-29.
de Boer, J.; de Boer, K.; Boon, J.P., 2000. Polybrominated biphenyls and diphenylethers.
In: Paasivirta, J. (Ed.), The Handbook o f Environmental Chemistry. Berlin,
Springer-Verlag, pp. 61-95.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

31

De Guise, S., Martineau, D., Beland, P., Fournier, M., 1995. Possible mechanisms of
action o f environmental contaminants on St. Lawrence beluga whales
(Delphinapterus leucas). Environ. Health Perspect. 103(Suppl. 4), 73-77.
De Guise, S., Martineau, D., Beland, P., Fournier, M., 1998. Effects o f in vitro exposure
o f beluga whale leukocytes to selected organochlorines. J. Toxicol. Environ.
H ealth 55A, 479-493.
De Guise, S., Beckmen, K.B., Halladay, S.D., 2003. Contaminants and marine mammal
immunotoxicology and pathology. In: Vos, J.G., Bossart, G.D., Fournier, M.,
O ’Shea, T.J. (Eds.), Toxicology o f Marine Mammals. Taylor & Francis, London,
pp. 38-54.

de Swart, R.L., Ross, P.S., Vedder, L.J., Timmerman, H.H., Heisterkamp, S.H., van
Loveren, H., Reijnders, P.J.H., Osterhaus, A.D.M.E., 1994. Impairment of
immune functions in harbour seals (Phoca vitulina) feeding on fish from polluted
waters. Ambio 23,155-159.
de Voogt, P., Brinkman, U.A.Th., 1989. Production, properties and usage o f
polychlorinated biphenyls. In: Kimbrough, R.D., Jensen, A.A. (Eds.),
Halogenated Biphenyls, Terphenyls, Naphthalenes, Dibenzodioxins and Related
Products. Elsevier Science Publishers, Amsterdam, pp. 3-45.
DeLong, R.L., Gilmartin, W.G., Simpson, J.G., 1973. Premature births in Californian
sealions: association with high organochlorine pollutant residue levels. Science
181, 1168-1170.
Eis, D., 1989. Simplification in the etiology o f recent seal deaths. Ambio 18, 144.
Eriksson, P., Viberg, H., Jakobsson, E., Om, U., Fredriksson, A., 2002. A brominated
flame retardant, 2,2 ',4,4 ',5-pentabromodiphenyl ether: Uptake, retention, and
induction o f neurobehavioral alterations in mice during a critical phase of
neonatal brain development. Toxicol. Sci. 67, 98-103.
Eriksson, J., Green, N., Marsh, G., Bergman, A., 2004. Photochemical decomposition o f
15 polybrominated diphenyl ether congeners in methanol/water. Environ. Sci.
Technol. 38, 3119-3125.
Fowles, J.R., Fairbrother, A., Baecher-Steppan, L., Kerkvliet, N.I., 1994. Immunologic
and endocrine effects o f the flame-retardant pentabromodiphenyl ether (DE-71) in
C57BL/6J mice. Toxicology 8 6 , 49-61.
Fujise, Y., Zenati, R., Kato, H., 1998. An examination o f the W-stock hypothesis for
North Pacific minke whales, with special reference to some biological parameters
using data collected from JARPN surveys from 1994 to 1997. Paper
SC/50/RMP12 presented to the IWC Scientific Committee, Oman.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

32

Gaskin, D.E., Holdrinet, M., Frank. R., 1971. Organochlorine pesticide residues in
harbour porpoises from the Bay o f Fundy region. Nature 233,499-500.
Gaskin, D.E., Smith, G.J.D., Arnold, P.W., Louisy, M.V., 1974. Mercury, DDT, dieldrin,
and PCB in two species o f odontoceti (Cetacea) from St. Lucia, Lesser Antilles. I.
Fish. Res. Board Can. 31, 1235-1239.
George, S.G., 1994. Enzymology and molecular biology o f phase II xenobioticconjugating enzymes in fish. In: Malins, D.C., Ostrander, G.K. (Eds.), Aquatic
Toxicology; Molecular, Biochemical and Cellular perspectives. Lewis Publishers,
CRC press, Boca Raton, pp. 37-85.
Goksoyr, A., Forlin, L., 1992. The cytochrome P450 system in fish, aquatic toxicology
and environmental monitoring. Aquat. Toxicol. 22, 287-312.
Goldey, E.S., Kehn, L.S., Lau, C., Rehnberg, G.L., Crofton, K.M., 1995. Developmental
exposure to polychlorinated biphenyls (Aroclor-1254) reduces circulating thyroid
hormone concentrations and causes hearing deficits in rats. Toxicol. Appl.
Pharmacol. 135, 77-88.
Gosselin, J.-F., Lesage, V., Robillard, A., 2001. Population index estimate for the beluga
o f the St. Lawrence River Estuary in 2000. Fisheries and Oceans Canada,
Canadian Science Advisory Secretary. Research document 2001/049, 21pp.
Grossman, C.J., 1985. Interactions between the gonadal steroids and the immune system.
Science 227, 257-261.
Gustafsson, K., Bjork, M., Burreau, S., Gilek, M., 1999. Bioaccumulation kinetics o f
brominated flame retardants (polybrominated diphenyl ethers) in blue mussels
(Mytilus edulis) Environ. Toxicol. Chem. 18,1218-1224.
Haglund, P.S., Zook, D.R., Buser, H.-R., Hu, J., 1997. Identification and quantification o f
polybrominated diphenyl ethers and methoxy-polybrominated diphenyl ethers in
Baltic biota. Environ. Sci. Technol. 31, 3281-3287.
Hakk, H., Larsen, G., Klasson-Wehler, E., 2002. Tissue disposition, excretion and
metabolism o f 2,2 ',4,4 ',5-pentabromodiphenyl ether (BDE-99) in the male
Sprague-Dawley rat. Xenobiotica 32, 369-382.
Hakk, H., Letcher, R. J., 2003. Metabolism in the toxicokinetics and fate o f brominated
flame-retardants (FRS) in laboratory organisms and wildlife. Environ. Int., 29,
801-828.
Hakk, H., Huwe, J., Low, M., Rutherford, D., Larsen, G., 2004. Tissue Disposition,
Excretion, and Metabolism o f 2,2',4,4',6-Pentabromodiphenyl ether (BDE-100) in
Male Sprague-Dawley Rats. Proceedings o f the third international workshop on

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

33

brominated flame retardants BFR2004, June 6-9. University o f Toronto, Toronto,
ON, Canada, pp. 429-432.
Hale, R.C., La Guardia, M.J., Harvey, E.P., Gaylor, M.O., Mainor, T.M., Duff, W.H.,
2001. Persistent pollutants in land-applied sludges. Nature 412, 140-141.
Hall, A.J., Kalantzi, O.I., Thomas, G.O., 2003. Polybrominated diphenyl ethers (PBDEs)
in grey seals during their first year o f life - are they thyroid hormone endocrine
disrupters? Environmental Pollution 126, 29-37.
Hallgren, S., Damerud, P.O., 1998. Effects o f polybrominated diphenyl ethers (PBDEs),
polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) on thyroid
hormone levels and enzyme activities in rats. Organohalogen Compds. 37, 147150.
Haraguchi, K., Kuroki, H., Masuda, Y., 1989. Occurrence and distribution o f chlorinated
aromatic methylsulfones and sulfoxides in biological samples. Chemosphere 19,
487-492.
Higuchi, K. (Ed.), 1976. PCB poisoning and pollution. Academic Press, New York, pp.
3-85.
Hites, R.A., 2004. Polybrominated diphenyl ethers in the environment and in people: a
meta-analysis o f concentrations. Environ. Sci. Technol. 38, 945-956.
Hoekstra, P.P., Letcher, R.J., O'Hara, T.M., Backus, S.M., Solomon, K.R., and Muir,
D.C.G., 2003. Hydroxylated and methylsulfone-containing metabolites o f
polychlorinated biphenyls in the plasma and blubber ofbow head whales (Balaena
mysticetus). Environ. Toxicol. Chem. 22, 2650-2658.
Hoekstra, P.P., O'Hara, T.M., Fisk, A.T., Borga, K., Solomon, K.R., Muir, D.C.G., 2003.
Trophic transfer o f persistent organochlorine contaminants (OCs) within an Arctic
marine food web from the southern Beaufort-Chukchi Seas. Environ. Pollut. 124,
509-522.
Holden, A.L., Marsden K., 1967. Organochlorine pesticides in seals and porpoises.
Nature 216, 1274-1276.
Ikonomou, M.G., Rayne, S., Addison, R.F., 2002. Exponential increases o f the
brominated flame retardants, polybrominated diphenyl ethers, in the Canadian
Arctic from 1981 to 2000. Environ. Sci. Technol. 36, 1886-1892.
Jansson, B., Jensen, S., Olsson, M., Renberg, L., Sundtrom, G., Vaz, R., 1975.
Identification by GC-MS o f phenolic metabolites o f PCB and p,p ’-DDE isolated
from Baltic guillemot and seal. Ambio 4, 93-97.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

34
Jensen, S., 1966. Report of a new chemical hazard. New Scientist 32, 612.
Jensen, S., Johnels, A.G., Olsson, M., Otterlin, G., 1969. DDT and PCB in marine
anim als from Swedish waters. Nature 224, 247.
Jensen, S., Jansson, B., 1976. Anthropogenic substances in seals from the Baltic:
methylsulfone metabolites o f polychlorinated biphenyls and DDE. Ambio 5, 257260.
Jones, K.C., de Voogt, P., 1999. Persistent organic pollutants (POPs): state o f the science.
Environ. Pollut. 100, 209-221.
Karlson, K., Ishaq, R., Becker, G., Berggren, P., Broman, D., Colmsjo, A., 2000. PCBs,
DDTs and methyl sulphone metabolites in various tissues o f harbour porpoises
from Swedish waters. Environ. Pollut. 110, 29-46.
Kato, Y., Haraguchi, K., Kawashima, M., Yamada, S., Isogai, M., Masuda, Y., Kimura,
R., 1995a. Characterization o f hepatic microsomal cytochrome P-450 from rats
treated with methylsulfonyl metabolites o f polychlorinated biphenyl congeners.
Chem. Biol. Interact. 95, 269-278.
Kato, Y., Haraguchi, K., Kawashima, M., Yamada, S., Masuda, Y., Kimura, R., 1995b.
Induction o f hepatic microsomal drug-metabolizing enzymes by methylsulfonyl
metabolites o f polychlorinated biphenyl congeners. Chem. Biol. Interact. 95, 257268.
Kato, Y., Haraguchi, K., Shibahara, T., Masuda, Y., Kimura, R., 1998. Reduction o f
thyroid hormone levels by methylsulfonyl metabolites o f polychlorinated
biphenyl congeners in rats Arch. Toxicol. 72, 541-544.
Kelce, W.R., Stone, C.R., Laws, S.C., Gray, L.E., Kemppainen, J.A., Wilson, E.M.,
1995. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor
antagonist. Nature 375, 581-585.
Kester, M.H.A., Bulduk, S., Tibboel, D., Meinl, W., Glatt, H., Falany, C.N., Coughtrie,
M.W.H., Bergman, A., Safe, S.H., Kuiper, G.G.J.M., Schuur, A.G., Brouwer, A.,
Visser, T.J., 2000. Potent inhibition o f estrogen sulfotransferase by hydroxylated
PCB metabolites: A novel pathway explaining the estrogenic activity o f PCBs.
Endocrinology 141, 1897-1900.
Kierkegaard, A., Burreau, S., Marsh, G., Klasson-Wehler, E., de Wit, C., Asplund, L.,
2001. Metabolism and distribution o f 2,2 ’,4,4’-tetrabromo[ 14C]diphenyl ether in
pike (Esox lucius) after dietary exposure. Organohalogen Compds. 52, 58-61.
Kingsley, M.C.S., 1999. Population indices and estimates for the belugas o f the St.
Lawrence Estuary. Can. Tech. Rep. Fish Aquat. Sci. 2266, 27 pp.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

35

Klasson-Wehler, E., Bergman, A., Athanasiadou, M., Ludwig, J.P., Auman, H.J.,
Kannan, K., Van Den Berg, M., Murk, A.I., Feyk, L.A., Giesy, J.P., 1998.
Hydroxylated and methylsulfonyl polychlorinated biphenyl metabolites in
albatrosses from Midway Atoll, North Pacific Ocean. Environ. Toxicol. Chem.
17, 1620-1625.
Lahvis, G.P., Wells, R.S., Kuehl, D.W., Stewart, J.L., Rhinehart, H.L., Via, C.S., 1995.
Decreased lymphocytes response in free-ranging bottlenose dolphins (Tursiops
truncatus) are associated with increased concentrations o f PCBs and DDT in
peripheral blood. Environ. Health Perspect. 103 (Suppl. 6 ), 67-72.
Law, R.J., Allchin, C.R., Bennett, M.E., Morris, S., Rogan, E., 2002. Polybrominated
diphenyl ethers in two whale species o f marine top predators from England and
Whales. Chemosphere 46, 673-681.
Law, R.J., Alaee, M., Allchin, C.R., Boon J.P., Lebeuf, M., Lepom, P., Stem, G.A., 2003.
Levels and trends o f polybrominated diphenylethers and other brominated flame
retardants in wildlife. Environ. Int. 29, 757-770.
Lebeuf, M., Gouteux, B., Measures, L., Trottier, S., 2004. Levels and temporal trends
(1988-1999) o f polybrominated diphenyl ethers in beluga whales {Delphinapterus
leucas) from the St. Lawrence Estuary, Canada. Environ. Sci. Technol. 38, 29712977.
Letcher, R.J., Lewis, W.E., van den Berg, M., Seinen, W., Boon, J.P., 1998.
Biotransformation o f coplanar PCBs, PCDD and PCDFs and specific cytochrome
P450 isozyme activities in harbour seal (Phoca vitulina): Selective inhibition o f in
vitro metabolism in hepatic microsomes. Organohalogen Compds. 37, 357-360.
Letcher, R.J., Norstrom, R.J., Muir, D.C.G., 1998. Biotransformation versus
bioaccumulation: sources o f methyl sulfone PCB and 4,4'-DDE metabolites in the
polar bear food chain. Environ.Sci.Technol. 32,1656-1661.
Letcher, R.J., Klasson-Wehler, E., Bergman, A., 2000a. Methyl sulfone and hydroxylated
metabolites o f polychlorinated biphenyls. In: Paasivirta, J. (Ed.), The Handbook
o f Environmental Chemistry, vol. 3K, Springer-Verlag, Heidelberg, pp. 315-359.
Letcher, R.J., Norstrom, R.J., Muir, D.C.G., Sandau, C., Koczanski, K., Michaud, R., De
Guise, S., Beland, P., 2000b. Methylsulfone polychlorinated biphenyl and 2,2bis(chlorophenyl)- 1 ,1 -dichloroethylene
metabolites
in
beluga
whale
(.Delphinapterus leucas) from the St. Lawrence River Estuary and western
Hudson Bay, Canada. Environ. Toxicol. Chem. 19, 1378-1388.
Letcher, R.J., D'Sa, I., Valters, K., Marsh, G., Li, H., Bennett, E., Alaee, M., 2003.
Polybrominated diphenyl ethers and hydroxylated and methoxylated analogues in
Detroit River fish. Organohalogen Compds. 61, 29-32.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

36

Letcher, R.J., Chu, S.G., Li, H., 2004. Determination o f hydroxylated polychlorinated
biphenyls (HO-PCBs) in plasma by high performance liquid chromatographyelectrospray-tandem quadrupole mass spectrometry. Submitted to J. Anal.
Toxicol.
Lewis, D.F.V., Eddershaw, P.J., Dickins, M., Tarbit, M.H., Goldfarb, P.S., 1998.
Structural determinants o f cytochrome P450 substrate specificity, binding affinity
and catalytic rate. Chem. Biol. Interact. 115, 175-199.
Lewis, D.F.V., Modi, S., Dickins, M., 2002. Structure-activity relationship for human
cytochrome P450 substrates and inhibitors. Drug Metab. Rev. 34, 69-82.
Li, H., Drouillard, K.G., Bennett, E., Haffner, G.D., Letcher, R.J., 2003a. Plasmaassociated halogenated phenolic contaminants in benthic and pelagic fish species
from the Detroit River. Environ. Sci. Technol. 37, 832-839.
Li, H., Boon, J.P., Lewis, W.E., van den Berg, M., Nyman, M., Letcher, R.J., 2003b.
Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro
metabolism/inhibition o f polychlorinated biphenyls and testosterone in Baltic grey
seal {Halichoerus grypus). Environ. Toxicol. Chem. 22, 636-644.
Lind, Y., Damerud, P.O., Atuma, S., Aune, M., Becker, W., Bjerselius, R., Cnattingius,
S., Glynn, A., 2003. Polybrominated diphenyl ethers in breast milk from Uppsala
County, Sweden. Environ. Res. 93, 186-194.
Lipnick, R.L., Muir, D.C.G., 2001. History o f persistent, bioaccumulative, and toxic
chemicals. In: Lipnick, R.L., Hermens, J.L.M., Jones, K.C., Muir, D.C.G. (Eds.),
Persistent, Bioaccumulative and Toxic Chemicals I Fate and Exposure. American
Chemical Society, Washington, pp. 1-12.
Lund, B.O., Orberg, J., Bergman, A., Larsson, C., Bergman, A., Backlin, B.M.,
Hakansson, H., Madej, A., 1999. Chronic and reproductive toxicity o f a mixture
o f 15 methylsulfonyl-polychlorinated biphenyls and 3-methylsulfonyl-2,2-bis-(4chlorophenyl)-1,1 -dichloroethene in mink (Mustela vison). Environ. Toxicol.
Chem. 18, 292-298.
Marquenie, J.M., Reijnders, P.J.H., 1989. PCBs, an increasing concern for the marine
environment. International Council for the Exploration o f the Sea. Copenhagen,
CM, N:12.
Marsh, G., Athanasiadou, M., Bergman, A., Asplund L., 2004. Identification o f
hydroxylated and methoxylated polybrominated diphenyl ethers in Baltic Sea
salmon (Salmo salar) blood. Environ.Sci.Technol. 38, 10-18.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

37

Martineau, D., De Guise, S., Fournier, M., Shugart, L., Girard, C., Lagace, A., Beland, P.,
1994. Pathology and toxicology o f beluga whale from the St. Lawrence Estuary,
Quebec, Canada. Past, present and future. Sci. Total Environ. 154, 201-215.
Meerts, I.A.T.M., van Zanden, J.J., Luijks, E.A.C., van Leeuwen-Bol, I., Marsh, G.,
Jakobsson, E., Bergman, A., Brouwer, A., 2000. Potent competitive interactions
o f some brominated flame retardants and related compounds with human
transthyretin in vitro. Toxicol. Sci. 56, 95-104.
Meerts, I.A.T.M., Letcher, R.J., Hoving, S., Marsh, G., Bergman, A., Lemmen, J.G., van
der Burg, B., Brouwer, A., 2001. In vitro estrogenicity o f polybrominated
diphenyl ethers, hydroxylated PBDEs, and polybrominated bisphenol A
compounds. Environ. Health Perspect. 109, 399-407.
Meironyte-Guvenius, D., Bergman, A., Noren, K., 2001. Polybrominated diphenyl ethers
in Swedish human liver and adipose tissue. Arch. Environ. Contam. Toxicol. 40,
564-570.
Meironyte-Guvenius, D., Hassanzadeh, P., Bergman, A., Noren, K., 2002. Metabolites o f
polychlorinated biphenyls in human liver and adipose tissue. Environ. Toxicol.
Chem. 21, 2264-2269.
Metcalfe, C., Metcalfe, T., Ray, S., Paterson, G., Koenig, B., 1999. Polychlorinated
biphenyls and organochlorine compounds in brain, liver and muscle o f beluga
whales {Delphinapterus leucas) from the Arctic and St. Lawrence estuary. Mar.
Environ. Res. 47, 1-15.
Michaud, R., Beland, P., 2001. Looking for trends in the endangered St. Lawrence beluga
population. Mar. Mamm. Sci. 17, 206-212.
Mio, T., Sumino, K., 1985. Mechanism o f biosynthesis o f methylsulfones from PCBs and
related compounds. Environ. Health Perspect. 59, 129-135.
Morck, A., Hakk, H., Om, U., Klasson-Wehler, E., 2003. Decabromodiphenyl ether in
the rat: absorption, distribution, metabolism, and excretion. Drug Metab. Dispos.
31,900-907.
Muir, D.C.G., Wagemann, R., Hargrave, B.T., Thomas, D.J., Peakall, D.B., Norstrom,
R.J., 1992. Arctic marine ecosystem contamination. Sci. Total Environ. 122, 75134.
Muir, D.C.G., Ford, C.A., Rosenberg, B., Norstrom, R.J., Simon, M., Beland, P., 1996.
Persistent organochlorines in beluga whales {Delphinapterus leucas) from the St.
Lawrence River Estuary-I. Concentrations and patterns o f specific PCBs,
chlorinated pesticides and polychlorinated dibenzo-p-dioxins and dibenzofurans.
Environ. Pollut. 93, 219-234.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

38

Nebert, D.W ., Nelson, D.R., Coon, M.J., Estabrook, R.W., Feyereisen, R., FujiiKuriyama, Y., Gonzolez, F.J., Guengerich, F.P., Gonsalus, I.C., Johnson, E.F.,
Loper, J.C., Sato, R., Waterman, M.R., Waxman, D.J., 1991. The P450
superfamily: Update on new sequences, gene mapping and recommended
nomenclature. DNA Cell Biol. 10, 1-14.
Norstrom, R.J., Simon, M , Muir, D.C.G., Schweinsburg, R.E., 1988. Organochlorine
contaminants in arctic marine food chains- identification, geographicaldistribution, and temporal trends in polar bears. Environ. Sci.Technol. 22, 10631071.
Norstrom, R.J., Muir, D.C., 1994. Chlorinated hydrocarbon contaminants in arctic marine
mammals. Sci. Total. Environ. 154,107-128.
Nyman, M., Raunio, H., Taavitsainen, P., Pelkonen, Q., 2001. Characterization o f
xenobiotic-metabolizing cytochrome P450 (CYP) forms in ringed and grey seals
from the Baltic Sea and references sites. Comp. Biochem. Physiol. 128C, 99-112.
Nyman, M., Bergnut, M., Fant, M.L., Raunio, H., Jestoi, M., Bengs, C., Murk, A.,
Koistinen, J., Pelkonen, O., Tysklind, M., Hirvi, T., Helle, E., 2003. Contaminant
exposure and effects in Baltic ringed and grey seals as assessed by biomarkers.
Mar. Environ. Res. 55, 73-99.
Olsson, M., Karlsson, B., Ahnland, E., 1994. Diseases and environmental contaminants
in seals from the Baltic and the Swedish westcoast. Sci. Total Environ. 154, 217227.
Om, U., Klasson-Wehler, E., 1998. Metabolism o f 2,2',4,4'-tetrabromodiphenyl ether in
rat and mouse. Xenobiotica 28, 199-211.
Peters, A.K., Sanderson, J.T., Bergman, A., van den Berg, M., 2003. Induction and
inhibition o f cytochrome P450 1A1, 1B1, and ethoxyresorafin-O-deethylation
activity by polybrominated diphenyl ethers (PBDE) in MCF7 cells.
Organohalogen Compds. 61, 100-103.
Reeves, R.R., Mitchell, E., 1984. Catch history and initial population o f white whales
(Delphinapterus leucas) in the river and gulf o f St. Lawrence, eastern Canada.
Nat. Can. (Rev. Ecol. Syst.) 111, 63-121.
Reijnders, P.J.H., 1986. Reproductive failure in common seals feeding on fish from
polluted coastal waters. Nature 324, 456.
Reijnders, P.J.H., Donovan, G.P., Aguilar, A., Bjorge, A., 1999. Report o f the workshop
on chemical pollutants and cetaceans. In: Reijnders, P.J.H., Aguilar, A., Donovan,
G.P. (Eds.), Chemical Pollutants and Cetaceans. J. Cetacean Res. Manag. (Special
Issue I). International Whaling Commission, Cambridge, pp. 1-42.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

39

Richard, P.R., 1993. Status o f the beluga, Delphinapterus leucas, in western and southern
Hudson Bay. Can. Field-Nat. 107, 524-532.
Ryan, J.J., 2004. Polybrominated diphenyl ethers (PBDEs) in human milk: occurrence
worldwide. Proceedings o f the third international workshop on brominated flame
retardants BFR2004, June 6-9. University o f Toronto, Toronto, ON, Canada, pp.
17-22.
Sandala, G.M., Sonne-Hansen, C., Muir, D.C.G., Valters, K., Bennett, E.R., Bom, E.W.,
Letcher, R.J., 2004. Methyl sulfone and hydroxylated PCB metabolites in adipose
and whole blood o f polar bear ( Ursus maritimus) from East Greenland. Sci. Total
Environ. 331, 125-141.
Schuur, A.G., Legger, F.F., van Meeteren, M.E., Moonen, M.J.H., van Leeuwen-Bol, I.,
Bergman, A., Visser, T.J., Brouwer, A., 1998. In vitro inhibition o f thyroid
hormone sulfation by hydroxylated metabolites o f halogenated aromatic
hydrocarbons. Chem. Res. Toxicol. 11,1075-1081.
Sijm, D.T.H.M., 2001. The ‘B ’ in PBT: bioaccumulation. In: Lipnick, R.L., Hermens,
J.L.M., Jones, K.C., Muir, D.C.G. (Eds.), Persistent, Bioaccumulative and Toxic
Chemicals I Fate and Exposure. American Chemical Society, Washington, pp. 1326.
Sladen, W.J.L., Menzie, C.M., Reichel, W.L., 1966. DDT residues in Adelie penguins
and a crabeter seal from Antarctica. Nature 218, 670-673.
Smith, D.A., 1991. Species-differences in metabolism and pharmacokinetics - are we
close to an understanding? Drug. Metab. Rev. 23, 355-373.
Stapleton, H.M., Letcher, R.J., Li, J., Baker, J.E., 2004a. Dietary accumulation and
metabolism o f polybrominated diphenyl ethers by juvenile carp (Cyprinus
carpio). Environ. Toxicol. Chem. 23, 1939-1946.
Stapleton, H.M., Letcher, R.J., Baker, J.E., 2004b. Debromination o f polybrominated
diphenyl ether congeners BDE 99 and BDE 183 in the intestinal tract o f the
common carp {Cyprinus carpio). Environ. Sci. Technol. 38, 1054-1061.
Stapleton, H.M., Alaee, M., Letcher, R.J., Baker, J.E., 2004c. Debromination o f the flame
retardant decabromodiphenyl ether by juvenile carp {Cyprinus carpio) following
dietary exposure. Environ. Sci. Technol. 38, 112-119.
Stegeman, J.J., Hahn, M.E., 1994. Biochemistry and molecular biology o f
monooxygenase: current perspective on forms, functions, and regulation o f
cytochrome P450 in aquatic species. In: Malins, D.C., Ostrander, G.K. (Eds.),
Aquatic Toxicology; Molecular, Biochemical and Cellular Perspectives. CRC
press, Boca Raton, pp. 87-206.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

40

Stine, K.E., Brown, T.M., 1996. Principles o f Toxicology. CRC Lewis Publishers, Boca
Raton, pp. 21-36.
Subramanian, A.N., Tanabe, S., Hidaka, EL, Tatsukawa, R., 1986. Bioaccumulation of
organochlorines (PCBs and P,P'-DDE) in Antarctic Adelie Penguins (Pygoscelis
Adeliae) collected during a breeding season. Environ. Pollut. 40A, 173-189.
Subramanian, A.N., Tanabe, S., Tatsukawa, R. Saito, S., Myazaki, N., 1987. Reductions
in the testosterone levels by PCBs and DDE in Dali’s porpoises o f Northwestern
North Pacific. Mar. Pollut. Bull. 18, 643-646.
Subramanian, B.R., Tanabe, S., Hidaka, H., Tatsukawa, R .,. 1983. DDTs and PCB
isomers and congeners in Antarctic fish. Arch. Environ. Contam. Toxicol. 12,
621-626.
Tanabe, S., Mori, T., Tatsukawa, R., Miyazaki, N., 1983. Global pollution o f marine
mammals by PCBs, DDTs and HCHs (BHCs). Chemosphere 12,1269-1275.
Tanabe, S., 1988. PCB problems in the future: foresight from current knowledge.
Environ. Pollut. 50, 5-28.
Tanabe, S., Iwata, H., Tatsukawa, R., 1994. Global contamination by persistent
organochlorines and their ecotoxicological impact on marine mammals. Sci. Total
Environ. 154, 163-177.
Tanabe, S., 2002. Contamination and toxic effects o f persistent endocrine disrupters in
marine mammals and birds. Mar. Pollut. Bull. 45, 69-77.
Tarasuki, A.G., Olney, C.E., Winn, H.E., 1975. Chlorinated hydrocarbons in cetaceans. J.
Fish. Res. Board Can. 32, 2205-2209.
Thomann, R.V., 1989. Bioaccumulation model o f organic chemical distribution in
aquatic food chains. Environ. Sci. Technol. 23, 699-707.
Troisi, G.M., Haraguchi, K., Simmonds, M.P., Mason, C.F., 1998. Methyl sulphone
metabolites o f polychlorinated biphenyls (PCBs) in cetaceans from the Irish and
the Aegean Seas. Arch. Environ. Contam. Toxicol. 35, 121-128.
Ulbrich, B., Stahlmann, R., 2004. Developmental toxicity o f polychlorinated biphenyls
(PCBs): a systematic review o f experimental data. Arch. Toxicol. 78, 252-268.
Valters, K. Alaee, M. Li, H. Marsh G., Bergman, A, D ’Sa, I., Letcher, R.J., 2004.
Polybrominated diphenyl ethers PBDEs), and hydroxylated-PBDEs and other
halogenated phenolics in the plasma o f Detroit River fish. In preparation.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

41

van den Hurk, P. Kubiczak, G.A., Lehmler, H.-J., James, M.O., 2002. Hydroxylated
polychlorinated biphenyls as inhibitors o f the sulfation and glucuronidation o f 3hydroxy-benzo[a]pyrene. Environ. Health Perspect. 110, 343-348.
Viberg, H., Fredriksson, A., Eriksson, P., 2003. Neonatal exposure to polybrominated
diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and
memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicol.
Appl. Pharmacol. 192, 95-106.
Wania, F., Mackay, D., 1993. Global fractionation and cold condensation o f low
volatility organochlorine compounds in polar regions. Ambio 22, 10-18.
Wania, F., Dugani, C.B., 2003. Assessing the long-range transport potential o f
polybrominated diphenyl ethers: A comparison o f four multimedia models.
Environ. Toxicol. Chem. 22, 1252-1261.
White, R.D., Hahn, M.E., Lockhart, W.L., Stegeman, J.J., 1994. Catalytic and
immunochemical characterization o f hepatic microsomal cytochromes P450 in
beluga whale {Delphinapterus leucas). Toxicol. Appl. Pharmacol. 126, 45-57.
White, R.D., Shea, D., Schlezinger, J.J., Hahn, M.E., Stegeman, J.J., 2000. In vitro
metabolism o f polychlorinated biphenyl congeners by beluga whale
{Delphinapterus leucas) and relationship to cytochrome P450 expression. Comp.
Biochem. Physiol. 126C, 267-284.
Wolkers, J., Witkamp, R.F. Nijmeijer, S.M., Burkow, I.C., de Groene, E.M. Lydersen, C.
Dahle, S. Monshouwer, M., 1998. Phase I and phase II enzyme activities in
ringed seals {Phoca hispida): characterization o f hepatic cytochrome P450 by
activity patterns, inhibition studies, mRNA analyses, and western blotting. Aquat.
Toxicol. 44,103-115.
Wolkers, H., Van Bavel, B., Derocher, A.E., Wiig, 0 ., Kovacs, K.M., Lydersen, C.,
Lindstrom, G., 2004. Congener-specific accumulation and food chain transfer o f
polybrominated diphenyl ethers in two Arctic food chains. Environ. Sci. Technol.
38, 1667-1674.
World

Health Organization, 1994. Polybrominated
Environmental Health Criteria, Geneva, 162.

diphenyl

ethers.

IPCS,

Zhou, T., Taylor, M.M., Devito, M.J., Crofton, K.A., 2002. Developmental exposure to
brominated diphenyl ethers results in thyroid hormone disruption. Toxicological
Sciences 6 6 , 105-116.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

42

CHAPTER 2

Characterization and Profiling of Hepatic Cytochromes P450 and Phase
II Xenobiotic-Metabolizing Enzymes in Beluga Whales {Delphinapterus

leucas) from the St. Lawrence River Estuary and the Canadian Arctic1"

2.1 Introduction
Marine mammals are particularly susceptible to contamination by organohalogens
due to their large lipid reserves, relatively long life spans and elevated positions in the
aquatic food web. A small, isolated and endangered population o f beluga whales
{Delphinapterus leucas) inhabits the St. Lawrence (SL) Estuary in Quebec, Canada, an
area downstream o f many sources o f industrial and agricultural contaminants.
Polychlorinated biphenyls (PCBs), organochlorine pesticides and other organohalogen
contaminants have been detected in SL beluga tissues (e.g. Martineau et al., 1988; Muir
et al., 1996; Gauthier et al., 1998; Metcalfe et al., 1999; Hickie et al., 2000; Hobbs et al.,
2003) not only at elevated levels in comparison to Canadian Arctic (CA) belugas
(Norstrom and Muir, 1994; Metcalfe et al., 1999), but also at levels known to elicit toxic

*M.A. McKinney, A. Arukwe, S. De Guise, D. Martineau, P. Beland, A. Dallaire, S. Lair,
M . L eb eu f, R.J. Letcher, 2 0 0 4 . Aquat. Toxicol. 6 9 , 35 -4 9 .
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effects in laboratory animals (Beland et al., 1993). A link has been suggested between
tissue organochlorine levels and the health o f the SL population (Martineau et al., 1994).
Reproductive and immunological impairment and a high incidence o f neoplasms are all
strongly associated with pollutant exposure (De Guise et al., 1995).
Metabolic capacity is an important determinant in the bioaccumulation,
biomagnification, toxicokinetics and potential toxicity o f lipophilic organohalogen
contaminants. The cytochrome P450 monooxygenases (CYPs) play a central role in the
oxidative biotransformation (phase I) o f a wide range o f xenobiotic and endogenous
compounds (Goksoyr and Forlin, 1992; Stegeman and Hahn, 1994; Lewis et al., 1998).
Products from phase I metabolism are conjugated to larger endogenous molecules via
catalytic mediation by phase II enzymes such as glutathione-S-transferase (GST) and
uridine diphosphoglucuronosyl transferase (UDPGT) (George, 1994; Wolkers et al.,
1998). Phase I and II enzymes, most abundant in hepatic tissues, may transform lipophilic
compounds into either detoxified or bioactivated forms. As there are qualitative and
quantitative differences in the levels and inducibility o f individual CYP isozymes among
species and populations o f species (Boobis et al., 1990; Smith, 1991), it is important to
determine the ability o f exposed animals to metabolically influence the toxicokinetics and
fate o f accumulated anthropogenic contaminants. There is limited documentation on the
metabolic capacity o f marine mammals towards xenobiotic compounds, and most reports
are from seal populations of various species (Boon et al., 1992; Nyman et al., 2001).
However, immunochemical characterization o f CYP isozymes has been reported for
some whale species and populations, mainly for families from the odontocete suborder.
White et al. (1994, 2000) found homologues o f CYP1A, CYP2B and CYP2E in the liver
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o f CA beluga (White et al., 1994, 2000) and a CYP1A isoform has been characterized in
various tissues o f SL beluga (Wilson et a l, 2000). CYP IB, CYP3A-like and CYP4A
isozymes have been discovered in striped dolphin (Stenella coeruleoalba), pilot whale
(Globicephala melas), minke whale (Balaenoptera acutorostrata) and/or sperm whale
(Physeter macrocephalus) (Goksoyr et al., 1988, 1989; Goksoyr, 1995; Celander et al.,
2000; Godard et al., 2000; Boon et al., 2001). In beluga, catalytic characterization has
been limited to CYP 1A-mediated EROD, PROD, MROD (7-ethoxy-, pentoxy- and
methoxyresorufm 0-deethylase, respectively) and AHH (aryl hydrocarbon hydroxylase)
activities (White et al., 1994, 2000; Addison et al., 1998). These studies rely on
enzymatically-active hepatic tissues, but in contrast to laboratory specimens, it is often
difficult to obtain well-preserved, enzymatically-viable tissues from stranded freeranging animals. Therefore, catalytic activity as a quantitative indicator o f metabolic
potential is questionable in situations where liver preservation cannot be assured.
Immunological profiling is a more robust technique to measure phase I and II enzymes,
providing suitably cross-reactive Ab interactions are found. On the other hand,
immunochemical characterization is not necessarily fully representative o f existing
protein profiles as identification depends on the constitutive and induced levels, and on
the cross-reactivity o f the selected antibodies for specific microsomal proteins (Goksoyr,
1995; Letcher et al., 1996; Lewis, 2000).
To more completely determine the metabolic potential o f beluga whale, a more
comprehensive assessment is required o f hepatic xenobiotic-metabolizing enzymes in
individuals from populations o f contrasting exposure to contaminants that are capable o f
enzyme induction or suppression. In the present study, major phase I and II isozymes,
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CYP1A, CYP2B, CYP3A, CYP2E, EH and UDPGT, known to be involved in xenobiotic
metabolism, were immunologically and catalytically characterized in the hepatic
microsomes o f belugas from the SL (tissue collected from stranded individuals) and from
the Arviat region o f western Hudson Bay in the Canadian Arctic (fresh tissue collected as
part o f native subsistence hunting). The results were used to evaluate the use o f
immunologic expression and catalytic activity o f xenobiotic-metabolizing enzymes in the
optimally preserved liver o f beluga from a CA population as a model o f metabolic
potential in SL and other beluga populations.

2.2 Materials and Methods
2.2.1 Reagents
Bovine serum albumin (BSA), Coomassie Brilliant Blue G-250, potassium
chloride, sodium dithionite, L-ascorbic acid, phenazine methosulfate, 7-ethoxyresorufm,
resorufin, sodium dodecyl sulfate (SDS), bromophenol blue, 4-chloro-1-naphthol, Brij58,

1 -naphthol,

1-naphthyl

P-D-glucuronide

sodium

salt

and

uridine

5'-

diphosphoglucuronic acid trisodium salt were purchased from Sigma (St. Louis, MO,
USA). Disodium ethylenediaminetetraacetate (Na2 EDTA), acrylamide/bisacrylamide
solution (30% w/v, monomer to cross-linker ratio o f 37.5:1), ammonium persulfate,
N,N,N',N'-tetramethylenediamine

(TEMED),

f3-mercaptoethanol,

glycine,

polyoxyethylene sorbitan monolaurate (Tween-20) and gelatin were acquired from BioRad Laboratories (Mississauga, ON, Canada).

Dithiothreitol (DTT), glycerol, 95%

ethanol, 85% phosphoric acid, sodium dihydrogen phosphate, HPLC grade methanol,
concentrated HC1, NaOH pellets and hydrogen peroxide (30% w/v) were obtained from
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EM Science (Gibbstown, NJ, USA). HPLC-grade dichloromethane and acetonitrile were
obtained from Merck (Darmstadt, Germany). Sodium chloride and P-nicotinamide
adenine dinucleotide phosphate (NADPH) reduced, tetrasodium salt were acquired from
Fluka (Buchs, SG, Switzerland). NADPH regenerating system solutions A (NADP+,
glucose-6 -phosphate, MgCL) and B (glucose-6 -phosphate dehydrogenase) were supplied
by Gentest (Woburn, MA). Tris(hydroxymethyl)-aminomethane was purchased from
Aldrich (Milwaukee, WI, USA). Dipotassium hydrogen orthophosphate (K 2 HPO 4) was
obtained from BDH Chemicals (Toronto, ON, Canada). Carbon monoxide was procured
from BOC (Mississauga, ON, Canada). Testosterone, androstenedione, 2a-, 6 a-, 6 p-, 7a , lip*, 15a-, 16a- and 16p-hydroxytestosterone were obtained from Steraloids (Wilton,
NH). Water was supplied by a Milli-Q system (Millipore, San Jose, CA) with a 0.22 pM
filter.
The following primary polyclonal antibodies were used for immunochemical
detection o f phase I and II proteins: goat anti-rat CYP1A1 (1:1000 dilution, Gentest),
rabbit anti-rat CYP2B1 (1:1000 dilution, Research Diagnostics, Flanders, NJ), rabbit anti
rainbow trout CYP3A iso-enzyme (1:1000 dilution, kindly donated by Dr. Malin
Celander, University o f Goteborg, Goteborg, Sweden), rabbit anti-human CYP2E1
(1:1000 dilution, Research Diagnostics), goat anti-rabbit EH (1:1000 dilution, Oxford
Biomedical Research, Oxford, MI) and rabbit anti-human UDPGT1A1 (1:500 dilution,
Gentest). The secondary antibodies were donkey anti-goat IgG (1:2500 dilution, Research
Diagnostics) for CYP1A and EH and goat anti-rabbit IgG (1:3000 dilution, Bio-Rad
Laboratories) for detection o f all other proteins. A pre-stained molecular weight standard
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was purchased from Bio-Rad Laboratories and a specific human UDPGT1A1 molecular
weight standard was acquired from Gentest.

2.2.2 Sample collection
Liver tissues were obtained from five SL belugas stranded in the summers o f
2000 and 2001. The samples, identified as SL1, SL2, SL3, SL4 and SL5, were excised
12-18 hours after discovery o f the carcass and immediately stored in liquid nitrogen. A
sixth individual, SL6 , was stranded alive in the summer o f 2003 and had to be
euthanized; hepatic tissue was taken within 15 min after death and frozen on dry ice for 2
d until it could be stored at -8 0 °C. Tissue degradation in these stranded SL animals is
ranked by the extent o f autolysis, which was measured histologically (Table 2.1).
Autolysis was minimal in SL6 and mild in SL4; however, all other SL samples were
moderately to severely autolysed. Liver tissues from ten CA belugas were obtained
during native subsistence hunting in August o f 2002 (CA1, CA2, CA3, CA4, CAS) and
2003 (CA 6 , CA7, CA 8 , CA9, CA10). All carcasses were sampled within 30-90 min o f
death, and liver samples were immediately transferred in the gas phase o f a liquid
nitrogen dry shipper. After transport, all samples were frozen at -8 0 °C. Biological and
physiological details on the SL and CA individuals are provided in Table 2.1.
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Table 2.1. Sample collection, biological and physiological data for beluga whale (A)
from the St. Lawrence River Estuary (Quebec) and (B) from the Canadian Arctic
(Nunavut).
A
Sample
ID
SL1
SL2
SL3
SL4
SL5
SL6

Sex
F
M

Age
(yr)
4.5
27

Length
(cm)
316.0
410.0

Weight
(kg)
625.0
410.0

Extent of
autolysis
Extreme
Extreme

Date
stranded
07/26/00
07/29/01

Location stranded

M
F
M
F

5.5
3.5
27.5
Neonate

298.0
300.0
385.0
144.0

342.0
334.5
839.5
41.5

Moderate
Mild
Marked
None

09/28/01
1 0 /0 2 / 0 1
11/19/01
07/31/03

Length
(cm)
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND

Weight
(kg)
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND

Date coUected

Location collected

08/11/02
08/11/02
08/12/02
08/12/02
08/12/02
08/06/03
08/06/03
08/06/03
08/08/03
08/09/03

Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay
Arviat, w. Hudson Bay

Tadoussac
lie au Caribou, Cote
Nord
lie Verte
Pointe-au-Pere
Baie du HaHa, Bic
Ste-Luce-sur-Mer

(<2d)

B
Sample Sex
ID
CA1
F
CA2
F
F
CA3
CA4
F
F
CA5
CA6
F
F
CA7
M
CA8
M
CA9
M
CA10

Age*
Adult
Juvenile
Adult
Neonate
Adult
Adult
Adult
Adult
Juvenile
Adult

^Estimated from skin colour (See Materials and Methods section).
ND = not determined.
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The age classification o f the SL and CA belugas, regardless o f precise age as in
the case o f the CA animals, was based on established practices. Based on data collected
from two Arctic beluga populations, sexual maturity o f beluga to adults occurs at
approximately 7 years o f age for females and

8

years o f age for males as indicated by a

transition o f the skin colour from grey to white (Hobbs et al., 2003). Therefore, SL1, SL3
and SL4 were juveniles and SL2 and SL5 were older adults. With the exception o f CA2
and CA9 (juveniles) and CA4 (neonate), all the CA belugas were adults.

2.2.3 Preparation o f hepatic microsomes
Microsomes were prepared by differential ultracentrifugation as described by
Nilsen et al. (1998). Briefly, liver tissues were thawed on ice. Three volumes (liver
weight per volume) o f buffer (0.1 M K 2 H P 0 4, 0.15 M KC1, 1 mM Na2 EDTA, 1 mM
DTT, 20% glycerol, pH 7.4) were added and the mixture was homogenized with an
Ultra-Turrex. The homogenate was centrifuged at 12 500 g (20 min, 4 °C). The
supernatant was centrifuged at 100 000 g (60 min, 4 °C). The pellet was resuspended in
one volume o f buffer (0.1 M K 2 HPO 4 , 1 mM Na 2 EDTA, 1 mM DTT, 20% glycerol, pH
7.4) and stored at -8 0 °C.

2.2.4 Microsomal protein and total cytochrome P450 content
Microsomal protein content was determined by the spectrophotometric method o f
Bradford (1976) using BSA as the standard (0.2 to 1.0 mg/ml). Absorbance was
measured using a Dynatech Labs MRX UV/Vis microplate reader equipped with a 570 ±
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5 nm filter. Total CYP content was initially assessed by the dithionite-difference spectra
of carbon monoxide-treated microsomes (Omura and Sato, 1964) using a Cary 300 Bio
dual-beam UV-Vis spectrophotometer. However, a large peak at 420 nm suggested
possible CYP degradation or hemoglobin and methemoglobin contamination. Treatment
with ascorbic acid and phenazine methosulfate allowed for measurement o f cytochrome
P450 content in the presence o f these contaminating proteins (Johannesen and DePierre,
1978).

2.2.5 Catalytic assays
The 7-ethoxyresomfin-O-deethylase (EROD) activity was assessed using the
fluorescence microplate assay o f Eggens and Galgani (1992). EROD activity in the
beluga microsomes was measured under optimized assay conditions (e.g., pH 8.0 and 37
°C) based on previously published procedures (White et al., 1994, 2000). Testosterone
hydroxylase activity was determined as per the method o f Li and Letcher (2002) based on
grey seal hepatic microsomes including the use o f 6 a-hydroxytestosterone as internal
standard, with a few exceptions. The buffer was set to pH 8.0 and the incubation mixtures
were pre-incubated for 5 min at 37 °C. At time t = 0 min, one addition o f NADPH
regenerating system was added (50 pi solution A, 10 pi solution B). Testosterone
metabolism was analyzed using a Waters 2695 Alliance HPLC system equipped with a
Zorbax Eclipse XDB-C18 column (5 pm, 250 x 4.6 mm i.d.) and a Waters 2487 UV-Vis
detector. Phase II glucuronidation was assessed using 1-naphthol as the substrate
(Wolkers et a l, 1998). In a total reaction volume o f 200 pi, 100 mM phosphate buffer
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(pH 8.0, 3 mM MgGh), 250 pM 1-naphthol, 1 mg/ml microsomes and Brij-58 (1 mg/ml)
were pre-incubated for 5 min at 37 °C. The reaction was initiated by UDP-glucuronic
acid (3 m M ) and was terminated by cold acetonitrile (200 pi) after 20 min. Mixtures were
vortexed, left on ice for 30 min, then centrifuged (2000 rpm, 10 min). The supernatant
was filtered through a 0.45 pm syringe filter and 5 pi was analyzed by HPLC using a
Jasco FP-920 fluorescence detector (A,ex = 290 nm, 7,em - 330 nm). A 200 pM 1naphthylglucuronide (1-NG) standard was prepared in methanol, and calibration curve
standards were prepared by serial dilution. 1-NG was eluted with lOmM NaH 2PC>4 (pH
2.5, 17.5% acetonitrile) (Wortelboer et al., 1992). The flow rate was set to 2.0 ml/min for
a total run time o f 20 min (retention time o f 1-NG was 15.4 min).

2.2.6 Immunochemical analysis
Microsomal proteins (45 pg per well) were separated by SDS-polyacrylamide gel
electrophoresis (Laemmli, 1970) and electroblotted from the gel onto a nitrocellulose
membrane (Towbin et al., 1979). Proceeding application o f the primary antibody, an
appropriate horseradish peroxidase (HRP)-labeled secondary antibody was incubated
with the membranes, followed by an HRP-colour reagent (4-chloro-1-napthol plus
hydrogen peroxide solution) to visualize the cross-reactive bands. Molecular weights
were approximated by comparison with a simultaneously run pre-stained molecular
weight standard (5 pi in well).
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2.2.7 Data analysis
The precision o f all assays was assessed by intraday (n > 3) replicate analysis for
each individual beluga. It was not possible to assess the statistical significance o f the
differences in specific catalytic activities for the CA and SL animals as a function o f sex
or age because o f the small number o f individual belugas, due to the inherent difficulty
and cost in obtaining samples. In the case o f the SL animals, catalytic activities were
generally not detectable. However, among adult CA animals it was possible to
statistically assess the significance o f the simple linear regression between pairings o f
EROD, testosterone hydroxylase and UDPGT activities. All hypotheses tested were twotailed and were based on a maximum probability o f a type-I error (a) that was set at 0.05
(p < 0.05).

2.3 Results
2.3.1 Microsomal protein and total CYP content
Microsomal protein and total CYP contents o f the beluga liver samples are given
in Table 2.2. Dithionite difference spectra o f SL1 to SL5 showed a peak at 420 nm, but
not at 450 nm, even when treated with ascorbic acid and phenazine methosulfate (PMS)
to remove the interfering CO-hemoglobin peak at 420 nm. Spectra o f SL 6 and the CA
individuals showed a large 420 nm peak and no detectable 450 nm peak using the
conditions o f Omura and Sata (1964). However, when the SL 6 and CA1 to CA10
microsomes were treated with ascorbic acid and PMS, a clear P450 peak was revealed
and detected (spectra not shown).
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Table 2.2. Microsomal protein content, CYP content and monooxygenase activity in the
livers o f stranded St. Lawrence and captured Canadian Arctic beluga whale.
Microsomal yield
Total CYP*
EROD
(mg microsomal protein/g tissue) (pmol/mg protein) (pmol/mg protein/min)
ND
SL1
ND
2.9 ±0.1
ND
SL2
ND
1 .6 ± 0 .1
ND
ND
SL3
2.9 ± 0.4
ND
SL4
6.3 ± 0.2
12 ± 1
ND
ND
SL5
3.1 ±0.4
170
SL6
8.4 ± 0.3
87 ± 15
CA1
180
1 1 .0 ± 2 .0
107 ± 6
140
CA2
13.0 ± 1.0
51 ± 3
130
CA3
11.2 ±0.4
61 ± 2
CA4
130
16.0 ± 2 . 0
107 ± 10
60
CA5
8.2 ± 0.5
33 ± 2
170
CA6
7.7 ±0.1
99 ±5
80
CA7
6.7 ± 0.2
6 6 ± 10
180
CAS
8 .1 ± 0 .2
90± 13
90
CA9
6.3 ± 0.2
47± 10
240
CA10
5.5 ±0.1
260 ± 2 0
Values are means ± SD (n > 3 replicates).
* Replicate analyses were not possible due to limited available tissue (microsomes).
ND = Not detectable.
Sample ID
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2.3.2 Phase I and II enzyme activities
Microsomal CYP1A activities, as measured by EROD activity, were not
detectable for the SL1, SL2, SL3 and SL5 belugas, whereas activity in the SL4 animal
was low but measurable (12 ± 1 pmol/mg/min). In contrast, the freshly sampled SL6
neonate had a mean EROD activity o f 87 ± 15 pmol/mg/min. The average EROD rates
in the hepatic microsomes o f the CA individuals were 68 ±34 pmol/mg/min in the three
juveniles, 73 ± 30 pmol/mg protein/min in the five adult females, and highest at 175 ± 85
pmol/mg/min in the two adult males (Table 2.2).
Fig. 2.1 presents the measurable testosterone hydroxylase activities in the hepatic
microsomes. The major hydroxytestosterone metabolite formed in all o f the CA
microsomes, and in SL6, was

6

p-hydroxytestosterone. In SL6 , the mean rate o f 613-

testosterone hydroxylase was 351 ± 4 2 pmol/mg/min, and was 343 ± 235, 613 ± 304, 450
± 115 pmol/mg/min in the CA juveniles, females and males, respectively. The other
minor metabolite detected in 9 o f the 10 CA assay samples was identified as
androstenedione, whereas 2a-,

6

a -, 7a-, 15a-, 16a- and 16P-hydroxytestosterone

metabolites were not detectable. No measurable hydroxytestosterone metabolite
formation was found for SL1 to SL5. There was no significant correlation between the
rates o f

6

P-hydroxytestosterone formation {p < 0.05, r 2 = 0.02, n = 10 samples) or

androstenedione formation (p < 0.05, f = 0.07, n = 9 samples) with CYP 1A-mediated
EROD activity in the CA animals. However, there was a significant positive correlation
{p < 0.05, r2 = 0.35, n = 9) between the rates o f

6

p-hydroxytestosterone and

androstenedione formation in the CA belugas.
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Fig. 2.1. Testosterone metabolism to 6 p-hydroxytestosterone (white bars, n = 3) and
androstenedione (black bars, n = 3) in the hepatic microsomes o f St. Lawrence River
Estuary (SL) and Canadian Arctic (CA) beluga whales. Microsomes (1 mg/ml) were
incubated with 250 pM testosterone at 37°C in phosphate buffer (lOOmM NaKLPCL, pH
8.0, 3mM MgCL, ImM EDTA), and the reaction was initiated by the addition ofNADPH
regenerating solution. Error bars represent the standard deviation.
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UDPGT activity in the beluga microsomes as measured by the rate o f 1-NG
formations is given in Fig. 2.2. The formation rate o f 1-NG was comparable for the CA
juveniles, adult females and adult males, at values o f 1922 ± 1063, 3076 ± 1237 and 2791
± 1 1 0 2 pmol/mg/min, respectively. For SL6, the 1-NG formation rate was 830 ± 244
pmol/mg/min.
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Fig. 2.2. Formation o f 1-naphthylglucuronide in the hepatic microsomes o f St. Lawrence
River Estuary and Canadian Arctic beluga whales. Microsomes (1 mg/ml) were incubated
with 250 pM 1-naphthol and 1 mg/mg (protein) Brij-58 at 37°C in PBS (lOOmM, pH 8.0,
3mM MgCfe). The reaction was initiated by the addition o f UDP-glucuronic acid (3 mM).
Each bar is the mean o f n = 3 replicates, and error bars indicate the standard deviation.
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2.3.3 Immunodetection o f phase I and IIproteins
W estern blotting o f the microsomal fractions with the anti-rat CYP1A1 antibody
revealed tw o distinct cross-reactive protein bands (around 50 and 53 kDa) in all the SL
and CA samples comparable to the characteristic molecular weight range for CYP
proteins (Fig. 2.3A). Using the CYP2B1 Ab, two weak bands at 48 and 55 kDa were seen
for SL6 and the CA beluga (Fig. 2.3B). A band cross-reactive with anti-rainbow trout
P450con (a putative CYP3A homologue) was visible at a molecular weight o f
approximately 52 kDa (Fig. 2.3C) in the SL and CA samples. Blotting with anti-CYP2E
resulted in one distinct band for all samples at a molecular weight near 53 kDa (Fig.
2.3D). Addition of anti-rabbit EH resulted in a strong band at around 52 kDa in the SL
and CA belugas (Fig. 2.3E).
Detectable cross-reaction with anti-human UDPGT1A was seen for SL4, SL5 and
SL6 (Fig. 2.3F). The mobility o f these approximately 50 kDa bands was comparable to
that o f a concurrently run human UDPGT1A molecular weight standard (about 56kDa,
Fig. 2.3F). In SL1, SL5 and SL6 a cross-reactive band was seen at around 45 kDa.
Further investigation is required to identify this protein, as the mobility is within the
appropriate range o f a UDPGT protein. All ten o f the CA samples exhibited both o f the
45 and 50 kDa bands.
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Fig. 2.3. Immunoblot o f St. Lawrence River Estuary and Canadian Arctic beluga whale
hepatic microsomes cross-reacted with (A) goat anti-rat CYP1A1 polyclonal antibody
(PAb) at a 1:1000 dilution, (B) rabbit anti-rat CYP2B1 PAb at a 1:1000 dilution, (C)
rabbit anti-rainbow trout CYP3A PAb at a 1:1000 dilution, (D) rabbit anti-human
CYP2E1 PAb at a 1:1000 dilution, (E) goat anti-rabbit EH PAb at a 1:1000 dilution, (F) a
rabbit anti-human UDPGT antibody at a 1:5Q0 dilution. An HRP-conjugated donkey anti
goat secondary antibody at a 1:2500 dilution was used to visualize CYP1A- and EH-type
protein bands. An HRP-conjugated goat anti-rabbit secondary antibody at a dilution o f
1:3000 was applied to visualize CYP2B-, CYP3A-, CYP2E and UDPGT-type bands. All
sample wells were loaded with 45 pg o f beluga hepatic microsomal protein. The first lane
was loaded with 5 pi o f molecular weight standard (Mw Std.). All membranes were
scanned at the same resolution and exposure except for the CYP2B membranes, which
were scanned at a higher exposure to ameliorate visualization o f faint cross-reactive
CYP2B-type bands.
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Two general points regarding the blots should be noted. Firstly, the CA beluga
protein bands were generally more intense (except in comparison to SL4 and SL6 ) and
the intensities varied less between individuals than the band intensities o f the SL
individuals. Secondly, although putative P450 cross-reactive protein bands in the MW
range for CYP proteins were detected in all CA lanes, often proteins in only a few o f the
SL samples exhibited cross-reactivity when incubated with the same antibodies under
identical immunoblotting conditions. It should also be noted that samples for each o f Fig.
2.3(A-F) were not all run in the same gel (due to a limited number o f lanes in each gel) or
in gels with the same lane width (i.e. 5 vs. 10 lanes). Therefore, membranes in the figure
were scaled as closely as possible to the same size, and bands from each population were
grouped together for clarity. It may thus appear that there are variations in band
mobilities; however, the band mobilities were calculated using the molecular weight
standard run with every gel (not all shown in Fig. 2.3) and showed no major differences
when comparing the same bands run on different gels.

2.4 Discussion
Although biotransformation is often a major factor in the toxicokinetics and fate
of organic contaminants, little is known regarding characterization and catalytic activity
o f phase I and II xenobiotic-metabolizing enzymes in marine mammals. A greater
understanding o f metabolic potential is particularly important in marine mammals that
are exposed to high levels o f contaminants, such as those living in the St. Lawrence River
Estuary. In this study, antibodies against different phase I and II isozymes showed cross
reactivity with homologous proteins in beluga liver microsomes. EROD, testosterone
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hydroxylase and UDPGT catalytic activities measured mainly in the CA animals were
consistent with the immunologically characterized enzyme proteins. Our study reports for
the first time in any cetacean species the catalytic and immunochemical detection o f
hepatic UDPGT and the immunochemical detection o f a hepatic EH protein. Despite the
specificity o f the different antibodies toward the respective proteins, there were
artifactual and non-specific cross-reactivities o f some antibodies due to the less specific
nature o f polyclonal antibodies (Luzio and Jackson, 1998).

2.4.1 CYP1A
The expression o f CYP1A is highly inducible across taxa, including marine
mammals, via an aryl hydrocarbon receptor-mediated mechanism as a consequence o f
exposure to AhR-active substrates such as polychlorinated dibenzo-p-dioxins (PCDDs)
and

dibenzofurans

(PCDFs)

and

other planar,

dioxin-like

contaminants

(e.g.,

benzo[a]pyrene and non-ortAo-chlorinated PCBs). Beluga whales from SL and Arctic
populations are exposed to contrasting levels and patterns o f AhR agonists (Metcalfe et
a l, 1999). However, an immunologic comparison o f CYP1A in individual belugas from
SL and a CA population has not been reported. Previously, the only published study on
hepatic CYP enzymes in beluga whale, from the MacKenzie River Delta (White et al.,
1994), revealed the presence of one CYP1A band at 53 kDa using a monoclonal anti-scup
antibody and a polyclonal anti-mouse antibody that is cross-reactive with CYP1A1 and
1A2 in mice and rats. Using the anti-rat antibody, which recognizes both rat CYP1A1 and
1A2, two distinct bands were detected in both the SL and CA (Arviat, western Hudson
Bay) samples. We postulate that the 53 kDa band is a CYP1A1 homologue based on
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electrophoretic migration (White et a l, 1994). The 50 kDa band may suggest the
presence o f a CYP1A2 homologue, according to previous studies o f CYP1A1 and 1A2
type proteins in other marine mammals using polyclonal anti-CY PlA l antibodies. In
1998, Goksoyr et al. using an anti-cod CYP1A1, reported two bands at 54 and 51-52 kDa
in minke whales which were thought to be CYP1A1 and CYP1A2-Iike. Bandiera et al.
(1995) reported the cross-reactivity o f a polyclonal anti-rat CYP1A1 antibody with two
separate proteins in polar bear microsomes, which the authors suggested were CYP1A1
and CYP1A2. The anti-rat CYP1A1 we used cross-reacts with rat CYP1A1 (52 kDa) and
1A2 (50 kDa). White et al. (1994) had previously suggested that expression o f CYP1A2
may have been too low to detect or that the enzyme did not exist in the individual beluga
(i.e., from the population in the MacKenzie River Estuary) that were examined. A further
explanation may be that the affinity o f the anti-mouse antibody for the CYP1A2 protein
in the liver o f the MacKenzie River beluga was less than that o f the anti-rat antibody used
in the present study. The presence o f a beluga protein similar to rat CYP1A2,
nonetheless, can only be suggested by our data and indicates the need for further
investigation.
We measured similar EROD activity levels in the CA belugas as was reported in
the MacKenzie River beluga collected in 1989 (White et al., 1994). Histological
examination revealed that SL4 was the least autolyzed o f the dead stranded SL beluga.
Although the EROD activity was low, the Ab cross-reactivity o f CYP1A proteins in SL4
was most intense o f all the animals under study, despite the apparently poorer tissue
preservation relative to the CA animals. This suggests that if appropriately preserved
adult liver tissue could be obtained, higher expression o f CYP1A protein would be
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observed, consistent with higher levels o f AhR agonist exposure in SL beluga than in the
CA belugas.

2.4.2 CYP2B
Isozymes o f the CYP2, CYP3 and CYP4 subfamilies are also inducible in
mammals (Lewis and Lake, 1997; Lewis, 2000). In polar bear, the expression o f CYP2B1
cross-reactive protein was highly correlated with levels o f ortho-chlorine substituted
PCBs and chlordane pesticides (Bandiera et al., 1995; Letcher et al., 1996). However,
immunochemical assessment o f the expression o f CYPs other than CYP1A is rare in
cetaceans, and comparisons among individuals from different populations are not known
(White et al., 1994, 2000; Boon et al., 2001). CYP2B substrates are usually nonplanar,
lipophilic compounds (Lewis et al., 1998). It has been postulated that marine mammals
are basically deficient in CYP2B-associated proteins (Goksoyr, 1995). Until recently,
there has been little immunochemical evidence o f CYP2B proteins in cetaceans. For
example, White et al. (1994) did not detect bands using polyclonal and monoclonal anti
rat antibodies against CYP2B, nor with a putative anti-scup CYP2B antibody. Cross
reactive bands were, however, visible using anti-rabbit CYP2B4 and anti-dog CYP2B11
polyclonal antibodies. Little to no CYP2B-like protein expression has been reported for
other cetacean species from any location. Goksoyr (1995) found low cross-reactivity in
minke whale using the Amersham ECL CYP2B1/2 kit. Boon et al. (2001) did not detect a
cross-reactive protein with a monoclonal anti-rat CYP2B1/2 in the liver o f sperm whale
(Physeter macrocephalus). The polyclonal anti-rat CYP2B1 antibody used in the present
study specifically recognizes rat CYP2B1 and CYP2B2. Two weakly cross-reactive

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

65

bands were observed in SL6 and in CA1-10. We conclude from the electrophoretic
migration that the two bands represent CYP2B-type proteins.
In this study, major metabolites associated with CYP2B activity in mammals,
16a- and 16P-hydroxytestosterone (Arlotto et al., 1991), were not detected in any o f the
beluga samples using the testosterone hydroxylase assay. However, androstenedione
formation was measurable in the CA animals, and is also known to be catalyzed in part
by CYP2B1 in rats (Arlotto et al., 1991). It is also possible that for beluga whale in
general, testosterone is a poorer substrate for CYP2B-like enzymes. Evidence supporting
the existence o f CYP2B-type catalytic activity in SL and CA beluga whales comes from
the fact that animals from both populations are capable o f metabolizing ortho-chlorine
substituted PCBs, known to be CYP2B1 substrates in rodents (McFarland and Clarke,
1989), leading to the formation o f methylsulfonyl- (MeSC>2 -) PCBs (Letcher et al.,
2000b). However, it is difficult to conclude that MeSCVPCB and MeSCh-DDE formation
is contingent only on CYP2B-like mediation o f precursor PCB metabolism. In seals for
example, other CYP isozymes (e.g. CYP3A) are involved in the PCB arene oxide
formation from ortho-chlorine substituted PCB congeners (Li et al., 2003).

2.4.3 CYP3A
CYP3A is a constitutive P450 that metabolizes steroid hormones, but it is also
associated with the biotransformation o f xenobiotics such as the chlorobomanes and
PCBs in seals (van Hezik et ah, 2001; Li et al., 2003). Immunoblots with anti-P450con
identified a single CYP3A-like protein in SL and CA beluga liver microsomes. Recently,
Celander et al. (2000) confirmed the presence (particularly in liver) o f CYP3A-like
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enzymes in various tissues o f four pilot whales by immunochemical methods.
Testosterone hydroxylase activities and Western blotting have also implicated the
existence o f CYP3A-like enzymes in minke whale (Goksoyr et al., 1988, 1989). The
molecular weight o f the CYP3A-type protein found in our beluga study, 52 kDa,
compares favourably with the immunological results for other cetacean species. 60Hydroxytestosterone formation is a marker o f CYP3A activity in mammals, and in all CA
and

SL 6

microsomes

the

major

conversion

of

testosterone

was

to

60-

hydroxytestosterone. A significant correlation between 60-hydroxytestosterone and
androstenedione formation would suggest that CYP3A mediates, at least in part, the
formation o f androstenedione in beluga whales.

2.4.4 CYP2E
CYP2E enzymes metabolize substrates o f relatively low molecular weight and
diverse structure (Lewis et al., 1998) and are associated with xenobiotic metabolism
(Peter et al., 1990). The rabbit anti-human CYP2E1 antibody used in this study is reactive
towards CYP2E1 in humans and CYP2E proteins in rat, rabbit and hamster hepatic
microsomal fractions. A hepatic CYP2E-like protein detected in the SL and CA animals
is in agreement with the previous immunochemical findings in the liver o f MacKenzie
River delta beluga (White et al., 1994).
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2.4.5 Epoxide hydrolase
Currently, no literature has been published on the existence of EH in either
cetaceans or pinnipeds, although Bandiera et al. (1995) immunochemically characterized
this enzyme in polar bear, which is at the top o f the Arctic marine food web. EH is an
important enzyme in the formation o f hydroxylated (HO) metabolites o f halogenated
aromatic contaminants such as PCBs (Letcher et al., 2000a). HO-PCBs and HOpolybrominated diphenyl ethers (PBDEs) are generally thought to be formed via CYPmediated formation o f arene epoxide intermediates or possibly via direct aromatic
hydroxylation o f PCB and PBDE congeners (Letcher et al., 2000a; Hakk and Letcher,
2003). The only known report o f HO-PCBs and HO-PBDEs in a cetacean species was in
the blood o f killer whale (Orcinus orca) fed a diet o f wild Pacific herring (Clupea
pallasi) (Bennett et al., 2004). Although a constitutive enzyme, EH exhibits moderate
induction by certain anthropogenic compounds, such as Arochlor 1254 in humans
(Hassett et al., 1998). The presence o f an EH protein similar to that found in rabbit is
indicated by the immunoblots o f all SL and CA beluga samples. To our knowledge this is
the only study on EH in marine mammals other than polar bear (Bandiera et al., 1995);
the importance o f EHs in xenobiotic metabolism calls for further investigation o f these
enzymes.

2.4.6 UDP-Glucuronosyltransferase
Limited knowledge exists regarding phase II enzymes in belugas and in marine
mammals in general. MeSCVPCB and -D D E metabolites found in the adipose tissue o f
SL and western Hudson Bay beluga is chemical marker evidence o f phase II glutathione
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conjugation with meta-para arene oxide intermediates formed via CYP enzymemediation from precursor PCBs (Letcher et a l, 2000b).

Goksoyr et al. (1988) found

UDPGT catalytic activities o f 640 and 55.4 pmol/mg/min towards 4-nitrophenol and
testosterone metabolism, respectively, in minke whale.

Wolkers et al. (1998)

characterized UDPGT activity in ringed seal (Phoca hispida) hepatic microsomes by
measuring the glucuronidation activity towards 1-naphthol metabolism. We found very
similar 1-naphthylglucuronide formation rates in the CA belugas. The UDPGT activity of
the neonate, SL 6 , was within the range o f activities found in the juvenile CA belugas.
Western blotting showed a UDPGT-type protein in three o f the SL belugas and all o f the
CA belugas we studied, with electrophoretic migrations comparable to that o f a human
molecular weight standard. The molecular weights o f UDPGT in the samples and the
standard are not expected to be identical due to potential differences in glycosylation o f
the proteins (Gentest).
A number o f variables, such as enzyme induction or suppression, nutritional and
reproductive status, age, sex and genetic variation, may account for differences in protein
expression and catalytic activity (and thus, contaminant biotransformation capacity)
among individual belugas and populations. Another factor m ay be sample preservation,
especially in marine mammal research where it is very difficult to obtain fresh tissues
from stranded individuals (Moore and Stegeman, 1996). Given the ~500 km coastline o f
the SL estuary where standings o f endangered beluga generally occur, and the large
distances carcasses must be transported before invasive sampling can be performed, it is
extremely rare that enzymatically viable tissues can be obtained. From a sampling
perspective, we were thus fortunate to come across SL 6 , which was found stranded alive,
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and also to obtain fresh CA tissues. For SL1 to SL5, questionable tissue preservation
compromised the immunochemical and catalytic integrity o f the phase I and II enzymes
in these belugas. Loss o f the heme group (as indicated by the absence o f total P450) and
loss o f binding site integrity may partially explain the loss o f catalytic activity. Generally
less intense bands than those o f the CA samples (or undetectable bands in the case o f
CYP2B) in the immunochemical analysis likely reflects loss o f epitopic integrity,
resulting in less cross-reactivity with the chosen antibodies. Preliminary examination
(based on tissue firmness, i.e. less firm and more “pudding-like” in appearance suggested
more degradation) o f the SL1 to five 5 livers did not indicate comparatively better
preservation o f SL4 hepatic tissues, which showed generally darker immunoblot bands
and measurable EROD activity. However, SL4 microsomes were an orange-yellow
colour comparable to the SL6 and CA microsomes, whereas microsomes from the other
SL samples were dark green. Additionally, histopathological examination indicated that
SL4 hepatic tissues were much less autolysed than tissues from the other dead stranded
SL belugas. Despite the tissue degradation, immunochemical analysis still proved useful,
regarding qualitative information on phase I and II proteins present in SL1 to SL5.
The acquisition o f tissue in the form o f skin/blubber biopsies from free-ranging
live SL belugas may be a non-lethal alternative to the use o f extracted tissues from SL
beluga carcasses (Hobbs et al., 2003) for measuring physiological, biochemical, genetic
and expression differences between the SL and other beluga populations. Gauthier et al.
(1999) recently reported the successful culturing o f skin fibroblasts from Arctic beluga
whale, which are likely to have retained enzymatically viable CYP enzymes. CYP
activity has also been measured in skin biopsies o f other marine mammals (Stenella
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coeruleoabla, Balaenoptera physalus) (Fossi et al., 1999). However, MFO activity was
only assessed through EROD, PROD, BROD and AHH assays, all o f which are mediated
mainly by CYP1A in marine mammals (Watanabe et al., 1989; Letcher et al., 1996;
Addison et al., 1998). It remains to be demonstrated whether other xenobioticmetabolizing enzyme activities in beluga skin or other nondestructively sampled tissues
would be a useful alternative to liver in studies o f metabolic potential. Here, we have
been able to report the presence o f phase I and UDPGT enzymes in the main organ
involved in detoxification/biotransformation, the liver. These results provide the rationale
for future investigation into the presence o f these enzymes in alternate, nondestructively
sampled tissues, and thus for the use o f such tissues in biotransformation and biomarker
studies in beluga whales.

2.5 Conclusions
We report on the detailed immunochemical and catalytic profiling o f the enzymes
mediating xenobiotic-metabolism in beluga whales from more than one distinct
population. Immunochemical results indicated that profiles o f several major CYP
enzymes, EH and UDPGT are similar between animals from the two populations, and for
certain enzymes are comparable with previous hepatic enzyme characterization in beluga
and other odontocete species. For the first time, proteins homologous to CYP3A, EH and
UDPGT

were

identified

in

beluga

whales.

Hydroxytestosterone

and

1-

naphtholglucuronide formation in adequately preserved tissues from individuals from
both populations indicate the presence o f CYP3A-type and UDPGT activities,
respectively, in addition to CYP1A catalytic activity. Although questionable preservation
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o f most o f the SL samples lead to virtually undetectable catalytic activity,
immunochemical protein profiling was still possible. We have shown that CA beluga
have the potential to act as models for contaminant biotransformation studies on SL
beluga, which will help to explain the potential impact o f specific organic pollutants on
the endangered SL population, or in contaminant-exposed animals from other
populations. Freshly sampled CA hepatic tissues are currently being used as a model in
vitro metabolism system to assess biotransformation o f organohalogen contaminants in
beluga whales.
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CHAPTER 3
Organohalogen Contaminants and Metabolites in the Livers of Beluga
Whales {Delphinapterus leucas) from the St. Lawrence River Estuary
and western Hudson Bay, Canada1"

3.1 Introduction
Beluga whales {Delphinapterus leucas) live for 3 to 4 decades, feed high in the
food chain and store large amounts o f fat as blubber. Akin to other marine mammals,
belugas are consequently vulnerable to accumulation and potential effects o f lipophilic
contaminants including established classes (PCBs and other organochlorines) and those
o f emerging concern (polybrominated diphenyl ethers, PBDEs) (Norstrom and Muir,
1994; Hites, 2004). In Canada, there are several populations o f beluga whales inhabiting
Arctic regions and one isolated, threatened (COSEWIC, 2004) and highly contaminated
(e.g. Muir et al., 1996a) population inhabiting the estuary o f the St. Lawrence River. High
occurrences o f neoplasms, immunological and reproductive dysfunction in St. Lawrence
beluga whales (SLB) have been linked to organochlorine exposures (De Guise et al.,
1995). Adipose concentrations o f PBDEs, used commercially as flame retardant additives

^M.A. McKinney, A. Arukwe, D. Martineau, P. Beland, S. De Guise, R.J. Letcher. In preparation.
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to polymers, are also reportedly much higher in SLB than in Arctic beluga whales (CAB)
(Law et al., 2003). Despite the still lower levels o f PBDEs cf. PCBs in both SLB and
CAB (Stem and Ikonomou, 2000a,b, 2001; Lebeuf et al., 2004), temporal studies have
demonstrated that PBDE concentrations in both populations remain on the rise (Law et
al., 2003; Lebeuf et al., 2004), whereas PCB and OC levels appear to be not significantly
changed or decreasing (Muir et al., 1996b).
In contrast to recent and continued use o f PBDEs, PCBs have been banned since
1977 in both Canada and the USA since they are persistent, bioaccumulative and toxic
(PBT) substances in the environment (Lipnick and Muir, 2001). PCBs have been
associated with reproductive impairment and endocrine- and immune-related toxicities in
cetaceans (Colbom and Smolen, 1996). Recent studies have demonstrated that PBDEs
elicit some similar effects in experimental animals, such as reproductive and liver
dysfunction as well as thyroid-associated developmental neurotoxicity (Damerud, 2003).
Although congeners o f both PCBs and PBDEs are considered persistent organic
pollutants, their biological recalcitrance and toxicities depend on congener structure.
Metabolic capacity is species- and population-specific, being influenced by a variety o f
physiological factors as well as by exposure to enzyme-inducing contaminants (Boobis et
al., 1990; Smith, 1991; Nyman et al., 2003). Biotransformation o f organic contaminants
is mediated mainly in the liver by the phase I cytochromes P450 (CYP) that convert
xenobiotics to less lipophilic, and potentially to more reactive forms. Metabolites formed
from aromatic organohalogens are subject to further metabolism via phase II conjugative
enzymes, such as glutathione-S-transferases (GSTs) and UDP-glucuronosyl transferases
(UDPGTs).
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For marine mammals (e.g., seals and whales), a classification scheme has been
proposed and applied to assess the capacity for CYP-mediated oxidative metabolism o f
PCBs based on congener structures and residual congener-specific concentrations found
in tissue (Boon et al., 1992, 1997; Li et al., 2003). Although structurally related, the
potential metabolic pathways of PBDEs in marine mammals remain unknown. Meerts et
al. (2000) found that CYP2B, and to a lesser extent CYP1A and CYP4A3, were involved
in the metabolism of some PBDE congeners in laboratory rats.
A more definitive and direct way o f assessing metabolic capacity towards PCBs
and PBDEs is by the determination o f tissue metabolite residues (Letcher et al., 2000a).
Hydroxylated- (HO-) PCBs have been identified as important classes o f PCB metabolites
in biota, and found mainly in blood. HO-PCBs form via CYP-mediated, direct insertion
o f the HO-group on a precursor PCB congener, or via CYP-mediated arene epoxide
formation, followed by either enzyme-mediated or spontaneous epoxide opening. Blood
retention occurs due to competition with thyroxine (T4) for binding to thyroid hormone
transport proteins (e.g., transthyretin (TTR)). HO-PCBs and other chlorinated phenolic
contaminants (e.g. pentachlorophenol (PCP) and 4-HO-heptachlorostyrene) have been
reported in the plasma o f humans, fish, birds, and mammals (e.g. Asplund et al., 1999;
Meironyte-Guvenius et al., 2002; Campbell et ah, 2003; Hoekstra et al., 2003; Li et ah,
2003; Sandala et al., 2004). Methylsulfonyl- (MeS 0 2 -) PCB metabolites are formed via
arene epoxide intermediates, and have been shown to be PBT substances in mainly
marine mammals and humans (e.g. Haraguchi et al., 1989; Troisi et ah, 1998; Karlson et
al., 2000; Letcher et ah, 2000b; Meironyte-Guvenius et ah, 2002; Chu et ah, 2003;
Hoekstra et ah, 2003).
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Although less is known concerning PBDE metabolism (Bakk and Letcher, 2003),
particularly in wildlife, HO-PBDEs have been reported in fish (Asplund et al., 1999;
Letcher et al., 2003) and also in killer whale (Bennett et al., 2004). Hydroxylated PBDE
metabolites were detected in laboratory rodents dosed with BDE47 ( 6 m and KlassonWehler, 1998), BDE99 (Hakk et al., 1999), BDE100 (Hakk et al., 2004) and BDE209
(Morck et al., 2003). Stapleton et al. (2004a,b) demonstrated that BDEs 99, 183 and 209
were debrominated to lower brominated congeners in the intestine of common carp
(Cyprinus carpio), indicating that debromination is also a metabolic pathway for PBDEs.
PBDE congener patterns in wildlife also suggest environmental or metabolic
debromination pathways (Ikonomou et al., 2002). To our knowledge, HO-PCBs, HOPBDEs or other HPCs have not been reported in liver tissues o f any wildlife species.
In this study, HO-PCB and HO-PBDE metabolites in addition to PBDEs, PCBs,
MeS 0 2 -PCBs and OC pesticides are identified, quantitatively determined and compared
in liver tissues from SLB and CAB. We also test the hypothesis that SLB have higher
liver concentrations o f enzyme-inducing contaminants and metabolites than CAB.

3.2 M aterials an d M ethods
3.2.1 Chemicals and standards
PCB and OC standards were supplied by the Canadian Wildlife Service (Ottawa,
ON, Canada). Standards for PBDE, MeO-PCB, MeO-PBDE and MeS 0 2 -PCB analyses
were provided by Dr. Ake Bergman (Stockholm University, Sweden), with the exception
o f BDE-28 and -49, which were purchased from Wellington Laboratories (Guelph, ON,
Canada). The internal standards used were as follows: CB83 and CB122 for PCBs and
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OCs, BDE-30 for PBDEs, 4-HO-CB72 (4-HO-2,3 \5 ,5 Metrachlorobiphenyl) for HOPCBs, 2 ’-HO-BDE28 (2’-OH-2,4,4’-tribromodiphenyl ether) for HO-PBDEs and 3CH 3 SO2 -2 -CH 3 - 2 ’,3 ’,4 ’, 5,5 ’-pentachlorobiphenyl (M eS02-PCB-IS) for M eS 0 2 -PCBs.
PCBs are numbered using the notation o f Ballschmiter and Zell (BZ, 1980). PBDEs are
numbered according to the corresponding BZ notation for PCBs. PCB and PBDE
metabolites are numbered keeping the same BZ notation and adding the position o f the
HO- and/or M eS 02- group as a prefix to the name (Maervoet et al., 2004).
The chromatographic supports used were: Florisil® deactivated with 1.2% H20
(Fisher Scientific, Ottawa, Ontario, Canada), basic alumina deactivated with 2.3% H20
(Fisher Scientific) and silica acidified with 22% H 2 S 0 4 (Milwaukee, WI, USA). All
solvents and other reagents were o f at least analytical grade quality.

3.2.2 Liver sampling
Details o f the beluga whales and tissue sampling are described in McKinney et al.
(2004). In brief, the liver tissues o f five dead, stranded SL belugas in 2000 and 2001 were
sampled 12-18 hours after stranding were reported and stored in liquid nitrogen. There
were two adult males and three juveniles. In 2003, the liver tissues o f a sixth SL beluga
(neonate), which was stranded alive, were sampled less than 15 min post-mortem. The
CA beluga (n = 11) liver tissues were taken within 30-90 min o f death from individuals
sacrificed as part o f native subsistence hunts in 2002 and 2003 near Arviat, Nunavut on
the western shore o f Hudson Bay. The CA animals were two adult males, six adult
females and three immature belugas. Age classification was based on the colour change
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from grey to white at sexual maturity. The tissues were put into long-term storage at -2 0
°C until chemical analysis.

3.2.3 Organohalogen and metabolite extraction
Extraction o f neutral, phenolic and methylsulfone organohalogens from beluga
whale liver tissue was based on methods described elsewhere for blood, serum or plasma
with modifications (Letcher et al., 1995, 2000b; Hovander et al., 2000; Sandau et al.,
2000a,b; Hoekstra et al., 2003; Li et al., 2003; Sandala et al., 2004). Briefly, 0.5 to 2.0 g
o f liver was ground with five equivalents o f sodium sulfate until homogenous. All
analytes were then extracted from the sample by column chromatography with 60 ml o f
1:1 DCM:hexanes. The lipid content was quantified gravimetrically.
Phenolic analytes were isolated from the tissue, deprotonated and extracted into
an aqueous phase o f 1 M KOH (in 1:1 EtOH: H 2 O). Deprotonated phenolics were reprotonated by

the

addition

o f concentrated

H 2 SO 4 , back

extracted with

1:1

MtBE:hexanes, and derivatized to their methoxylated analogues (MeO-PCBs, MeO-PCP,
4-MeO-HpCS and MeO-PBDEs) by treatment with diazomethane. The MeO-derivative
fraction (F5) was then concentrated and eluted through 3 g o f acid silica with 50 ml o f
15:85 DCM:hexanes.
The organic phase from the original extract (after 1 alcoholic KOH treatment)
contained all neutral analytes. After concentrating this fraction, analytes were separated
on a column o f

8

g o f Florisil® in sequential fractions as follows: 38 ml o f hexanes to

elute PCBs and PBDEs (FI), 34 ml o f 15:85 DCM:hexane to elute OC pesticides (F2), 54
ml 1:1 DCM:hexanes to elute heptachlor epoxide and dieldrin (F3), and 90 ml o f 7%
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MeOH in DCM to elute MeSOa-PCBs (F4). F4 was subjected to further clean up on a
basic alumina column (3 g) eluted with 50 ml 1:1 DCM:hexanes (the first 10 ml were
discarded).

3.2.4 Quantification o f contaminants and metabolites
PCBs and OCs were separated and determined on a fused silica DB-5 column
((5% phenyl)methylpolysiloxane, 30 m x 250 pm i.d., 0.25 pm film thickness, J&W
Scientific Inc., Folsom, CA) in an Agilent 6890 GC system (Palo Alto, CA) equipped
with a 63Ni pECD detector. An Agilent 7683 Series automatic liquid sampler and injector
were used. The carrier gas was helium and the makeup gas was 5% CH 4 in argon. Data
were collected with HP Chemstation software. The GC ramping program was as follows:
the oven temperature was held at 90°C for the Imin, increased to 200 °C at 15 °C/min
and held for 2 min, then increased further to 280 °C at 2.5 °C/min and held for 9 min for
a total run time o f 51.5 min. After PCB and OC determination in F I, F2 and F3, the three
fractions were subsequently combined for GC-MS determination o f PBDEs. PBDEs,
MeO-PCBs, MeO-PBDEs and MeSG 2 -PCBs were determined on an Agilent 6890N GC
system with an Agilent 5973N MSD in the electron capture, negative ionization (ECNI)
mode using selected ion monitoring (SIM). An Agilent 7683 Series injector and
autosampler were used as per the GC-pECD. Helium was used as the carrier gas, and
methane was used as the reagent gas. The GC ramping program for PBDE (F1/F2/F3)
and MeO-PBDE (F5) containing fraction was as follows: temperature held at 80 °C for 2
min, increased to 290 °C at 10 °C/min and held for 15 min, for a total run time o f 38 min.
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MS-ECNI(SIM) was set up for isotopic Br anions, i.e., m/z 79 and 81 amu (Sellstrom,
1999; Athanasiadou, 2003). For MeO-PCBs and other chlorinated MeO-HPCs (F5), the
initial oven temperature was 80 °C for 1 min, followed by an increase in the rate to 10
°C/min to 250 °C and held for 5 min, then increased again by 5 °C/min to 300 °C and
held for a further 5 min. The total run time was 38 min. SIM monitoring o f MeO-PCBs
and MeO-HPCs was for [M]', [M+2]' and [M-15]' (M-CH 3 ). Specifically, the ions
monitored were: m/z 322 and 324 for 4-MeO-HpCS, m/z 322, 324 and 307 for MeO-tetraCBs, m/z 356, 358 and 341 for MeO-penta-CBs, m/z 390, 392, 375 for MeO-hexa-CBs
and m/z 424, 426 and 410 for MeO-hepta-CBs. Finally, for GC-MS(ECNI)(SIM)
determination o f M eS 02-PCBs (F4), the GC oven program initially held the temperature
at 100 °C for 3 min, increased to 220 °C at 20 °C/min and held for 1 min, followed by an
increase to 280 °C at 3 °C/min and held for

8

min. The total run time was 38 min.

M eS 02-PCB ions monitored were [M]' and [M+2)‘ for tetra-, penta-, hexa-, and heptachloro M eS 0 2 -PCBs. All injections were made in the splitless mode using an injection
volume o f

1

pi.

All analytes under study were identified by comparison o f GC retention and
(where applicable) ECNI mass spectra to authentic standards. E-PCB is comprised o f the
following 47 congeners, in order o f elution (if detected): PCB 31/28, 52, 49, 44, 42, 64,
74, 70, 66/95, 60, 101, 99, 97, 110, 151, 149, 118, 146, 153, 105, 141, 179, 138, 158,
129/178, 182/187, 183, 128, 174, 177, 156/171/202, 200, 172, 180, 170/190, 201, 203,
195, 194 and 206. X-DDT consists o fp ,p ’-DDT, /?,/>’-DDD and p ,p ’-DDD. E-HCH is the
sum o f a-, P- and y-hexachlorocyclohexane. E-Chlordane (E-CHL) is the sum o f
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oxychlordane,

trans-chlordane,

czs-chlordane,

trans-nonachlor,

cis-nonachlor

and

heptachlor epoxide. Z-Mirex is the sum o f Mirex and photo-Mirex. Hexachlorobenzene
(HCB), octachlorostyrene (OCS) and dieldrin were also analyzed for in the OC fractions.
The average recovery for PCBs/OCs was 99 ± 9%, and thus recovery correction was not
necessary. PCBs and OCs were then quantified by an external standard method. The
PCB/OC method detection limit was 0.5 ng/g lipid weight.
For all o f the subsequent organohalogen classes, an internal standard approach
was used for quantification. E-PBDE is the sum o f the following 9 congeners, in order o f
elution (if detected): PBDE 28, 49, 47, 100, 99, 154, 153, 138 and 18 3 .1-HO-PCB is the
sum o f the quantification o f 13 congeners, if detected, as MeO-PCB analogues: 4 ’-HOCB104, 4 ’-HO-CB121, 3’-HO-CB85, 4 ’-CB120, 4-HO-CB112, 4-HO-CB107, 4-HOCB165, 3’-HO-CB138, 4 ’-HO-CB130, 4-HO-CB187, 4 ’-HO-CB159, 3 ’-HO-CB180, 4HO-CB193. Depending on detectability in the sample, some as yet unidentified penta-,
hexa- and hepta-chloro HO-PCBs were also included, namely four HO-Cls-CBs, four
HO-Cl6 -CBs and one HO-CI7 -CB. Although these congeners could not be definitively
identified by comparison to previous HO-PCB determinations in other animals (Li et al,
2003; Sandala et al, 2004; Sandau et al, 2000a,b), they were still quantified using the
relative response factors of standards in their appropriate chlorinated isomer groups.
Fourteen HO-PBDE congeners were analyzed for (as MeO-PBDE analogues):

6

’-HO-

BDE17, 4’-HO-BDE17, 6’-HO-BDE49, 2 ’-HO-BDE68, 6-HO-BDE47, 3-HO-BDE47, 5HO-BDE47,

4 ’-HO-BDE49,

4-HO-BDE42,

6-HO-BDE90,

6-HO-BDE99,

2-HO-

BDE123, 6-HO-BDE85 and 6-HO-BDE137. The E -M eS 02-PCBs is thus the sum o f the
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aforementioned congeners and the following sixteen congeners in the mixed standard: 3M eS02-CB52, 2-M eS02-CB49, 4-M eS02-CB52, 4-M eS0 2 -CB49, 4-M eS02-CB64, 3MeSO2-CB70, 3-MeSO 2 -CB101, 4-MeSO2-CB70, 4-MeSO 2 -CB101, 3-MeSO 2 -CB110,
3-M eS02-CB149,

4-MeSO 2 -CB110,

4-MeSG2-CB87,

3-MeSOr CB132,

4-M eS02-

CB132, and 4-M eS02-CB174. For six M eS02-PCB congeners, standards were not
available

(3-M eS02-CB64,

3-M eS02-CB91,

4-M eS02-CB91,

3-M eS02-CB87,

3-

M eS 02-CB149, 3-M eS02-CB141, 4-M eS02-CB141). Their identities were confirmed by
comparison to M eS02-PCB patterns from previous studies employing GC-MS(ECNI)
analysis (Letcher et al., 2000b), and the relative response factors o f standards in their
appropriate chlorinated isomer groups were used to quantify these analytes. Mean
recoveries were 84 ± 11%, 76 ± 16%, 61 ± 13% and 141 ± 12 for PBDEs, MeO-PCBs,
MeO-PBDEs and M eS 0 2 -PCBs, respectively. The high sulfone recoveries may be due to
matrix effects (residual lipids in the samples) on the fragmentation patterns by ECNI
because re-analysis by GC-pECD gave more consistent recoveries o f

68

± 3%. The

method limits o f quantification for these compound classes were all approximately 0.5
ng/g lipid weight (S/N = 10).

3.2.5 Quality control
The precision o f the method was confirmed by intra-day duplicate analysis of
three individual liver samples. For PCBs, PBDEs and M eS 02-PCBs, the internal standard
concentrations were within 8 %, 8 % and 10%, respectively, between duplicates. The intra
day repeatability for HO-PCBs and HO-PBDEs was higher; however, using the internal
standard method o f quantification, the variability in the congeners actually detected in the
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duplicated analyses was within 15%. With each batch o f five beluga whale liver tissues
analyzed, a method blank (n - 4) was also run. Where necessary (e.g. for BDE47), areas
were blank subtracted.

3.2.6 Data analysis
All statistical analyses o f variance in contaminant concentrations in liver o f
beluga from the two populations was carried out using STATISTICA (version 6.0,
StatSoft, 2003) or Excel (Microsoft, 1997). All hypotheses tested for analysis o f variance
in analyte concentrations between the SLB and CAB used a two-tailed Student’s Mest
where the maximum probability o f a type-1 error was set to a = 0.05. Therefore statistical
significance o f variance was set at p < 0.05. Variables that did not approximate the
normal distribution using the Shapiro-Wilk’s

Wtest (p < 0.01; Zarr,

1999) were logio-

transformed to meet the assumptions o f the statistical tests. Summary statistics for any
analytes were computed only if at least 50% o f the samples had concentrations above the
MLOQ. Any sample concentrations within such a group below the MLOQ were assigned
a random value between 0 and the [MLOQ]. The variance due to the effect o f differences
in individual extractable lipid content in liver tissue on OC, PCB, PBDE and MeSOaPCB concentrations was minimized by using lipid-normalized concentrations (ng/g lipid
weight). Age, sex and sampling date were examined as possible variables affecting
organohalogen concentrations in animals from both beluga whale populations.
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3.3 Results
3.3.1 PCBs and PCB metabolites
Preliminary examination o f the data showed no clear relationship between any
organohalogen compound class and either age, sex or sampling date, with only two
exceptions. First, a negative correlation (r2 = 0.76) between X-PBDE and age was found
in the SLB, as has been shown in pilot whale adipose tissues (Lindstrom et al., 1999). A
negative relationship between X-PBDE and sex was also seen in SLB, but it was likely
due to a third variable- age, because the only two adults were both males. Second, a
positive correlation was found for X-MeSCVPCB and age (r2 = 0.61) in SLB. Given the
small number o f samples obtained overall (n =

6

for SLB and n = 11 for CAB), the

heterogeneity o f the samples (in age, sex) and the lack o f relationship based on sub
classification (age, sex, collection date) in general, results were evaluated only on a
population basis (SLB cf. CAB).
The mean organohalogen contaminant and metabolite concentrations were
generally higher in the liver tissues o f beluga whales from the St. Lawrence Estuary than
in those from western Hudson Bay (Table 3.1). Although the concentration ranges for all
contaminant classes were large, the mean X-PBDE, X-PCB, X-HO-PCB and X-MeSC>2 PCB concentrations were all significantly higher (p < 0.05) in SLB than in CAB samples.
The mean X-PCB and X-DDT concentrations were 16 times, X-HO-PCBs 22 times and
X-MeSCVPCBs 49 times higher in SLB than in CAB. However, in both populations, XHO-PCB metabolites comprised < 0.2% o f X-PCBs. X-MeSCh-PCB were 49-fold higher
in SLB and comprised a larger contribution (11% cf. 4%) to the total PCB levels than in
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Table 3.1. The arithmetic mean (± S.E.) and range o f concentrations (ng/g, lipid weight)
o f major neutral and phenolic organohalogen compound classes in the liver tissues o f
beluga whales from the St. Lawrence River Estuary (collected from 2000 to 2003) and
from W estern Hudson Bay (collected in 2002 and 2003).

Analyte Class

St. Lawrence River Estuary
(n = 6 )

Western Hudson Bay
(n = ll)

% Lipid
X-PBDE
X-HO-PBDE

3.2 ± 0 .6 (0.7-5.1)
2210 ± 6 5 6 (246-3030)*
<0.5

3.4 ± 0.2 (2.0-4.9)
53 ± 16(2-183)
<0.5

X-PCB
I-H O -PC B
X -M eS02-PCB

31 937 ±6498 (1351-45392)*
65 ± 22 (<0.5-145)*
3801 ± 1322(18-8629)*

1939 ± 4 3 6 (320-4501)
3.1 ± 0 .5 (<0.5-5)
77 ± 2 3 (18-251)

X-DDT
3-M eS02-/y ? ’-DDE

4536 ± 1152 (39-7832)*
84 ± 44 (<0.5-256)

284 ±81 (41-913)
2 2 ± 1 0 (2 - 1 1 0 )

OCS
4-HO-HpCS

11 ± 4(< 0.5-23)
1.5 ± 0.4 (<0.5-4)

1.4 ± 0.3 (<0.5-3.5)
0.5 ± 0 (O .5-0.5)

X-HCH

74 ± 18(7-136)

45

X-CHL
Heptachlor epoxide

2355 ± 551 (56-3857)*
193 ± 5 9 (2-339)

808 ± 153 (181-1556)
123 ± 2 5 (<0.5-251)

X-Mirex
HCB
Dieldrin

47 ± 1 0 (0 .5 -7 7 )*
121 ±24(22-174)
757 ± 187 (34-1222)*

0.59 ± 0.04 ( 0 . 5-0.7)
144 ± 30 (9-264)
275 ± 49 (0 .5 -5 0 0 )

± 8

(12-97)

* Significantly higher (p < 0.05) in SLB relative to CAB.
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CAB liver tissues. X-MeSCh-PCBs were 58 and 27 times greater than X-HO-PCBs in
SLB and CAB, respectively. The highest mean concentrations in SLB were in the order
o f X - P C B > X-DDT > X-MeSCh-PCB, and in CAB the order was X-PCB > X-Chlordane
> X-DDT. Regardless o f males and females, for the CAB the highly recalcitrant CB153
showed strong correlations with X-PCBs, X-PBDEs and X-MeSCVPCBs, but not with
X-HO-PCBs (Fig. 3.1). With a lower number o f samples and with five individuals
exceeding 30,000 ng/g X-PCB, it was not surprising that similar (to CAB) and
statistically significant relationships between X-PCB and X-MeSCh-PCB, X-PBDE or XHO-PCB concentrations were not found for SLB (not shown).
PCB congeners in the tri- to nona-chlorinated isomer classes were detected.
Taking the ratio o f individual congener concentrations to the concentration o f the slowly
metabolized CB153 showed differences in the PCB congener profiles in liver o f
individuals from the two populations. CAB exhibited significantly (p < 0.05) larger ratios
for tri- to hexa-chlorinated congeners than SLB, whereas SLB showed significantly larger
ratios for hepta- and octa-chlorinated congeners (Fig. 3.2A). When grouped according to
the metabolic classification scheme for marine mammals (Boon et al., 1997), SLB
showed larger ratios to CB153 o f the recalcitrant Group I and II PCB congeners (Table
1 .1 ;

Fig. 3.2B). However, SLB appeared to have depleted ratios o f some Group III and IV

congeners relative to CAB liver tissues.
X-HO-PCB concentrations were low in comparison to other organohalogens
(Table 3.1). In SLB, 18 penta- to hepta-chlorinated HO-PCB congeners were found,
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Fig. 3.1. Correlations between the concentrations (ng/g lipid) o f CB153, X-MeSC>2 -PCB,
X-PBDE and X-HO-PCB with X-PCB (ng/g lipid) in the livers o f beluga whales from the
Canadian Arctic (n = 11).
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Fig. 3.2. The ratios o f the arithmetic means o f PCB congener to CB153 concentrations in
the livers o f St. Lawrence (black bars, n = 6 ) and Canadian Arctic beluga whales (white
bars, n = 11) (A) arranged by Cl-substitution pattern and (B) arranged by metabolic
classification (Boon et al., 1997). Significant differences (p < 0.05) between the two
populations are marked with asterisks. Error bars represent ± S.E. o f the mean.
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though penta-chlorinated congeners comprised > 90% o f the X-HO-PCB (Fig. 3.3). 4HO-CB107 and 4-HO-CB112 were the dominant congeners detected in the St. Lawrence
population. In CAB, only one HO-PCB congener was quantifiable, i.e. 4 ,-HO-CB120.
The concentration o f 4 ’-HO-CB120 was significantly higher ip < 0.05) in CAB relative
to SLB. A probable metabolite o f OCS (Sandau et al., 2000), low levels o f 4-HO-HpCS
were also detected in the phenolic fraction from SLB and CAB liver tissues (Table 3.1).
4-HO-HpCS constituted 15% o f the OCS concentration in SLB, but less than 1% o f the
total in CAB. Furthermore, 4-HO-HpCS concentrations were 3% and 17% o f the X-HOPCB concentrations in SLB and CAB, respectively.
E-M eS 0 2 -PCB concentrations in SLB and CAB were among the highest relative
to other organohalogen classes, with the exception o f X-PCB and X-DDT. Tetra- to hexachlorinated MeSOa-PCBs were detected in both populations, but significant differences
in the ratios o f individual MeS 0 2 -PCB congeners to CB153 concentrations between the
SLB and CAB were observed for a number o f congeners (Fig. 3.4). The concentration
ratios were higher for SLB and indicated different congener patterns between the two
populations. The dominant congeners were 3 ’- and 4 -MeSO 2 -CB 1 0 1 , -CB49 and -CB87
in beluga whale liver tissue from both populations. A methylsulfonated metabolite o f
DDT, 3 -MeS 0 2 -p,p '-DDE, was also found at higher but insignificantly different (p<0.05)
levels in SLB relative to CAB.
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Fig. 3.3. The arithmetic mean concentrations o f individual HO-PCB congeners in the
liver tissues o f beluga whales from the St. Lawrence Estuary (black bars, n = 6) and from
the Canadian Arctic (white bars, n = 11). HO-PCBs were determined as MeO-PCB
derivatives (see Materials and Methods). Significant differences (p < 0.05) are marked
with asterisks. Error bars represent the ± S.E. o f the mean.
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Fig. 3.4. The ratio o f the arithmetic mean o f the individual MeSCL-PCB congener to
CB153 concentrations in the livers o f beluga whales from the St. Lawrence (black bars, n
= 6) and the Canadian Arctic (white bars, n = 11). Significant differences (p < 0.05)
between the two populations are marked with asterisks. Error bars denote ± S.E. o f the
mean.
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3.3.2 PBDEs and HO-PBDE metabolites

X-PBDE concentrations were 42-fold and significantly higher (p < 0.05) in the
liver tissues o f SLB than in CAB (Table 3.1). In SLB, the juvenile animals had an order
o f magnitude higher concentrations then the two adult males, in comparison to the PCBs
where no obvious differences were observed. Nonetheless, X-PBDE levels were 14- and
2-fold lower than X-PCB and X-DDT in SLB, whereas they were 36 and 5 times lower in
CAB, respectively. PBDE congener profiles showed similarities in the liver tissues o f
beluga whales from both populations, with BDE47 and BDE99 concentrations
comprising about 40% and 20%, respectively, o f the X-PBDE in SLB and CAB (Fig.
3.5). However, BDE100 made up almost twice as much o f the X-PBDE in CAB than in
SLB. BDE153 and BDE154 made a significantly lower proportion o f X-PBDE in CAB
versus SLB. The minor congeners BDE28, BDE138 and BDE183 were only detected in
SLB. BDE49 was not detected in samples from either population. Other unidentified
brominated peaks were also detected but not identified in the neutral, PBDE-containing
fractions in liver o f animals from both populations.
Although the levels o f HO-PBDEs were below the limit o f quantification (0.01
ng/g wet weight, S/N = 10) in all samples from SLB and CAB, some compounds were
nonetheless detectable (3 < S/N > 10) in the phenolic fractions extracted from some liver
samples of animals from both populations. Only four HO-PBDEs could be identified: 2 5HO-BDE68,

6-HO-BDE47,

3-HO-BDE47

and

4 ’-HO-BDE49
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(Fig.

3.6).

Fig. 3.5. The arithmetic mean fractions (represented as percentage) o f individual PBDE
congener to 2-PB D E concentrations in the liver tissues o f St. Lawrence (black bars, n =
6) and Canadian Arctic (white bars, n = 11) beluga whales. Significant differences (p <
0.05) between the two populations are marked with asterisks. Error bars represent ± S.E.
o f the mean.
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Fig. 3.6. GC-MS(ECNI)(TIC) chromatograms (SIM anions: 79B f and 8lBr") o f (A) MeOPBDE external standard mixture and (B) the derivatized halogenated phenolic fraction
extracted from the liver tissues o f an adult female beluga whale from the Canadian
Arctic. Peak identification is as follows: 1 - 6’-HO-BDE17, 2 = 2 ’-HO-BDE28 (internal
standard, IS .), 3 = 4 ’-HO-BDE17, 4 = 6 ’-HO-BDE49, 5 = 2 ’-HO-BDE68, 6 = 6-HOBDE47, 7 = 3-HO-BDE47, 8 = 5-HO-BDE47, 9 = 4 ’-HO-BDE49, 10 = 4-HO-BDE42,
11 - 6-HO-BDE90, 12 = 6-HO-BDE99, 13 = 2-HO-BDE123, 14 = 6-HO-BDE85 and 15
= 6-HO-BDE137.
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3.4 Discussion
The toxicodynamics o f anthropogenic organohalogens, especially o f emerging
contaminants like PBDEs, in marine mammals remains unclear. Metabolic processes,
which can be selectively induced and inhibited by organohalogen exposures, may
facilitate detoxification and excretion o f these PBTs. There are, however, a growing
number o f studies suggesting the formation o f persistent secondary compounds, through
biotransformation processes, may be o f importance in the toxicity o f PBTs to not only
marine mammals, but also humans and wildlife in general. Previously, it was
immunologically shown that in liver tissues o f SL and Arviat (western Hudson Bay)
beluga whales there are cross-reactive isoforms o f several CYP450 monooxygenases and
UDGPT (McKinney et al., 2004). For the Arviat animals, there was also corresponding
catalytic activity. In this study, we determined the liver concentrations precursor (parent)
PCBs and PBDEs, and found relatively lower levels o f HO-PCB, MeSOa-PCB and
putative HO-PBDE metabolites in two populations o f beluga whales. However, there
were clear differences in precursor and metabolite levels between the two populations.

3.4.1 PCBs
Different congener profiles o f parent PCBs between populations and species o f
marine mammals (e.g. Bemt et al., 1999; Metcalfe et al., 1999, 2004; Hobbs et al., 2002)
suggest variability in metabolic capacities and/or exposures. St. Lawrence beluga whales
generally have higher levels o f OC contaminants than belugas from Arctic regions in
Canada due to historical exposures (Metcalfe et al., 1999). Here, we show variation in the
levels of PCB congeners between SLB and Arviat belugas, in agreement with one
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previous study quantifying PCBs in the livers o f St. Lawrence and Hendrickson Island
(Canadian Arctic) beluga whales (Metcalfe et al., 1999), indicative o f higher exposures to
OCs in SLB. The SLB and CAB adult male beluga whales we sampled had liver E-PCB
concentrations o f 41 444 and 3323 ng/g lipid weight, respectively, in good agreement
with, but slightly lower than, 53 884 and 4894 ng/g lipid weight found for such
individuals in the Metcalfe et al. (1999) study, sampled around 10 years earlier. Z-PCB
concentrations (lipid weight) in the present adult male SLB liver samples were somewhat
lower than those found in blubber o f dead males from this population between 1982 and
1994 (Muir et al., 1996b), but somewhat higher than those from live biopsied males from
1994 to 1998 (Hobbs et al., 2003). Greater representation o f higher chlorinated congeners
in the Z-PCB concentrations indicated their persistent/accumulative nature in comparison
to lower chlorinated congeners in both populations.

After correction to a slowly metabolized congener (CB153), different congener
profiles emerged in the liver tissues according to metabolic class between the SLB and
CAB. Higher ratios of Groups I and II PCBs in SLB versus CAB are likely related to
differences in exposure; higher-chlorinated compounds are less volatile and tend to be
less represented in remote regions such as the Arctic. In contrast, depleted ratios o f
Groups III and IV PCBs in SLB cf. CAB may more likely be due to increased
metabolism as a function o f induced phase I (e.g. CYP1A) and possibly phase II
biotransformation activities in more exposed populations (Nyman et al., 2003).
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3.4.2 PBDEs
To our knowledge, this is the first report o f PBDEs in liver tissues o f any species
o f whale. The hepatic PBDE congener profiles in both populations were very comparable
to that found in the blubber tissues o f SLB (Lebeuf et al., 2004). One exception was the
elevated percentage o f BDE100 (to total [PBDE]) in CAB vs. SLB. Comparison o f
PBDE levels in this study to those found in previous studies must be interpreted with
caution, as PBDE levels in the North American environment and biota are rapidly
increasing (Betts, 2001). Liver X-PBDE concentrations (74 ng/g lipid, sampled in 2003)
in western Hudson Bay male belugas in this study were higher than those found in male
Cumberland Sound (eastern Canadian Arctic) beluga (16 ng/g lipid, sampled in 1997)
and male Kugmallit Bay (western Canadian Arctic) beluga (17 ng/g lipid, sampled in
2001) adipose tissues (Law et ah, 2003). This may be due to temporal differences in
PBDE concentrations or to the closer proximity o f Hudson Bay to possible sources at
lower latitudes. This finding is less likely due to a preference o f PBDEs for liver tissue as
we found similar lipid-corrected concentrations o f X-PBDE in the liver tissues o f our two
St. Lawrence adult male belugas (average = 389 ng/g lipid) sampled in 2001 as Lebeuf et
al. (2004) reported in the blubber tissues o f five adult St. Lawrence belugas (average 541
ng/g lipid) sampled in 1999. Boon et al. (2002) also found no preference for PBDEs in
liver versus blubber tissues o f harbour seals (Phoca vitulina) and harbour porpoises
{Phocoena phocoena). In contrast, lipid-corrected concentrations o f some PCBs (<orthounsubstituted congeners) may be elevated in liver tissues, supposedly to due interactions
with CYP1A enzymes (van den Berg et al., 1994).

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

105

PBDEs exhibit large variation between congener profiles in the technical mixture
and profiles in the environment as well as in biota (Hites, 2004). Differences in PBDE
congener profiles between species in the same food chain has also been reported (Boon et
al., 2002; W elkers et al., 2004), which is suggestive o f PBDE biotransformation
potential. Although we and others have found that PBDE concentrations are still lower in
beluga whales than PCBs, as PBDE levels increase in wildlife, the need for further
research on PBDE metabolism is necessitated.

3.4.3 Hydroxylated PCBs and PBDEs
Both PCBs and PBDEs may be metabolically transformed with potential
biological activity to hydroxylated metabolites (Letcher et al., 2000a; Hakk and Letcher,
2003). In this study, we detected retained HO-PCB and HO-PBDE congeners, and PCP
and 4-HO-HpCS, in the liver o f beluga whales from two Canadian populations. Most
reports have focused on blood plasma as these hydroxylated compounds have perhaps the
highest affinity for this tissue due to their interactions with thyroid transport proteins
(Letcher et al., 2000a; Meerts et al., 2000). Thus, this is the first report o f these classes o f
halogenated phenolic compounds (HPCs) in a tissue other than blood in marine mammals
or any other wildlife species. A single previous publication reported HO-PCBs in human
liver and adipose tissues (Meironyte-Guvenius et al., 2002). HO-PCBs, HO-PBDEs, PCP
and 4-HO-HpCS may be retained in the liver, in part, because o f fatty acid conjugation
and/or interaction with hepatic proteins/enzymes. PCP and a hydroxy-DDT were both
shown to be conjugated by liver fatty acids in rats (Leighty et al., 1980, 1982). However,
it is possible that the presence o f HPCs in liver is a function o f blood residues (Bergman
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et a l, 1994). In addition to being protected by protein binding interactions, the lifetime o f
HO-PCBs in the liver may also be due to inhibition o f enzymes mediating conjugation
processes. HO-PCBs have demonstrated strong (inhibitory) interactions in vitro with
phase II intestinal biotransformation enzymes in catfish (Ictaluris punctatus), particularly
glucuronosyl transferases (van den Hurk et al., 2002). In addition, in vitro inhibition o f
thyroxine sulfation by HO-PCBs has been shown in rats (Schuur et al., 1998).
Elevated levels o f HO-PCB metabolites were found in the livers o f belugas
inhabiting the estuary downstream o f the contaminated St. Lawrence River in comparison
to those from the relatively less contaminated western Hudson Bay region. It is unlikely
that the HPCs present in beluga whale liver may be due to food chain bioaccumulation.
With differences in dietary exposure, HO-PCBs were reported in fish (major constituents
o f beluga whale diets) from marine (Baltic Sea) and freshwater (Great Lakes) systems
(Asplund et al., 1999; Campbell et al., 2003; Li et al., 2003). Metabolism o f the precursor
congeners is more than likely the mechanism. Differences in cytochrome P450 and/or
phase II conjugative biotransformation activities exist between animals in the
differentially exposed populations. This has been shown qualitatively by immunological
assessment for the present beluga whales (McKinney et al., 2004). Grey (Halichoerus
grypus) and ringed (Phoca hispida baltica) seals from the heavily polluted Baltic Sea
exhibited higher hepatic CYP1A-mediated EROD (7-ethoxyresorufin O-deethylase)
activities than those from reference sites, which were significantly correlated with liver
PCB loads (Nyman et a l, 2003). Evidence for differential metabolic capacity between the
two Canadian beluga populations also comes from the fact that HO-PCBs and MeS02PCBs were at higher concentrations relative to PCBs in SLB relative to CAB; X-HO-
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PCB and X-MeSCVPCB levels were 22- and 49-fold higher in SLB than in CAB,
whereas X-PCB were only 16-fold higher in the former population than in the latter. The
higher exposure o f SLB to enzyme-inducing contaminants is consistent with higher PCB
metabolite to PCB ratios.
Although 18 HO-PCB congeners were found in SLB, only 4’-HO-CB120 was
detectable in CAB. The concentrations o f 4 ’-HO-CB120 were weakly and positively
correlated with both testosterone to androstenedione conversion (r2 = 0.48, p = 0.03) and
UDPGT (r2 = 0 .41, p - 0.05) activities in catalytically viable microsomes from these
same CAB, reported previously (McKinney et al., 2004). However, androstenedione and
UDPGT and 6p-testosterone hydroxylase activities also co-varied significantly. In rats,
4’-HO-CB120 and 4-HO-CB107 are metabolically formed from CB118 (Sjodin et ah,
1998). CB118 is one o f the major PCB congeners in both the SLB and CAB hepatic
tissues we studied, and thus could be a precursor o f these retained metabolites. 4-HOCB107, which can also be formed from CB105 in rat (Sjodin et ah, 1998), was one o f the
dominant congeners in SLB, but it was not detected in CAB. Closer examination o f the
structures o f the HO-PCBs identified, reveals that roughly half (4-HO-CB165, 3’-HOCB180, 4-HO-CB187 and 4-HO-CB193) come from parent PCBs with no ortho-meta or
meta-para vicinal hydrogen-atom pairs (Fig. 3.2). Although Group I PCBs (Fig. 3.2B)
are “resistant” to degradation and thus have a slow rate o f metabolism, biotransformation
to these HO-PCB congeners still occurs. HO-PCB congeners o f metabolically “resistant”
Group I PCB congeners have also been found in human liver (Guvenius-Meironyte et al.,
2002), human plasma and grey seal blood (Bergman et ah, 1994), polar bear plasma

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

(Letcher et al., 2004; Sandala et al., 2004), bowhead whale plasma (Hoekstra et al., 2003)
and in various fish species (Li et al., 2003). Nonetheless, lower levels o f HO-PCBs
derived from Group I PCB congeners were found in the belugas relative to the other

quantifiable HO-PCBs. These other HO-PCBs must be derived from precursor PCB
congeners with 2 or less ortho -chlorines and ortho-meta unsubstituted sites, and some
with meta-para vicinal H-atom pairs as well (Groups II, III or IV). However, none o f the
retained HO-PCBs could have come from parent PCBs with only meta-para
unsubstituted sites on the biphenyl ring. It has been proposed that HO-PCB formation
from meta-para chlorine-unsubstituted PCBs via the arene epoxide intermediate must
compete with phase II conjugation o f the epoxide with glutathione and subsequent
formation o f MeS02-PCB metabolites (Letcher et al., 2000a).
Although this study does establish the presence o f HO-PBDEs in beluga liver
tissues (and/or residual blood), low concentrations o f HO-PBDEs prevented a
comparison o f the congener profiles and levels between the two differentially exposed
populations o f beluga whales. Whereas X-HO-PCB comprised around 10% or more of XPCB in human liver tissue (Meironyte-Guvenius et al., 2002) and represented an even
greater proportion in blood tissues o f other mammals (Bergman et al., 1994; Hoekstra et
al., 2003; Sandala et al., 2004), X-HO-PCB/X-PCB in the present beluga liver tissues was
< 0.2%. This suggests lower metabolic capacity o f beluga whales to form and retain HOPCBs, and/or greater capacity to deplete HO-PCBs by phase II conjugation processes. By
extension, the same is likely true for HO-PBDEs in beluga whale. There is also some
evidence that orfAo-substituted HO-PBDEs may be natural products in marine
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environments (Haglund et al., 1997). In Chapter 4, in vitro studies on parent PBDEs
directly address the possibility o f phase I CYP-mediated PBDE biotransformation (and
possible HO-PBDE formation) in beluga whale. Perhaps time trend studies examining
possible correlations between HO-PBDE levels and the rapid rise o f PBDEs in biota
would also distinguish between natural and (metabolic products of) anthropogenic
sources.

3.4.4 M ethyl sulfone PCBs and DDEs
In the only other study examining MeS02-PCBs and HO-PCBs in liver tissue,
Meironyte-Guvenius et al. (2002) reported that in Swedish humans the £-M eS02-PCB
and Z-HO-PCB concentrations were similar. In contrast, we found that X-MeSC»2 -PCB
concentrations were much higher in beluga liver than ZXHO-PCB. Liver Z-MeSC^-PCB
concentrations were much higher (49-fold) in SLB compared to CAB, and we similarly
found higher levels o f PCBs in individuals from the former population. Letcher et al.
(2000b) found comparable levels o f MeSCh-PCBs in the adipose tissues o f SLB and
CAB in a previous study, but also found similar levels o f PCBs between beluga whales

from the two populations. This m ay be due, in part, to the different sampling techniques.
In this study, SLB liver tissues were taken from dead stranded animals. In Letcher et al.
(2000b), adipose tissues taken by biopsy from live animals. As mentioned previously,
Hobbs et al. (2003) found that levels o f highly chlorinated PCBs were lower in biopsied
animals than those previously found for dead animals.
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It has been demonstrated in seals that (lipid normalized) MeSCVPCB
concentrations were higher in liver than in blubber, muscle or brain (Karlson et al, 2000).
A preference o f MeS02-PCBs for liver tissues is explained by specific protein binding
(Letcher et al., 2000a). Elevated MeSCh-PCB concentrations in SLB versus CAB liver
may be related to differences in exposures to parent PCBs or metabolites or possibly to
elevated metabolic activities in the highly exposed SLB population. MeS02-PCBs are
CYP2B1/2 inducers in rats (Kato et al., 1997) and CYP2B-type isozymes are ostensibly
the CYPs involved in mediating the formation o f meta-para unsubstituted HO-PCBs,
which are the precursors to MeS02-PCBs (Letcher et al., 1998).

3.5 Conclusions
Metabolism may play a critical role in the toxicokinetic sequence o f exposure to a
contaminant through to eventual toxicological outcome(s) in an organism. In this study,
we report for the first time the presence o f retained hydroxylated metabolites o f both
PBDEs and PCBs in the hepatic tissues o f beluga whales from two differentially exposed
Canadian populations. The more exposed St. Lawrence beluga whale population showed
higher levels o f HO-PCB and MeS02-PCB metabolites as well as generally elevated
concentrations o f PCBs, PBDEs and organochlorine pesticide residues. As it has been
reported that HO-PCB, MeS02-PCB and HO-PBDE metabolites, in addition to their

parent compounds, exhibit estrogenic, thyroidogenic and/or neurodevelopmental
toxicities, beluga whales, particularly from the St. Lawrence region, may exhibit
deleterious health effects associated with these and other organohalogen pollutants.
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CHAPTER 4
Hepatic Microsomal Biotransformation of Polybrominated Diphenyl
Ethers and Polychlorinated Biphenyls in Beluga Whale {Delphinapterus

leucas)^

4.1 Introduction
Marine mammals are exposed to persistent bioaccumulative toxic (PBT)
substances through their diets and tend to accumulate PBTs in lipid-rich tissues (blubber)
throughout their long life spans. Currently used as flame retardant additives in polymeric
materials, polybrominated diphenyl ethers (PBDEs) have been reported in a limited
number o f marine mammal species and populations (Andersson et al., 1992; Sellstrom et
al., 1993; Haglund et al., 1997; de Boer et al., 1998; Lindstrom et al., 1999; Boon et al.,
2002; Ikonomou et al., 2002a, 2002b, 2004; Law et al., 2002; She et al., 2002; Kajiwara
et al., 2004; Lebeuf et al., 2004; M cKinney et al, 2004a; Wolkers et al, 2004). In
cetaceans (all odontocete species), PBDEs have been found in pilot whales (Lindstrom et
al., 1999), killer whales (Rayne et al., 2004), beluga whales from the St. Lawrence

^M.A. M cK inney, S. De Guise, A. Arukwe, P. Beland, D. Martineau, R.J. Letcher. In preparation.
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(Lebeuf et al., 2004; McKinney et al., 2004a) and Arctic regions (Law et al., 2003;
McKinney et al., 2004a; Wolkers et al., 2004) and in deep-sea inhabiting sperm whales
(de Boer et al., 1998). BDE47 was found to be the dominant congener, but lesser amounts
o f BDE99, BDE100, BDE153, and BDE 154 were also found in these whales, a similar
pattern to that in most other humans and biota sampled to date (Hites, 2004).
Similar to recent temporal studies on PBDE concentrations in North American
humans (Schecter et al., 2003; Ryan, 2004), and in Great Lakes and Pacific coast fish
(Ikonomou et al., 2002a; Law et al., 2003), beluga whales (both those inhabiting the St.
Lawrence Estuary and the Canadian Arctic regions) show temporally increasing PBDE
levels (Stem and Ikonomou, 2000a,b, 2001; Law et al., 2003; Lebeuf et al., 2004). PBDE
concentrations in tissue (liver and blubber) o f beluga whales are lower, but increasingly
comparable to the already present body burdens o f more environmentally established
contaminants like polychlorinated biphenyls (PCBs) and organochlorine (OC) pesticides
(Metcalfe et al., 1999; Letcher et al., 2000a; Hobbs et al., 2003; McKinney et al., 2004a).
Multiple pathologies exhibited in the threatened (COSEWIC, 2004) St. Lawrence beluga
whale population have been associated with PCB and OC exposure (De Guise et al.,
1995), although PBDE exposure m ay be contributing to these contaminant-effects
associations.
Phase I cytochrome P450 (CYP) and phase II conjugative enzymes, mainly
operating in the liver, catalyze the metabolism o f many endogenous and xenobiotic
compounds in organisms including marine mammals (Goksoyr and Forlin, 1992;
Stegeman and Hahn, 1994; Lewis et al., 1998). A variety o f CYPs, as well as epoxide
hydrolase and UDP glucuronosyl transferase enzymes, that have been found in beluga
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whale (W hite et al., 1994, 2000; McKinney et al., 2004b) may influence the capacity o f
these cetaceans to detoxify and eliminate contaminants. As well, these catalytic processes
can result in the formation of toxic, retained and/or persistent metabolites from primary
organohalogen contaminants, e.g., methyl sulfonyl- (MeSCV) and hydroxylated- (HO-)
PCBs (Bergman et al., 1994; Letcher et al., 2000b; McKinney et al., 2004a). Exposure to
HO-PCB metabolites has resulted in thyroidogenic effects, altered vitamin A levels, and
inhibition o f phase II sulfation and glucuronidation in experimental organisms (Brouwer
et al., 1986; Schuur et al., 1998; van den Hurk et al., 2002). MeS 0 2 -PCB treatment led to
altered enzyme activities and thyroid hormone levels in rats (Kato et al., 1995a,b; 1998),
as well as reproductive toxicities in mink (Lund et al., 1999).
In the case o f PCBs, congener patterns in tissues from prey and predator species
in relation to the expression and activities o f CYP enzymes has given rise to a metabolic
classification scheme for marine mammals (Boon et al., 1997). In beluga whale from
Canadian populations, oxidative metabolism o f PCBs has also been evidenced by the
finding o f HO- and MeS02-PCBs in the liver and/or adipose tissues (Letcher et al.,
2000a; McKinney et al., 2004a).
In general, the toxicokinetics o f PBDEs and other BFRs o f environmental
importance is not nearly as well understood as PCBs in wildlife and in particular in
marine mammals (Hakk and Letcher, 2003). Regardless, apparent metabolites o f PBDEs,
the HO-PBDEs, have been found in the liver tissues of beluga whales (McKinney et al.,
2004a), in the blood plasma o f a killer whale (Bennett et al., 2003), and in some fish
species (Asplund et al., 1999; Marsh et al., 2004; Letcher et al., 2003). In addition, MeOPBDEs have been reported in ringed seal, beluga whale and fish (Haglund et a l, 1997;

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

Asplund et al., 1999; Marsh et al., 2004; Wolkers et al., 2004). Direct evidence o f PBDE
metabolism to HO-PBDE metabolites was reported in laboratory rodents after oral
administration o f the congeners BDE47, 99, 100 and 209 ( 6 m and Klasson-Wehler,
1998; Hakk et al., 2002; Morck et al., 2003; Hakk et a l, 2004). Catalytic debromination
o f higher brominated to lower brominated BDE congeners has also been recently
reported. In the gut o f dietary exposed common carp (Cyprinus carpio), within 2 hrs o f
exposure, debromination o f BDE209 to octabromo- and nonabromo-BDE congeners,
BDE 183 to BDE 154, and BDE99 to BDE47 was shown (Stapleton et al., 2004a,b,c). HOPBDEs have shown estrogenic and thyroidogenic activities in experimental organisms
(Meerts et al., 2000, 2001). However, it has yet be demonstrated for beluga whale, or any
Arctic marine mammal, that the presence o f HO-PCB and HO-PBDE congener residues
in tissue are definitively metabolic products o f PCBs and PBDEs, rather than having have
accumulated through the diet from anthropogenic or, in the case o f HO-PBDEs, natural
origins.
Ethical obstacles generally prevent organohalogen dosing studies in marine
mammals, but in vitro assays provide a viable alternative. The contaminant(s) o f interest
can be incubated with prepared sub-cellular liver fractions and metabolic activity can
examined by monitoring depletion o f the parent compound(s) and/or formation o f
metabolites (Murk et al., 1994; Boon et al., 1998; de Boer et al., 1998; Letcher et al.,
1998; White et al., 2000; van Hezik et al., 2001; Li et al., 2003a). In this study, we
examine and compare the metabolism o f PBDE and PCB congeners o f environmental
significance and where residues o f associated HO-PCBs and HO-PBDEs have been
detected previously (McKinney et al., 2004a) in an in vitro system using the catalytically-
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viable, hepatic microsomes of Canadian beluga whale. We assess the hypothesis that
biotransformation plays a role in the fate and bioaccumulation o f PCBs and PBDEs in
beluga whale via 1) CYP mediated oxidative biotransformation resulting in the formation
o f HO-PCB and -PBDE metabolites, and 2) catalytic debromination o f higher brominated
to lower brominated BDE congeners.

4.2 Materials and Methods
M ixed congener assays (MCA) and individual congener assays (ICA) were
performed to study both PBDE and PCB metabolism (Table 4.1). PCBs used in the MCA
were chosen as representative congeners o f PCB metabolic groups, according to the
metabolic classification proposed by Boon et al. (1997). As structure-activity
relationships for the oxidative metabolism o f PBDEs in marine mammals are unknown,
the suite o f PBDEs in the MCA represented environmentally relevant congeners ranging
from di- to hepta-bromodiphenyl ethers. PBDE and PCB congeners that were either (1)
significantly biotransformed in the MCA, (2) metabolized in rodent studies (e.g. Om and
Klasson-Wehler, 1998; Hakk et al., 1999), and/or (3) were putative parent compounds o f
HO-PBDE and -PCB congeners found previously as residues in beluga livers (McKinney
et al., 2004a), were then chosen for further studies to monitor individual PBDE/PCB
depletion and possible metabolite formation in beluga whale via the ICA.

4.2.1 Sampling, microsome preparation and protein and catalytic activity determinations
A healthy adult male beluga whale (CA10, Table 2.1) was caught on 9 August
2004 during a native subsistence hunt near Arviat, Nunavut in western Hudson Bay,
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Canada. Hepatic tissues were removed within 1 hr o f death and immediately stored in a
liquid N 2 dry shipper. Once transported back to the laboratory (GLIER, University o f
Windsor), the hepatic tissues were stored for the long-term at -8 0 °C. Beluga whale
microsome preparation and protein content analysis were based on previously reported
methods (Bradford, 1976; Nilsen et al., 1998) and described in McKinney et al. (2004b).
This beluga whale was selected for in vitro metabolism studies because it showed the
most catalytically viable hepatic enzymes o f all the whales captured near Arviat in the
summers o f 2002 and 2003 (Section 4.3.1). Due to experimental constraints and the fact
that CA10 showed qualitatively similar phase I enzyme expression as other Canadian
Arctic as well as St. Lawrence belugas (McKinney et al., 2004b), biotransformation was
investigated in this individual beluga whale. Liver microsomes from pooled male W istar
Han rats were purchased (Gentest, Woburn, MA, USA) and used as a model mammalian
system for PCB and PBDE metabolism in vitro in comparison to the male beluga whale
under study.

4.2.2 Reagents
Stock solutions o f individual PBDE congeners were provided by Dr. Ake
Bergman (Stockholm University, Sweden) and Wellington Laboratories (Guelph, ON,
Canada). Individual PCB (in isooctane, TMP) congener standards were obtained from
Cambridge Isotope Laboratories (Andover, MA, USA). NaH 2 P 0 4 ® H 2 O and M gCl 2 •
6

H2 O

were

obtained

from

Sigma-Aldrich

(St.

Louis,

MO,

USA).

Disodium

ethylenediaminetetraacetate (Na2 EDTA) was obtained from Bio-Rad Laboratories
(Mississauga, ON, Canada). NADPH regenerating system Solutions A (NADP+, glucose-
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6

-phosphate, MgCl2) and B (glucose- 6 -phosphate dehydrogenase) were purchased from

Gentest. A ll other reagents and solvents were o f analytical grade quality. Water was
supplied by a Milli-Q system (Millipore, San Jose, CA, USA) equipped with a 0.22 pm
filter.

4.2.3 Preparation o f PCB and PBDE standards
The beluga liver microsomes were incubated with either a mixture o f PCBs or a
mixture o f PBDEs (Mixed Congener Assay) or with individual PCB or PBDE congeners
(Individual Congener Assay) (Table 4.1). Every mixed or individual standard contained
CB153 as the internal standard because o f its negligible metabolic depletion in the assay
(van Hezik et al., 2001; Li et al., 2003a). Mixed standards were prepared by combining
the required volume o f individual standards (including CB153), evaporating the mixture
to dryness under a gentle stream o f nitrogen and redissolving it in analytical grade
acetone. Individual standards were prepared in a similar fashion. The congeners in the
mixed standard solutions and the individual standard solutions and their concentrations
are given in Table 4.1 A and 4 .IB, respectively. These concentrations represent a
compromise between ( 1 ) approximating zero-order kinetics and (2 ) being low enough to
detect metabolism (depletion) within the short time-frame o f the assay.
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Table 4.1. Concentrations o f PCB or PBDE congeners in the standard solutions (3 pi
added to incubation mixture) for (A) the Mixed Congener Assay and (B) the Individual
Congener Assay.
A
Congener

Mixed PCB Standard

Concentration Concentration
(pg/ml)
(pM)

CB15 (4,4’-diCB)
CB26 (2,3’,5-triCB)
CB31 (2,4,5-triCB)
CB52 (2,2’,5,5’-tetraCB)
CB77 (3,3’,4,4’-tetraCB)
CB101 (2,2’,4,5,5’-pentaCB)
CB105 (2,3,3’,4,4’-pentaCB)

5.3
5.3
5.3
5.3
5.3
5.3
5.3

Mixed PBDE Standard BDE 15 (4,4’-diBDE)
BDE28 (2,4,4’-triBDE)
BDE47 (2,2’,4,4’-tetraBDE)
BDE49 (2,2 ’,4,5 ’-tetraBDE)
BDE99 (2,2’,4,4’,5-pentaBDE)
BDE 100 (2,2’,4,4’,6-pentaBDE)
BDE153 (2,2’,4,4’,5,5’-hexaBDE)
BDE 154 (2,2’,4,4,5,6’-hexaBDE)
BDE183 (2,2 ’,3,4,4’,5 ’,6 -heptaBDE)

5.0
5.0
5.0
4.9
4.9
6.0
4.9
5.0
5.0

24
20
20

18
18
16
16
15
12
10
10

8.7
11
7.6
7.8
6.9

B
Congener

Individual PCB
Standards

Individual PBDE
Standards

Concentration Concentration
(pM)
(pg/ml)

CB15 (4,4’-diCB)
CB105 (2,3,3 ’,4,4’-pentaCB)
CB118 (2,3’,4,4’,5-pentaCB)

7.4
3.9
8.4

BDE 15 (4,4’-diBDE)
BDE28 (2,4,4’-triBDE)
BDE47 (2,2’,4,4’-tetraBDE)
BDE99 (2,2’,4,4’,5-pentaBDE)
BDE154 (2,2’,4,4,5,6’-hexaBDE)

5.4
9.9
9.8
5.6

11
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12

26
34
13
20

17
9
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4.2.4 In vitro microsomal assay
For each contaminant standard mixture in the MCA, there were eight tubes: four
samples (with NADPH regenerating system) and four controls (without NADPH
regenerating system). For the ICA, three samples and three controls were run. Two
blanks (containing only buffer and microsomes) were also run with each batch of
samples. The microsomal assay followed the same procedure for the MCAs and the
ICAs. A mixture (1 ml final volume) o f buffer (80 mM NaBhPC^,

6

mM MgCl2 , 1 mM

Na 2EDTA, pH 8.0), the appropriate PCB or PBDE standard (3 pi, thus only 0.3% acetone
in the incubation mixture) and microsomal suspension

(1

mg protein) were combined on

ice. The mixtures were covered with solvent-washed foil and pre-incubated at 37 °C for 5
min. The assay was started by the addition o f NADPH regenerating solution (50 pi o f
Solution A and 10 pi o f Solution B) sequentially to all tubes and allowed to proceed for
90 min in a 37 °C, shaking (90 rpm) water bath. To control tubes (containing buffer, PCB
or PBDE standard and microsomes), 60 pi o f buffer was added instead o f NADPH.

4.2.5 Extraction o f parent and metabolite compounds
Mixed Congener Assay: For the mixed assays, depletion o f the parent PCB or
PBDE compounds was measured. The reaction was stopped after 90 min by the
sequential addition of 1 ml o f ice-cold MeOH to all tubes. The extraction procedure is
based on previously published methods (Boon et al., 1998; Li et al., 2003a). In short,
each tube was given 2 ml o f hexane, vortexed for 30 sec and centrifuged at 2500 rpm for
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5 min. The (upper) hexane fraction was collected in a new tube, and the entire procedure
was repeated three times more. The

8

ml hexane was then treated with 0.5 ml o f

concentrated H 2 SO 4 to degrade/remove residual microsomal lipids. The hexane layer was
passed through the acid layer by rocking the tube 10 times. The acid layer was then
removed, and the hexane layer was rinsed with
above pH 5 (around

6

8

ml o f H 2 O until the last aliquot was

rinsings). The tubes were capped with clean foil and stored at -2 0

°C until frozen (30 min). The hexane layer was then separated from the ice and removed
to a clean tube. A 2 ml ice-cold hexane rinsing was also transferred to the new tube. A
0.4 ml aliquot o f TMP was then added and the extract was evaporated under nitrogen to
around 0.1 ml. The contents were transferred to a GC vial and made up to 500 pi by
weight with TMP.
Individual Congener Assay: In the individual assays, it was possible to monitor
depletion o f the parent compound and formation o f potential metabolites. The incubation
reaction was stopped after 90 min by the sequential addition o f 1 ml o f ice-cold 0.5 M
NaOH to all tubes. Internal standards for the phenolic fractions were added at this point,
because their susceptibility or resistance to enzymatic conversion in this in vitro system is
not known. For PBDE assays, 2 ’-HO-BDE28 (5 pi, 206 pg/pl) was added as the internal
standard. For PCB assays, 4-HO-CB72 (5 pi, 457.5 pg/pl) was used as the internal
standard. The separation o f neutral and phenolic contaminants is based on a combination
o f previously published methods (Hovander et al., 2002; Li et al., 2003b; Rozemeijer et
al., 1997; White et al., 2000). After addition o f the appropriate phenolic ISTD, tubes were
heated at 70 °C for 10 min. Then 2 ml o f

6

M HC1 and 1 ml o f 2-propanol were added,
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followed b y vortexing for 1 min to break down proteins. Next, 2 ml o f 1:1 methyl t-butyl
ether (MtBE): hexanes were added. The tubes were vortexed for 1 min, then centrifuged
at 2500 rpm for 5 min. The (upper) organic fraction was collected in a new tube, and the
entire procedure was repeated two more times. The organic extract containing both
neutral and phenolic contaminants was then concentrated to around 1 ml. A 2 ml aliquot
of KOH was added, the tube vortexed, and the (bottom) aqueous phase containing the
deprotonated phenolics was transferred to a clean tube. This KOH partitioning step was
repeated three times. The KOH/aqueous (phenolic) fraction was rinsed with 3 x 1 ml
hexanes and the rinsings were transferred back to the organic (neutral) fraction. The
neutral fraction was then eluted through hexane-saturated Na 2 S0 4 into a clean tube. The
phenolics in the aqueous fraction were reprotonated by the addition o f approximately

20

drops o f concentrated H 2 SO4 (to a pH o f 2). A 2 ml aliquot o f 1:1 MtBE:hexanes was
added, the tube vortexed, and the (upper) organic phase was transferred though
MtBE :hexanes-saturated Na 2 SC>4 into a new tube. This procedure was repeated twice
more. The phenolic extract was then evaporated to around 0.5 ml, and treated with
diazomethane as the methylating reagent. Both fractions were evaporated to around 1 ml,
followed by the addition o f 5 drops o f concentrated H 2 SO 4 . After removal o f the acid, the
extract was neutralized with around 4 x
the hexane layer, followed by a

1

x

2

8

ml o f H 2 O. The residual water was frozen and

ml hexane rinsing, was transferred to a new tube.

Extracts were transferred into TMP and into GC vials and made up to 250 pi by weight.
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4.2.6 Analysis o f neutral and phenolic fractions
Neutral fractions, containing either PCB or PBDE congeners, were separated
using an Agilent 6890 GC (Palo Alto, CA, USA) equipped with a fused silica DB-5
column ((5% phenyl)methy!polysiloxane, 30 m x 250 pm i.d., 0.25 pm film thickness,
J&W Scientific Inc., Folsom, CA, USA), an Agilent 7683 Series automatic liquid
sampler and injector. Halogenated contaminants were monitored with a 63Ni pECD
detector. Helium and 5% methane in argon were used as the carrier and makeup gases,
respectively. For PCBs, the temperature program was as follows: 90°C for the first 1 min,
increased to 200 °C at 15 °C/min and held for 2 min, then increased further to 280 °C at
2.5 °C/min and held for 9 min. The total run time was 51.5 min. For PBDEs, the oven
temperature was held at 80 °C for 2 min, increased to 290 °C at 10 °C/min and held for
15 min, for a total run time of 38 min. HP Chemstation software was used to collect and
process data from the GC-pECD.
The phenolic fractions were analyzed for methoxylated- (derivatized from
hydroxylated-) PCBs or PBDEs on an Agilent 6890N GC system, with the same
autosampler, injector and column as described for the GC-pECD, coupled to an Agilent
5973N MSD in the electron capture, negative ionization (ECNI) mode. The MSD was
used in selected ion monitoring (SIM) mode. The carrier and reagent gases were helium
and methane, respectively. The GC ramping program for MeO-PCBs started with an
initial temperature o f 80 °C for the first minute. It was then increased at a rate o f 10
°C/min to 250 °C and held for 5 min. Another increase at 5 °C/min to 300 °C was held
for a further 5 min. The total run time was 38 min. For possible formation o f HO-PCB (as
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M eO-PCBs) metabolites, the [M]', [M+2]~ and [M-CH 3 ]' ions were selectively monitored.
For CB15, di-chlorinated MeO-PCBs were monitored (ions o f m/z: 252, 254, 237), as
well as tetra-chlorinated MeO-PCBs (ions o f m/z: 322, 324, 307) to detect the ISTD.
Further attempts to identify CB15 metabolites involved monitoring for di-chlorinated diMeO-PCBs (ions o f m/z: 282, 284, 267). For CB105 and CB118, tetra- (ISTD) and pentachlorinated MeO-PCBs (ions o f m/z: 356, 358, 341) were monitored. For MeO-PBDEs,
the same GC temperature profile chosen for the PBDEs was used. Negative Br-isotope
masses o f 79 and 81 amu were monitored, as the Br‘ fragment ion has been shown to be
highly abundant for PBDEs. A 1 pi injection, made in the splitless mode, was employed
for all samples. The MLOQ (S/N = 10) for neutral compounds, based on the response of
the ISTD CB153, was around 1 pg/pl. The MLOQs for derivatized phenolic metabolites,
based on the appropriate ISTD, was around 4 pg/pl for MeO-PCBs and 1 pg/pl for MeOPBDEs.

4.2.7 Data analysis
The results are reported as the fraction o f PCB or PBDE congener depleted
(metabolized) during the 90 min time-frame o f the microsomal assay (Boon et al., 1998;
de Boer et al., 1998; Li et al., 2003a). For each incubation (MCA or ICA), the results for
the parent PCB or PBDE congeners were first internal standard corrected:

ratiocBi53 =

peak areax

(1)

peak areacei53
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where x is a PCB or PBDE congener. The ratiocsisa for the sample replicates (to which
NADPH was added) was then compared to the ratiocBi53 for the corresponding control
replicates (to which NADPH was not added), and the fraction o f congener x remaining
after metabolism is:

fraction remaining = ratiocBi53 {sample)

(2 )

ratiocBi53 {control)

Student’s /-tests were used to determine if the sample and control groups were
significantly different from each other, assuming a two-tailed distribution and a
maximum probability o f a type-I error set to a = 0.05.
The neutral fraction recoveries are reported as the ratiocBi53 in the control divided
by the ratiocBi53 in the standard. The recoveries o f PCB and PBDE congeners from the
Mixed Congener Assay extraction were thus all above 75%, except for CB15, which had
a lower, but still reproducible, recovery o f 70 ± 7 %. The PCB and PBDE recoveries
from the Individual Congener Assay extraction were thus > 74% and > 73%,
respectively. For the phenolic fractions, the ratio o f the peak area o f either 4-MeO-CB72
or 2 ’-MeO-BDE28 in the control to that in the standard was used to calculate recoveries.
Therefore, the HO-PCB and HO-PBDE recoveries were > 73% and > 67%, respectively.
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4.3 Results
4.3.1 Microsomal protein content and enzyme activities
The hepatic microsomes o f this adult male beluga whale from western Hudson
Bay in the Canadian Arctic showed the highest catalytic viability, as measured by
CYPlA-mediated EROD activity, o f all beluga whales sampled during Arviat subsistence
hunts in the summers o f 2002 and 2003 (McKinney et ah, 2004b). Putative CYP3Amediated

testosterone

6|3-hydroxylase

and

phase

II

UDPGT -mediated

1-

naphthylglucuronidase rates in this individual were, though, similar to rates among the
other belugas sampled (McKinney et al., 2004b). Elevated protein levels and CYP1A
activity in this male are likely, in part, due to the fact that most other belugas sampled
were females, which generally exhibit lower expression o f CYP1A than males (White et
al., 1994). As well, a shorter time span between sacrifice and liver sampling for this
individual than for some o f the other animals may have contributed. Overall, this
individual exhibited reasonable induced-type (CYP1A) and constitutive-type enzyme
(CYP3A-like) hepatic enzyme activities and was therefore an appropriate choice for the
study o f PBDE and PCB metabolism within the time constraints o f a 90 min in vitro
assay. Table 4.2 compares some CYP enzyme activities between this male beluga whale
and the (pooled) male rat liver microsomes.

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

134

Table 4.2. Phase I cytochrome P450 activities in male beluga and male rat liver
microsomes.
Enzyme Activity (pmol/mg/min)
(CYP measured)*

Male beluga** (n = 1) Male rat*** (pooled, n = 25)

Total spectral P450 (pmol/mg)

240

590

Ethoxyresorufin O-deethylase
(CYP1A)

260

120

Androstenedione formation
(from testosterone)
(CYP2B/2C/3A)

70

NA

Testosterone 16a-hydroxylase
(CYP2C)

ND

3400

Testosterone 6p-hydroxylase
(CYP3A)

560

3700

ND = not detected
NA = not available
*For belugas, specific CYP isozymes have not been confirmed to mediate particular
testosterone metabolism activities. CYPs indicated in parentheses are involved in this
conversion in laboratory rodents (Arlotto et al., 1991)
**McKinney et al., 2004b.
***Gentest, Wobum, MA, USA.
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4.3.2 In vitro PBDE metabolism
W ithin the MCAs, beluga whale and rat liver microsomes were able to metabolize
the PBDE mixture to different extents within the 90 min time frame o f the in vitro assay
(Fig. 4.1). Dibromo-BDEIS was completely depleted by the beluga, and 11% o f BDE28
was also metabolized to a significant extent ip < 0.05). However, the beluga whale did
not significantly metabolize the other PBDE congeners, specifically BDE49, 99, 100,
153, 154 and 183. In contrast, the rat biotransformed BDE28, 49, 99 and 154 (13%, 44%,
11% and 17% depleted, respectively) to a significant extent. Thus, although both
organisms showed comparable metabolic capacity towards tri-BDE28, the beluga more
rapidly metabolized BDE15, and the rat exhibited more rapid metabolism o f the higher
brominated PBDE congeners (BDE 49, 99 and 154). BDE47 was also included in the
Mixed Congener Assay; however, the MCA extraction procedure introduced either a
peak to the chromatogram that interfered with BDE47 or BDE47 contamination itself.
Although background correction was included, depletion results were inconsistent for
BDE47 (data not shown). As shown later in the ICAs, the BDE47 contamination issue
did not arise and therefore satisfactory results could be obtained for this congener.
In the ICAs, BDE 15 was again rapidly metabolized, but to a lesser extent than in
the MCA, which is probably a consequence o f a higher treatment concentration in the
ICA (Table 4.3). The concentration o f BDE28 used in both conditions was nearly the
same, and the fraction o f BDE28 remaining was nearly identical under both assay
conditions (89 ± 3 % for MCA and 90 ± 1% for ICA). In the ICAs, BDE47 was slightly
but significantly metabolized within the 90 min period. BDEs 99 and 154 were not
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Br2

Br3

Br4

Brs

Br6

Br?

Fig. 4.1. Fraction o f BDE congener concentrations remaining after a 90 min in vitro
metabolism assay using hepatic microsomes from adult male beluga whale (white bars, n
= 1 individual) and adult male rat (black bars, 1 pool o f n = 25 individuals). The dotted
line signifies no depletion. Significant depletion (p < 0.05) is marked by an asterisk. Error
bars represent ± S.D. for replicate assays (n = 4).
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Table 4.3. The concentration fraction remaining for PBDE congeners after metabolism in
Individual Congener Assays (ICAs) by adult male beluga whale (n = 1). Statistical
significance o f the depletion was reported as the j>value obtained from a Student’s t-test
comparing ratiocBi53 between sample (n = 3) and control (n = 3) groups.
PBDE Congener

Fraction Remaining ± S.D.

Statistical significance (p-value)

BDE 15

37 ± 10%

0.001*

BDE28

90 ± 1%

0.007*

BDE47

95 ± 3%

0.05*

BDE99

99 ± 3%

0.8

BDE 154

103 ± 5 %

0.6

*Indicates statistically significant depletion.
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significantly metabolized as individual congeners, which is in agreement with the MCA

results.
The presence of HO-BDE metabolites was assessed as a result of in vitro PBDE
metabolism. For all BDEs in the ICAs, any phenolic metabolites (e.g. mono- or di-HOCBs) potentially formed from the small amounts o f BDE28 and BDE47 metabolism
observed w ere below the MLOQ (1 pg/|il based on ISTD). The lone exception was
BDE15, where a single phenolic metabolite o f BDE 15 was detected in the phenolic
extract from the microsomal incubation (Fig. 4.2). In the neutral fractions from the ICAs
o f PBDEs, debrominated or methoxylated metabolite peaks were not observed in the
ECD chromatograms (not shown). Even though 63% o f BDE 15 was depleted, the
phenolic BDE metabolite had a S/N ratio o f only 16, where the method limit o f
quantification is set to S/N =1 0 . Thus, it is unlikely that BDE28 or BDE47 metabolites
could in fact be detected given the slower rates o f biotransformation o f BDE28 and
BDE47 in comparison to BDE15.
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Fig. 4.2. Extracted ion (m/z 79) chromatograms o f phenolic extracts from an in vitro
metabolism assay o f BDE 15 with beluga whale hepatic microsomes. Samples were
incubated with the cofactor NADPH, whereas NADPH was not added to controls.
Comparative EIC mass chromatograms o f m/z 81 gave the same result (not shown).
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4.3.3 In vitro PCB metabolism
As for PBDEs, the beluga whale and the rat showed congener-dependent
differences in the ability to deplete in vitro the PCB congeners present in the MCAs (Fig.
4.3). CB15 and CB77, substrates o f CYP1A, were the most rapidly metabolized (0% and
7% remaining, respectively) PCB congeners in beluga whale, whereas 68% o f CB15 and
100% o f CB77 remained after incubation with the rat microsomes. CB52 was partially
metabolized by both rat and beluga, but the rat more rapidly depleted this Group IV,
putative CYP2B-type substrate (49% cf. 87% remaining). Beluga whale and rat
comparably metabolized the Group VI, mixed CYPlA/2B-type substrate tri-CB31, at
29% and 33% depleted, respectively. Rat exhibited a greater metabolic capacity towards
the other Group VI congener, CB26, than beluga whale 79% versus 25% depleted).
Penta-CBlOl and penta-CB105 (Groups IV and III, respectively) were not metabolized
significantly by either beluga whale or rat.
For beluga whale, we also ran ICAs for CB15, CB105 and CB118. Previous
contaminant residue studies showed that some o f the major HO-PCB residues found in
the liver tissues o f beluga whales were likely metabolites o f CB105 and CB118
(McKinney

et

al.,

2004a).

CB118

was

slowly,

but

nonetheless

significantly

biotransformed by beluga whale (Table 4.4). Any pentachloro-HO-PCB metabolites that
may have formed were below the MLOQ (4 pg/pl based on ISTD). As in the MCA,
metabolism o f CB105 was too slow to be detected in the assay (Table 4.4), and
pentachloro-HO-PCB metabolite peaks were below the MLOQ in the phenolic fractions.
Although CB15 was rapidly metabolized as in the MCA (although less depletion in the
ICA is more than likely due to a higher starting concentration than in the MCA, as seen

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout perm ission.

/A

N°N

G9

&

n <o

G^

4 o,m

2 o,m

2 o,m

0 o,m

0 o,m

1 o,m

2 o,m

0 m,p

0 m,p

0 m,p

2 m,p

1 m,p

2 m,p

1 m,p

Oo-Cl

Oo-Cl

1 o-CI

2 o-CI

2 o-CI

1 o-CI

1 o-CI

III

IV

VI

Fig. 4.3. The concentration fraction remaining for the PCB congeners after a 90 min in
vitro metabolism assay using liver microsomes from adult male beluga whale (white bars,
n = 1) and adult male rat (black bars, n = 25). No depletion is indicated by the dotted line.
Significant depletion (p < 0.05) is indicated by dotted bars and asterisks. Error bars
represent ± S.D. between replicates (n = 4).
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Table 4.4. The concentration f r a c t i o n remaining for PCB congeners after metabolism in
Individual Congener Assays by adult male beluga whale (n - 1). Statistical significance
o f the depletion was reported as the j?-value obtained from a Student’s t-test comparing
ra tio c B i5 3 between sample (n = 3) and control (n = 3) groups.
PCB Congener

Fraction Remaining ± S.D.

Statistical significance (p-value)

CB15

9 ± 2%

CB105

100 ± 3 %

0.79

CB118

98 ± 1%

0.03*

0.000005*

*Indicates statistically significant depletion.
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for BDE 15), no metabolite peaks could be detected measuring for methylated derivatives
o f mono-HO-dichloro-CBs (m/z 252, 254, 237). However, when run for di-MeOdichloro-CBs, a small peak was found indicating the metabolic conversion o f CB15 to a
di-HO-dichlorinated PCB metabolite.

4.4 Discussion
Reports that demonstrate the metabolic biotransformation o f PCBs in marine
mammals are limited in number, generally focussing on only one or two specific
congeners, i.e., CB77 and CB52 (Murk et al., 1994; White et al., 2000) or PCB congener
mixtures (Lecher et al., 1998; Li et al., 2003a). For fish there are published reports
showing PBDE metabolism (oxidative and debromination) in vivo (Kierkegaard et al.,
2001; Stapleton et al., 2004a,b), but there are no reports as yet for PBDEs in marine
mammals, especially cetacean species (Hakk and Letcher, 2003). We report and compare
the metabolism o f a suite o f PCB and PBDE congeners in the hepatic microsomes of
beluga whale, and compare these to analogous results determined at the same time in rat.
In addition to quantifying the extent o f metabolism o f the parent compounds, we
monitored the potential formation o f neutral/lipophilic and water-soluble metabolites.

4.4.1 Biotransformation o f PBDEs in beluga whale
To our knowledge, this is the first report demonstrating direct evidence o f PBDE
metabolism in any mammalian wildlife species (Hakk and Letcher, 2003). Our findings
suggest a role for liver CYP isozymes in the toxicokinetics o f PBDEs in beluga whales.
Previous studies demonstrated low, but measurable levels o f HO-PCB and putative HO-
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PBDE metabolite residues in the liver tissues o f beluga whales from two Canadian
populations (McKinney et al., 2004a). Bioaccumulative MeSCVPCB metabolites were
found at much higher levels in the same liver samples. Within the limited time frame o f
an in vitro assay, beluga whale significantly metabolized di-BDE15, tri-BDE28 and tetraBDE47. For at least one congener (BDE15), metabolism resulted in the formation o f a
water-soluble, phenolic BDE metabolite. Since the anions o f the isotopes 79Br' and 81Br'
were monitored, the phenolic metabolite could be singly or multiply hydroxylated, and
could possibly contain only one bromine atom as a result o f metabolic debromination.
One potential explanation for such a small phenolic BDE metabolite response m ay be the
consequence o f full metabolic debromination with hydroxylation, which would have
resulted in no detectable Br-anion fragments. The extent o f depletion o f PBDE congeners
seemed to be inversely associated to the degree o f bromination o f the aromatic rings.
Other structural factors are likely also involved, such as the position o f bromine atoms
around the aromatic rings. BDE 15, 28 and 47 have four, three and two pairs o f orthometa vicinal H-atoms, respectively, suggesting that the number o f ortho-meta
unsubstituted sites influences metabolic capacity towards PBDEs. In further support o f
this, tetra-BDE47 was slightly but significantly depleted by beluga, whereas metabolism
o f tetra-BDE49 was not detectable. Non-ortho-HO-PBDE metabolites found previously
in beluga liver tissues were likely metabolites o f the most biologically important PBDE
congener, BDE47 (McKinney et al., 2004a). Both BDE47 and BDE49 contain two ortho
Br-atoms, but BDE47 contains two ortho-meta vicinal H-atom pairs, whereas BDE49
contains one ortho-meta and one meta-para unsubstituted site.

These results parallel
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PCB metabolism findings in that beluga whale show greater metabolic capacity towards
congeners w ith (more) ortho-meta unsubstituted sites {Section 4.4,2; White et al., 2000).
The differential capacity o f the beluga whale to metabolize the PBDEs studied
suggests unequal CYP enzyme affinity for different congeners or perhaps the
involvement o f various/multiple CYP isoforms. That metabolic rates o f the two
significantly depleted congeners, BDE 15 and BDE28, in the MCA assay were not slower
than in the ICA suggests that these two congeners may not have been competing for the
same CYP isozyme. Both the beluga whale and the rat were able to metabolize PBDEs,
but there were clear species-specific differences in the ability to metabolize individual
congeners. This is likely due to species differences in CYP isozyme expression and
activities (Table 4.2; Boobis et al., 1990; Smith, 1991).
It has been suggested that PBDEs are very resistant, more resistant than PCBs, to
metabolic degradation in marine mammals (de Boer et al., 1998). The present study
provides evidence that for lower halogenated congeners in the same isomer class
(specifically, di-CBs cf. di-BDEs and tri-CBs cf. tri-BDEs), beluga whale show congenerspecific, but nonetheless comparable capacities to biotransform PBDEs and PCBs. Also,
both PBDE and PCB congeners o f higher degrees o f halogenation are metabolized much
less rapidly, resulting in slow or negligible metabolism in the time frame o f the in vitro
assay. Harbour and ringed seals did not exhibit detectable metabolism o f highly
chlorinated PCBs in similar in vitro assays (Letcher et al., 1998; Li et al., 2003a).
Nonetheless, these results do not suggest the inability o f beluga whale to biotransform
higher brominated PBDE congeners. This result more likely suggests that slower
metabolic transformation o f such PBDEs cannot be detected within the time constraints
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o f the microsomal assay, a finding similar to that for PCB metabolism {Section 4.4.2).
Indeed, evidence o f metabolism o f PBDEs o f greater degrees o f halogenation is provided
by tissue residue analyses. HO-PBDEs have been found in the liver tissues o f beluga
whales, which appeared to be metabolites o f BDE47 (McKinney et ah, 2004a). However,
these HO-BDE metabolites were only detectable and not quantifiable. Low levels o f
mainly tetrabromo-mono-HO-BDE residues have been found in the blood plasma (likely
the most important compartment for HO-PBDE retention) o f a limited number o f other
wildlife species, i.e. Detroit River fish (Letcher et al., 2003; Valters et al., 2004) and
snapping turtle (Chu et al., 2004), killer whale (Bennett et al., 2003) and Baltic salmon
(Asplund et al., 1999). The source o f the observed HO-BDEs may be both metabolic or
accumulated through diet. Additional, direct evidence for the formation o f HO-PBDE
metabolites comes from dosing studies using experimental rodents, in which metabolism
can be measured on a scale o f days and not minutes. Hydroxylated metabolites formed
from tetra-BDE47 (Om and Klasson-Wehler, 1998), penta-BDE99 (Hakk et al., 1999),
penta-BDElOO (Hakk et al., 2004) and even deca-BDE209 (Morck et al., 2003) have
been detected in rat and/or mouse.
In the only other study o f PBDE metabolism in marine mammal species, de Boer
et al. (1998) did not detect depletion o f BDE47, 99 or 209 congeners in sperm whale
(Physeter macrocephalus), whitebeaked dolphin {Lagenorhyncus albirostris), minke
whale (Balaenoptera acutorostrata) or harbour seal {Phoca vitulind) using a similar in
vitro assay. We also did not find any detectable in vitro metabolism o f congeners with 5
or more bromine atoms, consistent with their BDE99 and 209 results. This was the case
under both the MCA and ICA regimes in our study, suggesting that it is the slow or
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negligible biotransformation o f such congeners in the assay and not competition with
lower brominated congeners that prevented detection o f parent depletion or metabolite
formation, as found in analogous PCB studies with Baltic grey seal (Li et al., 2003a).
Detectable metabolism o f BDE47 in the present study o f beluga whale, but not by
organisms in the de Boer et al. (1998) study, may be due to a somewhat higher metabolic
capacity o f beluga towards this environmentally-dominant PBDE, although variations in
assay conditions may also be partially responsible. In vitro BDE47 metabolism may
suggest that retained, hydroxylated forms o f BDE47 (3-HO-BDE47, 4 ’-HO-BDE49)
reported at low levels in liver tissues (McKinney et ah, 2004a) are the result o f
biotransformation o f BDE47 in beluga whales.

4.4.2 Biotransformation o f PCBs in beluga whale
CYP isoforms have previously been implicated in the metabolism o f CB77 and
CB52 in beluga whale (White et al., 2000). Here, we find that isozymes from the CYP
family are also involved in the biotransformation o f a number o f other PCB congeners,
representing different metabolic classes (Boon et ah, 1997), as seen in grey and harbour
seals (Letcher et al., 1998; Li et ah, 2003a). However, the differential rates o f metabolism
of PCB congeners between and within metabolic groups (Fig. 4.3) imply the involvement
o f various isozymes (e.g. CYP1A, CYP2B, CYP3A) and differential enzyme affinities
between PCB congeners, respectively. The use o f CYP-specific chemical and/or antibody
inhibitors would further clarify the involvement o f specific CYP isozymes in the
metabolism o f individual congeners (Letcher et ah, 1998; Kramer et ah, 2000; van Hezik
et ah, 2001; Li et ah, 2003a).
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Previously, penta- through hepta-chlorinated HO-PCB residues were detected in
beluga w hale hepatic tissue (McKinney et ah, 2004a). However, in the present in vitro
assay very slow to undetectable rates o f metabolism were observed for higher chlorinated
PCB congeners (CB101, CB105 and CB118). In contrast, the di- through tetrachlorinated congeners all showed significant depletion in the 90 min assay, but such HOPCB metabolites o f these congeners are not generally found as tissue residues, suggesting
that these metabolites are rapidly excreted, and do not show significant tissue retention.
Significant metabolism o f CB118 in the present study supports the hypothesis that the
presence o f higher-chlorinated, toxicologically active HO-PCBs as contaminant residues
in beluga whales and in other marine mammals tissue is due to oxidative CYP
biotransformation enzyme activities in liver tissues.
For the rapidly metabolized CB15, we were able to detect the formation o f a diHO-PCB metabolite. In a previous study o f CB77 metabolism in beluga whale liver, only
mono-HO-PCB type metabolites were found, even though di-hydroxy, sulfonated and
(mono- and di-) hydroxylated m/z were monitored (White et al., 2000). In addition, only
mono-HO-PCBs were found in liver extracts o f fish (White et al., 1997) and laboratory
rodents (Klasson-Wehler et al., 1989). However, CB15 is co-planar and has four, orthometa vicinal H atom pairs. It is likely that after a single (meta or para) hydroxylation, the
mono-HO-dichloro-CB metabolites would still be somewhat coplanar (especially in
comparison to higher chlorinated congeners used in the previous studies), and thus still
good substrates for a second CYP 1A-mediated hydroxylation to occur.
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4.5 C onclusions
Here we show, within the limited time frame o f an in vitro microsomal
assay, direct evidence of congener- and species-specific cytochrome P450 mediated
metabolism o f PBDEs and PCBs in beluga whale (cf. in rat). This pathway in addition to
other metabolic processes may influence not only the rates o f accumulation and
elimination o f these contaminants, but also potential biological effects. Highly exposed
populations, such as the St. Lawrence beluga whales, may exhibit elevated, induced
biotransformation capacities, possibly resulting in the formation o f retained metabolites.
As the body burdens o f PBDEs rise in beluga whales and in other sensitive marine
mammal populations, further research is imperative to reach a better understanding o f the
kinetics and potential toxicological outcomes o f these flame retardant chemicals and their
retained metabolites.
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CHAPTER 5
Conclusions

The biological fate and effects o f organic environmental pollutants are contingent
upon

the

specific

metabolic

capacity

of

an

organism.

Ideally,

contaminant

biotransformation is investigated in vivo, but this research requires an alternate approach
when marine mammals are the organisms o f study. In this thesis, a “weight o f evidence”
approach was used to assess the hepatic capacity and potential o f beluga whale to
enzymatically biotransform PCBs and PBDEs. Three separate studies were employed to
address this objective: (1) profiling o f xenobiotic-metabolizing enzymes, (2) identifying
and quantifying PCB, PBDE and metabolite residues and (3) assessing metabolic
potential o f beluga towards environmentally-relevant PCB and PBDEs using an in vitro
microsomal assay. The overall important conclusions from these studies are summarized
here.
In the first study, immunochemical and catalytic investigations revealed that
beluga whales exhibit analogous hepatic enzyme activity to, and homologous proteins of,
hepatic phase I (CYP1A, CYP2B, CYP3A, CYP2E, EH) and II (UDPGT) enzymes
known to metabolize PCBs and/or PBDEs in laboratory rodents (Chapter 2). However,
the levels and activities o f these putative xenobiotic-metabolizing enzymes appeared to
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be dissimilar between the two populations o f differentially exposed beluga whales (St.
Lawrence and western Hudson Bay beluga whales), as well as different from those found
in laboratory rodents. Results suggested higher levels o f inducible (AhR-receptor
mediated) CYP1A in St. Lawrence animals relative to their Arctic conspecifics, and this
finding m ay be related to the reported toxic effects of organohalogens in the St. Lawrence
population (e.g. immune and reproductive dysfunction, lesions). As for other cetacean
populations, CYP2B-type activities and expression were low, supporting the hypothesis
that low levels o f these enzymes explain, in part, higher levels o f certain contaminants in
whales.
In the second study, retained and/or persistent toxic metabolites o f PCBs,
hydroxylated- and methyl sulfonated-PCBs, were detected in both populations (Chapter
3). Significantly higher levels o f HO-PCBs and MeS02-PCBs were found in the St.
Lawrence population. In addition, different parent PCB congener profiles were observed
between the two populations. These results may be related to the (possibly induced)
elevated enzyme activities (Chapter 2) and to the elevated exposures o f PCBs (Chapter 3)
in the St. Lawrence population. The low to non-detectable concentrations o f HO-PBDEs
in both populations may be due to the currently lower levels o f precursors, the PBDEs, in
STB and CAB in comparison to PCBs; yet, the relative importance o f metabolic
formation from PBDEs versus accumulation o f natural products remains unclear.
Nonetheless, in the relatively short time frame o f an in vitro assay, metabolism o f
BDEs 15, 28 and 47 occurred (Chapter 4). This clearly demonstrated CYP-mediated
oxidative biotransformation as a pathway in the toxicokinetics o f PBDEs in beluga
whales. Hepatic metabolism o f a number o f PCBs, putative substrates o f CYP1A and
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CYP2B/3A, also occurred in beluga whale in the same in vitro assay. This suggested
similarities between PCB and PBDE metabolism in this particular cetacean species. In
addition, water-soluble metabolites were found after incubation with the rapidly
metabolized PCB and PBDE congeners, CB15 and BDE15. Both beluga whale and rat
metabolized PCBs and PBDEs, however, there was a preference towards metabolism o f
ortho-meta unsubstituted congeners (of both PCBs and PBDEs) in beluga whale, whereas
rat metabolized meta-para unsubstituted congeners more rapidly. This is in agreement
with the low levels and activity o f CYP2B enzymes that we found in beluga whales
(Chapter 2).
Overall, the weight of evidence from Chapters 2 to 4 indicated that beluga whales
exhibit an exposure-influenced capacity to oxidatively biotransform PCBs. The results
also demonstrated that congener-specific metabolism likely leads to the formation o f
retained and/or persistent and potentially toxic PCB metabolites. Beluga whales also
demonstrate the capacity to oxidatively metabolize PBDEs. However, the importance o f
metabolism as a mechanism in fate and potential bioactivation o f PBDEs in beluga
whales remains unclear because o f the positive evidence o f PBDE metabolism in vitro
(Chapter 4), but the very low levels o f HO-PBDEs detected as liver residues (Chapter 3).
Regardless, beluga whales (particularly SLB) are chronically exposed to a continually
increasingly complex mixture o f contaminants, including those yet to be identified and
secondary bioactivated contaminants i.e. metabolites. A high incidence o f neoplasms,
reproductive and immune dysfunction have been found in SLB, and similar toxic effects
have been demonstrated in animals experimentally exposed to PBDEs, PCBs, other
organohalogens and/or their metabolites. The biotransformation o f PCBs (and possibly
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PBDEs) to biologically active metabolites, demonstrated in this thesis, suggests a
bioactivation mechanism in the possible toxic effects o f these contaminants. Moreover,
these results provide a possible mechanistic link between high contaminant exposures
and the health problems and pathologies documented in the endangered St. Lawrence
beluga whale population.
The results from these studies presented herein have generated further questions,
especially regarding the toxicokinetics o f PBDEs in marine mammals. Elevated levels o f
PCBs and other OCs in St. Lawrence beluga whales have been implicated in the various
pathologies seen in this population. These beluga whales showed 42 fold higher
concentrations o f PBDEs versus only 16 fold higher concentrations o f PCBs than in the
Arctic belugas (Chapter 3). This significantly elevated exposure o f SLB to PBDEs
indicates the need to examine their toxicokinetics and potential toxicities in SLB in
particular. There are a growing number o f studies reporting PBDE concentrations in other
marine mammals as well, but the fate and toxicology o f these contaminants in such
organisms remains virtually unknown. For instance, what are the CYP enzymes involved
in PBDE metabolism? Biotransformation assays with CYP-specifxc chemical and
antibody inhibitors would clarify the role o f different CYP isozymes. Do PBDE
congeners induce or inhibit CYPs, UDPGTs, or GSTs in beluga whales? If so, which
congeners are most important in mediating these effects? In addition, are the low levels
o f HO-PBDEs due their rapid phase II conjugation and subsequent elimination, or due the
biological persistence of, at least, certain parent PBDE congeners? How do the rates o f
HO-PBDE conjugation compare to those for HO-PCBs? These questions warrant further
research, which may also illuminate the potential influence o f PBDEs, as well as PCBs
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and metabolites, on hormones and receptors o f the endocrine system. For instance, as has
been seen in seals, do current (and possible future) concentrations o f PBDEs influence
the levels o f thyroid hormones in this population? Further studies clarifying the origin(s)
o f HO-PBDE, such as time-trend studies or !4C analysis o f extracted HO-PBDEs, are also
o f importance.
The health and ultimate survival o f sensitive and highly contaminated populations
(such as St. Lawrence belugas) may be impacted by chronic exposure to PCBs and
PBDEs and an increasingly complex mixture o f other pollutants. The studies in this thesis
and other similar research will aid in clarifying risks to marine m ammals (as well as to
other biota and humans) posed by exposure to these contaminants. A better understanding
o f the current impact and future risks o f such biological contamination will allow for
more informed decisions as to the production and use o f chemicals with demonstrable
PBT characteristics in the future.
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